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The principal methylglyoxal (MG)-detoxifying system in most living organisms is the two-
metalloenzyme Glyoxalase system. Glyoxalase I (GlxI) initially converts the non-enzymatically 
formed MG-GSH hemithioacetal to the thioester S,D-lactoylglutathione. The hydrolase, Glyoxalase II 
(GlxII) regenerates GSH and liberates the product D-lactate. Ni2+/Co2+- and Zn2+-activated GlxI 
enzymes exist in nature. The Ni2+/Co2+-activated GlxI are not active as Zn2+-holoenzymes in spite of 
the structural similarities to the Zn2+-dependent enzymes. The Zn2+-GlxI enzymes have been 
investigated heavily relative to the Ni2+/Co2+-activated enzymes, which have been isolated more 
recently.  As part of this study the three GlxI homologs isolated from Pseudomonas aeruginosa were 
characterized. The homologous genes encode GlxI enzymes of both metal activation type.  The Zn2+-
activated P. aeruginosa GlxI is difficult to de-metallate compared to the Ni2+/Co2+-activated enzymes, 
reflecting a difference in metal-binding/insertion between the two types of GlxI. The E. coli GlxII 
was isolated and characterized to determine whether Ni2+/Co2+-activation is a characteristic of the Glx 
system as a whole in this organism. Inductively coupled plasma mass spectrometry on purified E. coli 
GlxII confirms that the active protein is a binuclear Zn2+-metalloenzyme.  The results to date indicate 
a detectable isotope effect for the Cd2+-holoenzyme but not the Ni2+-reconstituted enzyme. Chemical 
crosslinking experiments indicate that the SlyD Ni2+ metallochaperone does not form a complex with 
E.coli GlxI. This indicates that the E. coli active site is not metallated in vivo by this accessory 
protein. The principal biophysical experiment in this project was determining of Ni2+-binding 
stoichiometry for E. coli GlxI by 1H-15N heteronuclear single quantum coherence (HSQC) NMR. The 
GlxI dimer reorganization ceases when the metal:dimer stoichiometry reaches 0.5 during apoenzyme 
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Chapter 1  
Review of the Glyoxalase System and Project Synopsis 
1.1  The Glyoxalase System and Methylglyoxal Toxicity 
The glyoxalase (Glx) system is a well-studied carbon metabolism pathway conserved in many living 
organisms. This enzyme system is generally considered a major detoxification pathway of cytotoxic 
methylglyoxal (MG) and related α-ketoaldehyde substrates (10).  There are two metalloenzymes that 
comprise the Glx system and the tripeptide glutathione (GSH) participates in the reactions as a co-
substrate (Figure 1.1) (11). Glyoxalase I (GlxI: S-D-lactoylglutathione methylglyoxal lyase 
(isomerizing) E.C. 4.4.1.5) converts the hemithioacetal of MG and GSH to the corresponding 
thioester S-D-lactoylglutathione (Figure 1.1). The MG-GSH hemithioacetal is formed non-
enzymatically prior to enzymatic conversion.  The second enzyme in the pathway Glyoxalase II 
(GlxII: S-2-hydroxyacylglutathione hydrolase E.C. 3.1.2.6) hydrolyzes the thioester to generate the α-






































Figure 1.1: The reactions of the Glyoxalase system 
 
 2 
α-Ketoaldehyde byproducts are potent electrophiles that are deleterious to biological systems, 
because of their propensity to form covalent adducts with protein and nucleic acid molecules (12, 13). 
Adduct formation is due to the tendency of the aldehydic group of α-ketoaldehydes to undergo attack 
by a nucleophile (See structure of MG in Figure 1.1).  
Protein glycation is a consequence of MG reactivity that constitutes a form of long-term 
tissue damage in diabetic pathologies (14). Cysteine, lysine and arginine residues in proteins are 
particularly prone to MG modification (15, 16). Irreversible covalent adducts formed by the 
interaction of MG with protein are called "advanced glycation end products” or AGE's (17).  The 
conversion of a protein to an AGE frequently eliminates or reduces function of the molecule.  
Arginine is the most commonly observed site of modification and a recent study of MG-modification 
on human hemoglobin demonstrates that this residue is most frequently converted into a 
hydroimidiazolone derivative (18). 
The guanidine modification of tobacco mosaic virus ribonucleic acid (RNA) is one of the 
earliest documented examples of MG-dependent nucleic acid adduct formation (19). Krymkiewicz, 
Zwaig and Dieguez characterized the deleterious effects of RNA and DNA adduction by MG during 
the 1970’s. These two research groups resolved that MG toxicity inhibits protein synthesis as a 
consequence of nucleic acid modification at the genetic level (DNA) and transcriptional (mRNA) 
level (20). Since then, small molecule analysis techniques such as mass spectrometry have enhanced 
detection of MG modification on genomic and transcript material.  For instance, Frischmann et al. 
have detected the formation of N2-1-carboxyethyl)-2’-deoxyguanosine following the incubation of 
salmon sperm DNA with MG at physiological concentrations (10 µM) at 37 degrees Celsius (21).  
The identification of guanosine adducts in this study was possible because the investigators used 
liquid chromatography mass spectrometry to analyze the DNA.   
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1.2 Non-Glx Pathways for MG Detoxification 
The glyoxalase enzymes in mammalian systems are the predominant methylglyoxal detoxifying 
components in liver tissue.  A different enzyme called aldose reductase (AR) also detoxifies MG in 
eukaryotes. This enzyme has been identified in mammals and Saccharomyces cerevisiae (14, 22).  
AR is expressed at relatively higher levels in cardiovascular and renal tissues of multi-organ system 
eukaryotes.  This enzyme is an NADPH-dependent aldo-keto reductase that converts MG to acetol.  
AR can be considered an extrahepatic detoxification system for diverse aldehyde-containing 
substrates.  The products of reduction are the corresponding alcohols of the substrates.  AR can 
reduce glucose, catecholamines and steroid metabolites to sorbitol, phenylglycol derivatives, and 
androstandiol derivatives respectively (23, 24, 25, 26).   
 Recently Yabe-Nishimura and co-workers were able to demonstrate upregulation of AR 
activity in response to physiologically relevant MG concentrations (27).  Their experimental system 
involves incubating isolated rat aortic smooth muscle cells with MG.  They observed an increase in 
the amount of AR-encoding mRNA transcript generated by the cells exposed to MG.  The increase in 
the amount of AR-encoding transcript was proportional to MG exposure time as well as dosage.  
Additionally AR activity levels and protein quantity (as assessed by Western blot analysis) increased 
with longer MG exposure times.   
Another interesting finding is that intracellular reactive oxygen species (ROS) production 
increases following MG exposure, but precedes transcriptional induction of AR by several hours (27).  
This observation suggests that MG may mediate AR induction with ROS as the signaling molecule(s) 
for the process.  Finally Yabe-Nishimura and co-workers noted that the p38 kinase pathway might be 
involved in AR regulation in response to MG stress.  Thus, AR constitutes a secondary, thiol 
independent route for MG detoxification that may be more important for responding to MG stress 
outside of the liver.   
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1.3 Metabolic Routes of MG Production 
The origin of MG in biological systems can be attributed to several metabolic sources.  Enzymatic 
routes of production include, direct enzymatic formation (from MG synthase), amino acid 
degradation, cytochrome P450 IIE1 isozymes and amine oxidases.  The triosephosphate isomerase 
(TIM) reaction in the glycolytic pathway can produce MG as an unwanted side reaction and this will 
be discussed in the following section. 
1.3.1 MG Formation by Triose Phosphate Isomerase 
The glycolytic enzyme TIM normally catalyzes the interconversion of dihydroxyacetone phosphate 
(DHAP) and glyceraldehyde-3-phosphate.  The reaction typically proceeds via the formation of an 
enediolate intermediate.  However the TIM-catalyzed reaction can result in an unwanted side reaction 
where inorganic phosphate is eliminated from the intermediate resulting in the generation of MG 
(Figure 1.2) (28).  This elimination mechanism may occur at a sufficient frequency that cells could 
accumulate MG at a rate of 0.4 mM/cell/day (28).  This reaction constitutes a significant contribution 















































Figure 1.2: TIM-catalyzed isomerization and elimination reactions  
 
1.3.2 MG and the Glycolytic Bypass 
One of the most interesting aspects of MG metabolism is that production of this toxic electrophile 
may be metabolically relevant to some organisms.  The enzyme MG synthase catalyzes the formation 
of MG from dihydroxyacetone phosphate with liberation of inorganic phosphate (29).  MG synthase 
was first isolated from E. coli, but has also been purified from Saccharomyces cerevisiase, 
Pseudomonas saccharophila, goat liver and Clostridium acetobutylicum (30, 31, 32, 33).  Inorganic 
phosphate (Pi)  is an allosteric inhibitor of MG synthase. The enzyme is also negatively regulated by 
3-phosphoglycerate, phosphoenolpyruvate and pyrophosphate, but not to the same extent as with Pi 
(30). In organisms possessing MG synthase, the enzyme is thought to function within a metabolic 
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pathway that bypasses phosphorylating glycolysis (Figure 1.3) (34, 35).  The bypass functions under 
conditions of intracellular Pi limitation, such that there is an accumulation of DHAP.  Consequently 
MG synthase activity increases, so that there is an increased amount of intracellular MG.  The MG 
can be converted to pyruvate via the glyoxalase system enzymes and D-lactate dehydrogenase, 
thereby conserving the existing pool of Pi within the cell (Figure 1.3).  The bypass enzymes therefore 
constitute a non-phosphorylating means for producing the end glycolytic product, pyruvate. 
1.3.3  MG Formation during Amino Acid Degradation  
The glyoxalase system is also proposed to play a role in amino acid degradation. Glycine and 
threonine degradation yields the product aminoacetone (1). The accumulation of methylglyoxal has 
been observed during the feeding of S. cerevisiae of L-threonine as a nitrogen source and also in goat 
plasma (36, 37).  Investigation of methylglyoxal production from aminoacetone suggests that 
conversion occurs using the enzyme monoamine oxidase (Figure 1.3) (Elliot 1959, (38). The 
existence of amine oxidases that produce methylglyoxal has been confirmed in Saccharomyces 
cerevisiae and Staphylococcus aureus (36, 39).  
1.3.4 Cytochrome P450-Catalyzed MG Production 
Isozymes of the cytochrome P450 IIEI subfamily are also capable of producing MG from 
acetone as part of the gluconeogenic pathway (See Figure 1.3)(40). Acetone-converting 
monooxygenases were characterized as part of this pathway from analysis of hepatic microsomes 
from rats that consumed acetone in drinking water. The analysis revealed the presence of an acetone 
monooxygenase that converts acetone to acetol (See Figure 1.4). A second acetol monooxygenase 
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Figure 1.3: Summary of MG sources in living systems. This diagram was adapted from (1). 
 
1.4 Microbial GlxI enzymes with Alternative Roles in Cellular Physiology 
A number of putative glyoxalase-like proteins have been identified recently as gene products that are 
upregulated in expression during colonization activities by prokaryotic pathogens.  The host 
specificity of these bacterial species is quite diverse as they include plant and human pathogens.  
These recent investigations are stimulating additions to this research area because they connect the 
Glx system to cellular functions other than MG detoxification.  These novel contexts for the Glx 
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system include type III secretion, host-cell colonization, and acid tolerance as described in the 
following sections.   
1.4.1 Ralstonia solanacearum 
The vascular pathogen Ralstonia solanacearum has a protein with predicted GlxI function that is 
upregulated by the HrpB transcriptional activator (41).  This AraC-type activator controls expression 
of the type III secretion system common to many Gram-negative bacteria (41).  The type III secretion 
system consists of a needle- (animal pathogens) or pilus-like (phytopathogens) assembly that 
facilitates protein translocation into the host organism during the colonization process (41).  The 
promoter region of this putative GlxI -encoding gene contains a plant-inducible-promoter box motif, 
which is associated with regulation by HrpB (41).  Secretion analysis revealed that the putative GlxI 
can accumulate to significant levels in the R. solanacearum cells grown in hrp-inducing medium, but 
remains in the cytoplasm of the bacteria (42).  Deletion of this gene increased the MG susceptibility 
of R. solanacearum, indicating that it likely codes for a GlxI enzyme (42).  
1.4.2 Salmonella typhimurium 
The pathogen Salmonella enterica serovar Typhimurium (Salmonella) has also been examined using 
proteomic analysis to identify genes upregulated during macrophage colonization.  Shi et al. recently 
identified 39 proteins that were strongly upregulated during in vitro macrophage infection by 
Salmonella, including a putative GlxI sequence (43).  The deletion of the GlxI-encoding gene called 
STM3117 rendered Salmonella less viable during macrophage infection (43).  The impaired viability 
was apparent as a reduced rate of replication in the macrophages.  This finding implicates a GlxI-like 
protein as a potential virulence determinant for Salmonella.  Several other genes upregulated during 
infection included a monoamine oxidase, which can produce MG from aminoacetone and an acetyl-
CoA hydrolase, which produces acetate.  Shi et al. postulated that the coordinate upregulation of all 
three genes might be pertinent to cell wall modification during Salmonella replication and host cell 
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colonization.  The reason for this inference is that D-lactate, the final product of Glx system MG 
detoxification can be used to make peptidoglycan, the principal constituent of bacterial cell walls.  
Also, the acetate from the acetyl-CoA hydrolase can be used to modify peptidoglycan, conferring 
resistance to enzymatic degradation.  Further study is necessary and may reveal a novel role for MG 
synthesis and turnover in the adaptive physiology of Gram-negative pathogens. 
1.4.3 Bacillus anthracis 
Bacillus anthracis is a Gram-positive animal pathogen lacking enzymes for glutathione synthesis, but 
contains several GlxI-family genes that are transcriptionally upregulated when cells are subjected to 
paraquat-induced superoxide stress (44).  Transcription of these putative GlxI-encoding genes is 
upregulated in wild type cells and in an isogenic oxidative stress-prone mutant (containing a deletion 
of the superoxide dismutase-encoding gene) when subjected to paraquat stress (44).  Futhermore, 
paraquat priming of the cells increased their MG resistance as assessed by disk diffusion assay (44).  
Although this data suggests a redox-response by a putative B. anthracis Glx system, there may be 
other detoxification/resistance mechanisms that are pleiotropically regulated in the presence of 
oxidative stress (44).   
1.4.4 Streptococcus mutans 
The Gram-positive bacterium Streptococcus mutans is associated with the formation of dental caries 
in humans.  S. mutans facilitates the formation of dental caries by producing acidic metabolites in 
substantial quantities (45).  The accumulation of acidic byproducts is believed to be due to 
modulation of the flux through the glycolytic pathway by S. mutans (45).  The glycolytic rate in S. 
mutans is directly influenced by the “feast-or-famine” conditions in the oral cavity which is 
dependent upon the host diet (45).  The net result of these physiological changes is a substantial 
increase in the S. mutans biofilm layer, which contributes to the destructive invasion of dental enamel 
(45).  The increased flux through the glycolytic pathway can result in the accumulation of toxic 
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metabolites, including MG from the TIM side reaction.  Therefore MG detoxification systems should 
be present in S. mutans to prevent premature cell death in the biofilm.   
Recently a putative GlxI sequence has been identified in S. mutans strain UA159 that appears 
to be regulated as part of the aciduric response by this organism (45).  No putative GlxII-encoding 
gene has been identified in the S. mutans genome, yet the degradation of S-lactoylglutathione is 
detectable in lysates of S. mutans cultures (45).  Interestingly, S. mutans also does not synthesize the 
glutathione co-substrate commonly associated with glyoxalase system activity. However S. mutans 
can import glutathione from its surrounding based on culture experiments, so it may rely on host-
provided thiols for intracellular redox and detoxification activities.  Korithoski et al. also deleted the 
GlxI-encoding gene, which decreased MG resistance in S. mutans strain UA159 and increased the 
glycolytic rate under acidic growth conditions.  Acid tolerance for the GlxI knockout strain was 
diminished in a biofermentor growth competition experiment against the isogenic wild type strain 
(45).  Korithoski et al. were able to demonstrate that GlxI activity in S. mutans strain UA159 
increases under conditions of acid adaptation.  
Transcriptional profiling experiments confirm that the GlxI-encoding gene expression 
increases, as indexed by level of mRNA transcripts under acidic growth conditions (pH 5.0 versus pH 
7.0) and also under acid-adapted conditions (grown to mid-logarithmic phase at pH 7.5, then exposed 
to pH 5.0 for 2 hours) (45).  GlxI-mRNA levels also increases with the exposure of cultures to 
exogenous MG (45). 
1.5 Glx as a Metalloenzyme System 
Davis and Williams first described the metal ion requirement of GlxI in 1966 (46).  They were 
characterizing calf liver GlxI when the metal activation of this enzyme was discovered.  GlxI 
enzymes were initially described as Mg2+-dependent because some preparations of the enzyme (calf 
liver, sheep liver, human liver, rat erythrocyte and porcine erythrocyte) could be successfully 
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reconstituted with this ion (46, 47, 48, 49).  However in 1978 Aronsson, Marmstal and Mannervik 
determined that purified preparations of human erythrocyte, porcine erythrocyte, rat liver and yeast 
GlxI enzymes contained bound Zn2+ as determined by atomic absorption spectroscopy (50).  Since the 
publication of this study all GlxI enzymes were considered Zn2+-dependent in nature.   
 The first example of a non-Zn2+ activated GlxI enzyme was Escherichia coli GlxI (51).  When 
this enzyme was first isolated for characterization, the similarity of the amino acid sequence and 
conservation of active site residues (36% identity to human GlxI) seemed indicative of a Zn2+-
activated GlxI enzyme (51).  However, initial screens of metal activation revealed that E. coli GlxI 
becomes maximally activated by Ni2+-ions and not Zn2+-ions (51).   
Since E. coli GlxI was the first non-activated Zn2+-dependent form of this enzyme, a 
comparative biochemical survey of several other bacterial GlxI enzymes was carried out in the 
laboratory of Honek et al.  The GlxI-encoding genes of Yersinia pestis, Pseudomonas aeruginosa and 
Neisseria meningitidis have been cloned and overexpressed in E. coli (3).  The recombinant GlxI 
enzymes have been characterized to ascertain whether the non-Zn2+-dependent metal activation 
profile is present in other prokaryotes with similar enzymes.  The results indicate that all three GlxI 
enzymes characterized are similar in catalytic efficiency (3).  These enzymes also exhibit optimal 
activation with Ni2+ and Co2+ ions, similar to E. coli GlxI (3).  Therefore the GlxI enzymes can be 
broadly classified into two groups based on metal activation: Zn2+-dependent and non-Zn2+-dependent 
(Ni2+/Co2+-activated).   
1.5.1 Structure of GlxI Enzymes 
E. coli GlxI is the first crystallographically characterized non-Zn2+-dependent GlxI enzyme (52).  The 
crystal structure for the archetypal Zn2+-dependent human GlxI was available three years prior to the 
bacterial enzyme data (53).  Having both structures available allowed for comparisons to be made that 
could be potentially correlated to the difference in metal activation between these two enzymes.   
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Overall, human and E. coli GlxI enzymes exhibit a highly conserved topology within a 
homodimeric framework (Figure 1.4) (52). The monomer of the human enzyme is larger than that of 
E. coli GlxI because of the N-terminal arm region that wraps around the adjacent subunit (Figure 1.4). 
GlxI enzymes belong to a structural superfamily called the βαβββ superfamily (9, 54).  The 
superfamily consists of evolutionarily divergent proteins all containing tandem βαβββ motifs (Figure 
1.5) (9).  In the case of the dimeric GlxI enzymes each consituent monomer is composed of two 
βαβββ motifs connected by a linker.  A semi-circular cleft is created by the approach of the β-sheet 
portion of two βαβββ motifs in superfamily members (9, 54).  This cleft is important, as it constitutes 
the active site in enzymatic superfamily members.  In the case of the GlxI enzymes the active 
site/metal-binding cleft is formed from βαβββ motifs at the dimeric interface, such that each motif is 
on a different polypeptide subunit.  This arrangement is classified as a domain-swapped dimer (Figure 
1.6). Other βαβββ proteins such as methylmalonyl coA epimerase contain the active site cleft within 
one monomer, so that the dimer consists of back-to-back subunits (Figure 1.6) (55).   
 
                             
Figure 1.4: Crystal structures of A) E. coli GlxI (PDB ID: 1F9Z) and B) human GlxI (PDB ID: 
1QIN). The subunits in each dimer can be distinguished from the shading in the diagram (dark grey 
module and light grey) module in each protein.  The spheres at the dimeric interface represent bound 
metal ions.  The N-terminal arm with a helical segment in the human enzyme is labeled in the above 
figure 
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Figure 1.5: Structure of the βαβββ motif (from PDB ID: 1F9Z) 
 
                      
 
Figure 1.6: Structures of A) P. shermanii MMCE (non-domain swapped, PDB ID: 1JC5) and B) 
E. coli GlxI (domain swapped, PDB ID: 1F9Z). Individual subunits in each dimer can be 
distinguished by the grey tube trace of one subunit and the black wireframe trace of the other subunit.  
Active site residues are shown in stick form and the black double-headed arrow indicates the dimer 
interface of each protein. The cleft where the active site residues are located is labeled 
correspondingly. 
 
The contiguous assembly of βαβββ motifs in these proteins is thought to originate from gene 









enzymes as homodimers, which is common to human, bacterial, leishmanial and trypanosomal forms 
of the enzyme.  Fused dimer GlxI enzymes also exist, which are monomeric forms of the enzyme 
with all four constitutive motifs in a single polypeptide.  GlxI enzymes of this type tend to be found in 
plants, yeast (Saccharomyces cerevisiae) and Plasmodium falciparum (55, 56, 57, 58).   
1.5.2 Human and E. coli GlxI Enzymes have Similar Active Sites  
GlxI sequence comparisons and structural characterization shows that the four amino acid metal 
ligands are very well conserved (51, 52, 53).  Two amino acid metal ligands are contributed from 
each monomer in human and E. coli GlxI (Figure 1.4 and Figure 1.7).  These residues are generally 
two histidines and two glutamates (52).  However the human enzyme has a Gln residue at position 34, 
which corresponds to His5 in E. coli GlxI (Figure 1.7) (53).  The variation of this single metal ligand 
is not predictive of Zn2+-dependent metal activation in GlxI enzymes.  Several other GlxI enzymes 
known to be Zn2+-activated, possess a histidine residue at the position that Gln34 would be located in 
the human enzyme.  Such examples include the GlxI enzymes of Saccharomyces cerevisiae and 
Pseudomonas putida (57, 59).  
 Initial studies of E. coli GlxI led to the creation of a His5 → Gln5 variant, so that the active 
site residues were “humanized” in composition (60).  The aim of this investigation was to assess 
whether amino acid variation at this position was a determinant of metal selectivity.  The purified 
variant is substantially impaired for metal binding and activation, yet retains maximal activation in 
the presence of Ni2+ (60).  A shift towards low levels of Zn2+ activation is detectable with this E. coli 
GlxI variant.  This indicates that the ligand substitution could influence metal activation but it is not 
the dominant determinant of metal selectivity.  
One notable finding in active site comparisons of the human and E. coli GlxI enzymes at the 
structural level is the coordination environment around the metal ion.  The active human and E. coli 
GlxI enzymes (Zn2+-bound and Ni2+-bound respectively) both possess octahedral coordination 
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geometry around their active site metal ions (52, 61, 62).  Four conserved amino acid residues at the 
dimeric interface and two monodentate water ligands chelate metal ions at the active site.  The 
inactive Zn2+-bound GlxI from E. coli exhibits trigonal bipyramidal geometry at the active site 
(Figure 1.8) (52).  The five-coordinate geometry around the Zn2+ ion is due to the loss of one of the 
water ligands (Figure 1.8) (52).  This finding indicates that octahedral coordination is a prerequisite 
for the formation of active holoenzyme (52).  GlxI enzymes do not exhibit catalytic activity in their 
apo-forms (51). Inactive GlxI enzymes can result from the loss of metal during purification steps for 
enzyme preparation, or by chelator treatment (EDTA, 1,10-phenanthroline) of holoenzyme samples.  
The structure of E. coli GlxI does not undergo any major re-organization that can be detected by X-






                           
Figure 1.7: Active sites of A) E. coli GlxI (PDB ID: 1F9Z) and B) Human GlxI (PDB ID: 1QIN). 
The large spheres ligated with hexacoordinate geometry depict bound Ni2+ and Zn2+ ions in each 









Figure 1.8: Active site of the Zn
2+
-bound E. coli GlxI (PDB ID: 1FA5). Pentacoordinate geometry 






Besides coordination of the activating metal, the amino acid ligands have been implicated as 
catalytic bases in the function of GlxI enzymes.  The glutamatic acid residues of the active site have 
been probed in human and P. falciparum GlxI by site-directed mutagenesis for their involvement in 
MG-GSH hemithioacetal isomerization (8, 63).  Inspection of the active site for human and E. coli 
GlxI indicates that no residues other than the metal-coordinating glutamic acid residues are present as 













































Figure 1.9: Proposed mechanism for GlxI-catalyzed isomerization 
 
In human GlxI, Glu172 seems like a more plausible candidate for participation in catalysis 
because of the 3.3Å distance from the catalytic Zn2+ and its optimal position to re-protonate the bound 
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S-(N-hydroxy-N-p-iodophenylcarbamoyl)glutathione (HIPC-GSH) (transition state analogue) 
observed in the crystal structure (Figure 1.10) (64).  Ridderstrom et al. have conducted a mutagenesis 
study on human GlxI comparing the activities of various active site Glu →Gln variants.  The 
Glu99Gln mutant exhibits only 0.1% of the activity observed for the wild type GlxI (63).  In contrast, 
the Glu172Gln variant exhibits less than 10-5 the activity of the wild type enzyme (63). The 
investigators concluded that Glu172 was relevant to the GlxI mechanism in part because of its 
proximity and positioning to substrate analogues in the active site. Glu172 also appeared catalytically 
relevant because of the large difference in activity loss when it was substituted for Gln versus 
modification of Glu99.   
1.5.3 Evidence for Glutamate as a Catalytic Base 
The co-crystallization of human GlxI and the transition state analogue HIPC-GSH (a mimic of the 
enediol intermediate) HIPC-GSH provides some evidence in favor of a Glu residue as a general base 
(Figure 1.10) (64).  In this structure, direct coordination of the inhibitor coordinated directly to the 
active site metal, and the ligand Glu172 is 3.3 Å away from the Zn2+ ion. The 3.3 Å distance is too 
great for direct metal coordination with the Glu172 residue.  Cameron et al. proposed an inner sphere 
catalytic mechanism based on these findings.  In this mechanism, the incoming substrate would 
displace the ligating water molecules in addition to the catalytic glutamate residue (64).  This change 
in coordination environment changes the Glu172 pKa so it can function as a proton abstractor (64). 
X-ray absorption fine structure (EXAFS) analysis of the E. coli GlxI in complex with a hydroxamate 
peptide inhibitor exhibits a similar change in coordination environment (65).  The EXAFS data 
indicates that the inhibitor interacts directly with the active site metal, displacing the water molecule 
and Glu122 ligands (65).  Although this mode of coordination is similar to the active site of the 
HIPC-bound human GlxI, an important caveat is that hydroxamate-based structures are inherently 
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prone to metal chelation.  Therefore the E. coli GlxI-inhibitor complex must be interpreted with 




Figure 1.10: Active site of HIPC-GSH- bound human GlxI (PDB ID: 1QIN). The inhibitor, Zn2+ 
ion, and glutamic acid ligands are labeled in the above figure.  The carboxylate oxygen atoms of the 
glutamic acid residues are depicted as dense black spheres.  The increased distance between Glu172 
and Zn2+ due to inhibitor binding is highlighted with the double-headed arrow. 
1.5.4 Two Classes of Metal Activation for GlxI Enzymes 
The metal activation class of a GlxI sequence can be inferred by amino acid sequence comparisons 
(Figure 1.11) (3, 66).  The homodimeric Ni2+/Co2+-activated GlxI enzymes tend to have shorter amino 
acid sequences for the monomeric subunit with molecular masses under 20 kDa.  The metal ligands 
tend to be the conserved two histidine and two glutamate residues, where the first histidine ligand in 
the sequence is not preceded by a long (>20 amino acids) N-terminus (Figure 1.11) (3, 66).  In 
contrast, the homodimeric Zn2+-activated GlxI enzymes tend to have the N-terminal arm preceding 
the first histidine or glutamine ligand.  In the case of the human GlxI enzyme, the 29 amino acid long 
N-terminal engages in contacts with the opposing monomer in the native protein (Figure 1.4 and 








Ni2+/Co2+-activated GlxI enzymes are homodimers in apo- and holo- form (3, 51, 52).  Sequence 
alignment of Zn2+-dependent GlxI enzymes against Ni2+/Co2+-activated GlxI enzymes also reveals 
several short regions of amino acid sequence in the former proteins that are absent in shorter forms of 
this enzyme (Figure 1.11) (3, 66). These regions assume loop conformations in the human GlxI 
enzyme based on the published crystal structure (53).  Thus it would appear that a longer module of 
βαβββ motifs with greater intersubunit contacts evolved to facilitate the GlxI enzyme activation with 
Zn2+ ions.  How the presence of an extended amino acid sequence promotes Zn2+-binding and 





Figure 1.11: Sequence alignment comparing long and short dimeric GlxI enzymes.  The longer 
Zn2+-activated GlxI sequences are from H. sapiens and P. putida (National Centre for Biotechnology 
Information (NCBI) accession numbers are NP_006699 and NP_745896 respectively). The shorter 
Ni2+/Co2+-activated GlxI sequences are from E. coli, Y. pestis, P. aeruginosa (GloA1 homologue) and 
N. meningitidis (NCBI accession numbers are U57363, CAL21009, NP_252214 and NP_284840 
respectively).  The α-helix and β-strand structures in the GlxI enzymes are based on the human (HS) 
and E. coli (EC) sequences.  The letters A, B and C represent sequences present in longer GlxI 
enzymes that are absent in the shorter non-Zn2+-activated class of enzymes.  The active site ligands 




The Ni2+/Co2+ activation profile for GlxI is not limited to enzymes of bacterial origin.  
Recently, GlxI enzymes have been isolated from the protozoan parasites Leishmania major, L. 
donovani and Trypanosoma cruzi that are very similar to the E. coli enzyme (67, 68, 69) .  The 
monomers of L. major and T. cruzi are 18.5 kDa and 16.6 kDa respectively (67, 69) .  As observed 
with other GlxI enzymes these proteins are active as homodimers.  Sequence alignment indicates that 
these parasitic GlxI enzymes are comparable in length to the bacterial non-Zn2+-activated GlxI 
enzymes (Figure 1.12). The metal activation profile for L. major GlxI closely mirrors that of E. coli 
GlxI, where the level of Ni2+-activation of apoenzyme exceeds Co2+-activation by approximately 74% 
(67).  Another similar feature between L. major and E. coli GlxI is that they are not Zn2+-activated 
(67).  In contrast, T. cruzi GlxI exhibits a less stringent metal activation profile, such that Co2+ 
reconstitution is almost as effective for restoring maximal activity as Ni2+.  Furthermore, T. cruzi GlxI 

















E. coli  ------------------------------MRLL HTMLRVGDLQRSIDFYTKVLGMKLLR 30 
T. cruzi  ---------------------------MSTRRLM HTMIRVGDLDRSIKFYTEALGMRLLR 33 
H. sapiens  MAEPQPPSGGLTDEAAL-SCCSDADPSTKDFLLQQTMLRVKDPKKSLDFYTRVLGMTLIQ 59 
P. putida  MS--------LHDLQTLPGVTAQPDAATAQFVFN HTMLRVKDIEKSLDFYTRVLGFRLVD 51 
L. major  ---------------------------MPSRRML HTMIRVGDLDRSIKFYTERLGMKVLR 33 
 
 
E. coli   TSENPEYKYSLAFVGYGPETE---------------EAVI ELTYNWGVDK-----YELGT 70 
T. cruzi  KWDCPEDKFTLVFLGYGTESE---------------TAVL ELTYNYGQSE-----YKHGD 73 
H. sapiens  KCDFPIMKFSLYFLAYEDKNDIPKEKDEKIAWALSRKATLE THNWGTEDDETQSYHNGN 119 
P. putida  KRDFPEAAFSLYFLALVDPAQIPADDTARHQWMKSIPGVLELTHNHGTENDADFAYHNGN 111 
L. major   KWDVPEDKYTLVFLGYGPEMS---------------STVL ELTYNYGVTS-----YKHDE 76 
 
 
E. coli   A----YG HIALSVDNAAEACEKIRQNGGNVTREAGPVKGGTTVIAFVEDPDGYKIELIEE 126 
T. cruzi   A----YG HIAIGVEDVNEEIARLKKMNVPIDYES-----EDGFMAFIVDPDGYYIELLNT 124 
H. sapiens  SDPRGFGHIGIAVPDVYSACKRFEELGVKFVKKP--DDGKMKGLAFIQDPDGYWIEILNP 176 
P. putida  TDPRGFGHICISVPDVRAACARFEELEVPFQKRL--QDGRMNHLAFVKDPDGYWVEVIQP 168 
L. major   A----YG HIAIGVEDVKELVADMRKHDVPIDYED-----ESGFMAFVVDPDGYYIELLNE 127 
 
 
E. coli   KDAGRGLGN----------- 135 
T. cruzi   ERM---LEKSREQMNEQGTA 141 
H. sapiens   NKMATLM------------- 184 
P. putida  TELEG--------------- 173 
L. major   KTM---MEKAEADMKEQGTA 144 
 
Figure 1.12: Sequence alignment comparing the GlxI enzymes from E. coli, T. cruzi, H. sapiens, 
P. putida and L. major (NCBI accession numbers are U57363, XM_813363,  NP_006699, 
NP_745896 and AY604654 respectively)  . The GlxI sequences from E. coli, T. cruzi and L. major 
are Ni2+/Co2+-activated and are similar in length.  The H. sapiens and P. putida GlxI sequences are 
included in this alignment to highlight that the parasitic enzymes resemble the E. coli GlxI in length.  
The active site residues are shown with grey highlighting in the sequences 
1.5.5 Non-GSH-Dependent GlxI Enzymes 
The relatedness of Ni2+/Co2+-activated bacterial GlxI enzymes to Leishmanial and Trypanosomal GlxI 
enzymes is remarkable because the thiol co-substrate used for detoxification differs significantly.  
Unlike E. coli, leishmanial and trypanosomal parasites depend on trypanothione (TSH) as a major 
intracellular thiol for redox and detoxification processes (Figure 1.13) (70).  The kcat/Km value for L. 
major GlxI utilization of MG-TSH hemithioacetal is 200 times greater than that observed with the 
MG-GSH hemithioacetal (67).  Correspondingly, L. major GlxI kcat/Km values for phenylglyoxal(PG)-
TSH are 147 times greater than for turnover of PG-GSH (67).  L. major GlxI can also efficiently 
 
 24 
isomerize hemithioacetals of N1-glutathionylspermidine and MG (67).  However the most significant 














































Figure 1.13: Structures of trypanothione and glutathione co-substrates 
 
Kinetic characterization of T. cruzi GlxI indicates that it isomerizes MG hemithioacetals of 
TSH and glutathionylspermidine 2400 and 14000 times more efficiently respectively, when compared 
to MG-GSH hemithioacetal (69).  In this case T. cruzi GlxI appears more selective for 
glutathionylspermidine as a co-substrate, yet promastigotes of this organism tend to have higher 
intracellular concentrations of TSH relative to the spermidine thiol (69)l.  T. cruzi likely uses both co-
substrates for MG detoxification in vivo.   
The crystal structure of L. major GlxI indicates that the active homodimer contains conserved 
βαβββ topology with an identically positioned active site as observed in E. coli and human GlxI 
enzymes (Figure 1.14) (71).  The dimer is more similar to the E. coli enzyme structurally with a root 
mean squared deviation value for C-alpha of 0.9 Å versus 1.2 Å when compared to the human 




                         
   
Figure 1.14: Crystal structures of A) L. major GlxI (PDB ID: 2C21) and B) E. coli GlxI (PDB 
ID: 1F9Z).  Although the structure shown for L. major GlxI has electron density for two bound metal 
ions, only one active site was reported to contain electron density for bound Ni2+ in the 
crystallographic data set. 
1.5.6 Half-of-the-Sites Metal Activation in Non-Zn2+-Activated GlxI Enzymes 
The metal coordination environment in L. major GlxI is highly similar to E. coli and human GlxI, so 
that the bound Ni2+ ion in the structure is ligated to two histidine residues, two glutamate residues and 
two water molecules (71).  However, the L. major GlxI structure has only one metal ion bound per 
dimer, whereas the E. coli GlxI structure shows both active sites occupied for the holoforms 
containing Ni2+, Co2+, Cd2+ and Zn2+(71).  The presence of only one metal per dimer in the L. major 
holoenzyme structure is in agreement with estimates of the metal: enzyme stoichiometry from atomic 
absorption spectroscopy (71).  The structure of L. major GlxI exhibiting half-of-the-sites metal 
binding converges with biochemical data indicating that active E. coli GlxI requires one metal ion per 
dimer (51, 71). 
1.6 GlxII: Review of Biochemical and Structural Properties 
Racker recognized GlxII as an enzyme involved in MG metabolism during the 1950’s (11).  The first 




the metal ion requirement of the hydrolase was suspected since metal-catalyzed thioester hydrolysis 
had been observed in aqueous model systems not involving enzymes (73).  Uotila noted that storage 
of human liver GlxII in EDTA-containing buffer slowly deactivated the preparation (72).  Attempts at 
reconstitution of the EDTA-treated GlxII by adding metal ions (Mg2+, Mn2+, Co2+, Ni2+, Zn2+, Ca2+, 
Cu2+) were ineffective, and could not provide unambiguous evidence for GlxII functioning as a 
metalloenzyme (72).   
Ridderstrom et al. characterized recombinant human GlxII but made no mention of a metal 
ion requirement or the evaluation of metal-dependency as part of their report (74).   Ridderstrom and 
Mannervik also isolated and characterized a GlxII enzyme from Arabidopsis thaliana, and concluded 
from their studies that there was no metal ion requirement for the enzyme (75).  The metal ion 
requirement was discounted because they failed to observe any augmentation of activity in the 
purified recombinant enzyme (expressed in E. coli) with the addition of Zn2+ or Mg2+ to the growth 
medium (75).  However in the same year, Crowder et al. published a characterization of a 
recombinantly expressed cytosolic GlxII from A. thaliana (76).  They reported a metal ion 
requirement for the enzyme in this publication.  Crowder et al. were able to determine from 
inductively coupled plasma atomic emission spectroscopy that their purified recombinant GlxII 
possessed two equivalents of Zn2+ per monomer (76).  Additionally they performed a sequence 
alignment comparing glyoxalase II enzymes from human and A. thaliana, to metallo-β-lactamase 
sequences from several bacterial sources. They noted that the metal ligands in these proteins were all 
well conserved (76).   
A highly conserved T-H-X-H-X-D-H motif associated with metal binding is common to both 
the GlxII enzymes and the metallo-β-lactamases (Figure 1.15) (77).  Two additional histidine residues 
can be found in GlxII that contribute to metal binding (Figure 1.15) (77).  These residues are 
conserved amongst all GlxII enzymes but external to the aforementioned binding motif.  Based on 
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these findings it was postulated that all GlxII enzymes would likely have bound metal ions as part of 










H. sapiens  ------------------------------------------------------------ 
A. thaliana cyt ------------------------------------------------------------ 
A. thaliana mit MPVISKASSTTTNSSIPSCSRIGGQLCVWPGLRQLCLRKSLLYGVMWLLSMPLKTLRGAR  
Sm MBL L1  ------------------------------------------------AEVPLPQLRA--  
Pa MBL VIM-2 MFKLLSKLLVYLTASIMA---IASPLA-------FSVDSSGEYPTV--SEIPVGEVRL—- 
 
 
H. sapiens  -----------------MKVEVLP----ALTDNYMYLVIDDETKEAAIVD--PVQPQKVV 
A. thaliana cyt  -----------------MKIFHVP----CLQDNYSYLIIDESTGDAAVVD--PVDPEKVI 
A. thaliana mit  KTLKITHFCSISNMPSSLKIELVP----CSKDNYAYLLHDEDTGTVGVVD--PSEAAPVI 
Sm MBL L1  YTVDASWLQPMAPLQ--IADHTWQ----IGTEDLTALLVQTPDGAVLLDGGMPQMASHLL 
Pa MBL VIM-2 YQIADGVWSHIATQS--FDGAVYPSNGLIVRDGDELLLIDTAWGA-------KNTAALLA 
 
 
H. sapiens  DAARKHGV---KLTTVLTTHHHWDHAGGNEKLVKLESGLKV------------------- 
A. thaliana cyt  ASAEKHQA---KIKFVLTTHHHWDHAGGNEKIKQLVPDIKV------------------- 
A. thaliana mit  EALSRKNW---NLTYILNTHHHDDHIGGNAELKE-RYGAKV------------------- 
Sm MBL L1  DNMKARGVTPRDLRLILLSHAHADHAGPVAELKR-RTGAKVAANAESAVLLARGGSDDLH 
Pa MBL VIM-2 EIEKQIGL---PVTRAVSTHFHDDRVGGVDVLR--AAGVAT------------------- 
 
 
H. sapiens  YGGD-D--RIGALTHKITHLSTLQVG-SLNVKCLATPCHTS--G HICYFVSKPGGSEPPA 
A. thaliana cyt  YGGSLD--KVKGCTDAVDNGDKLTLGQDINILALHTPCHTK--G HISYYVNGKEG-ENPA 
A. thaliana mit  IGSAVDKHRIPGIDILLKDSDKWMFA-GHEVRILDTPGHTQ--G HISFYFPGSAT----- 
Sm MBL L1  FGDGIT-YPPANADRIVMDGEVITVG-GIVFTAHFMAGHTP--GSTAWTWTDTRNGKPVR 
Pa MBL VIM-2 YASP--------STRRLAEVEGNEIP-THSLEGLSSSGDAVRFGPVELFYPGAAH----- 
 
 
H. sapiens  VFTGDTLFVAGCGKFYEGTADEMCKALLEVLGRLPPDTRVYCGHEYTINNLKFARHVEPG 
A. thaliana cyt  VFTGDTLFVAGCGKFFEGTAEQMYQSLCVTLAALPKPTQVYCGHEYTVKNLEFALTVEPN 
A. thaliana mit  IFTGDLIYSLSCGTLSEGTPEQMLSSLQKIVS-LPDDTNIYCGRENTAGNLKFALSVEPK 
Sm MBL L1  IAYADSLSAPGYQ--LQGNPR------------YPHLIEDYRRSFATVRALPCDVLLTPH 
Pa MBL VIM-2 STDNLVVYVPSASVLYGGCA-------------IYELSRTSAGNVADADLAEWPTSIE— 
 
 
H. sapiens  NAAIREKLAWAKEKYSIGEPTVPSTLAEEFTYNPFMRVREKTVQQHAGETDPV---TTMR 
A. thaliana cyt  NGKIQQKLAWARQQRQADLPTIPSTLEEELETNPFMRVDKPEIQEKLGCKSPI---DTMR 
A. thaliana mit  NETLQSYATRVAHLRSQGLPSIPTTVKVEKACNPFLRISSKDIRKSLSIPDSATEAEALR 
Sm MBL L1  PGA--SNWDYAAGARAG---------AKALTCKAYADAAEQKFDGQLAKETAGAR----- 
Pa MBL VIM-2 ----RIQQHYPEAQFVIPGHGLPGGLD-------LLKHTTNVVKAHTNRSVVE------- 
 
 
H. sapiens  AVRREKDQFKMPRD 
A. thaliana cyt  EVRNKKDQWRG--- 
A. thaliana mit  RIQRARDRF----- 
Sm MBL L1  -------------- 
Pa MBL VIM-2 -------------- 
Figure 1.15: Amino acid sequence comparison of H. sapiens GlxII, A. thaliana cytosolic GlxII, 
A. thaliana mitochondrial GlxII, S. maltophilia metallo-β-lactamase L1, and P. aeruginosa 
metallo-β-lactamase VIM-2 (NCBI accession numbers are Q16775, NP_187696, NP_565999, 
BAF47409 and ABR10840 respectively). The conserved T-H-X-H-X-D-H motif region is 
highlighted in grey.  Additional active site His residues in the GlxII enzymes are highlighted in black. 
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The crystal structure for human GlxII was reported in 1999 by Cameron et al. and was 
resolved to 1.9 Å (78).   The monomeric protein is approximately 29 kDa in size and composed of 
two structurally distinct domains (Figure 1.16).  The N-terminal domain consists of a four-layered 
β sandwich, the first half of which possesses βββαβαββ topology and the second half assumes 
ββββαβ topology (Figure 1.16) (78).  The two halves of the sandwich are rotated relative to each 
other and the overall layering in the domain is such that two mixed β-sheets are flanked by α-helices 
(78).  The C-terminal α-helical domain is connected to the N-terminal β-sandwich domain via a β-
hairpin region and it consists of five α-helices (Figure 1.16) (78).  There is significant similarity 
between the topology of the N-terminal GlxII domain and that of the zinc-metallo-β-lactamases.  In 
fact GlxII and metallo-β-lactamase are members of the zinc-metallohydrolase family of proteins (78).   
 
 
Figure 1.16: Crystal structure of human GlxII (PDB ID: 1QH5) 
1.6.1 GlxII has a Binuclear Active Site 
The electron density within the human GlxII crystal structure clearly indicates the presence of a 
binuclear metal centre at the active site of the protein (78).  The enzyme was considered to be a Zn-
N-terminal β-sandwich domain 
C-terminal α-helical domain 
  Binuclear zinc centre 
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metalloenzyme even though metal analysis of the prepared protein indicated only 1.5 equivalents of 
the metal per monomer (78).  Metal exchange during purification was assumed to be the reason for 
the less than binuclear stoichiometry observed by metal analysis.  The positions of the metal binding 
sites in human GlxII are very similar to those found in metallo-β-lactamase enzymes.  The 
coordination environment for the two Zn2+ ions in the human GlxII resemble the environment found 
in the binuclear centre or the metallo-β-lactamase L1 from Stenotrophomonas maltophilia (78).  The 
catalytic metal ions are located along the edge of the β-sandwich when comparing the structures of 
both metalloenzymes (Figure 1.16) (78).  The distance separating both metal ions is approximately 
3.3-3.5 Å (78).  Seven amino acid residues and a single water molecule ligate to the zinc ions 
according to the crystal structure (Figure 1.17) (78).  There are bridging ligands between the metal 
ions consisting of the water molecule and Asp 134, via oxygen atoms (Figure 1.17).  The ligands 
coordinating zinc atom 1 include His54, His56 and His110 (Figure 1.17)  (78).  The amino acids 
ligating to zinc atom 2 are Asp58, His59 and His173 (Figure 1.17) (78).  The crystal structure of 
human GlxII with GSH bound to the active site contains an additional water molecule positioned such 
that the aqua and sulfur ligands (from GSH) gives each zinc ion octahedral or square pyramidal 





Figure 1.17:  Active site of human GlxII (PDB ID: 1QH5). The arrow points to the oxygen atom 
from a bridging water ligand. 
  
Although GlxII is a member of a zinc metalloprotein family, there is evidence that the 
enzyme can bind other activating metals in the active site.  The A. thaliana GlxII enzymes have been 
the focus of most structural and metal activation studies. They have also been of interest in plant 
physiology owing to the presence of organelle specific isoforms. There are three mitochondrial forms 
of A. thaliana GlxII designated GLX2-1, 2-4 and 2-5 (2).  The cytoplasmic isoform is designated 
GLX2-2. The isoform designated GLX2-3 deviates from the typical GlxII protein sequence especially 
for residues in substrate binding positions, and may not actually be a GlxII enzyme by function (2).   
Zang et al. conducted a series of experiments on GLX2-2 probing the effect of ligand substitutions on 
metal content of the enzyme (79).  The metal ligand variants of the enzyme were created by site-
directed mutagenesis and the purified enzyme was subjected to metal analysis by inductively coupled 
plasma atomic emission spectroscopy (79).  Their findings revealed that GLXI2-2 tends to be 












that the first metal site in this GlxII enzyme has a preference for binding iron where the second 
activating metal site was selective for zinc over iron (79).   
1.6.2 Heterogeneous Metallation in GlxII  
Schilling et al. performed a more biophysical investigation of metal binding in GLX2-2 by examining 
the binuclear active site using EXAFS and electron paramagnetic resonance (EPR) techniques (80).  
Their results were most interesting because the metal analysis they performed indicates 
heterogeneous holoforms of recombinant GLX2-2 are produced in complex growth media (80). The 
metal content of the purified enzyme from these conditions contained 0.8 ± 0.2 iron, 0.4 ± 0.2 zinc, 
and 0.30 ± 0.05 manganese per protein (80).  They also found that supplementation of the growth 
medium with iron-, zinc- or managese- containing salts yields GLX2-2 with proportional amounts of 
the exogenously supplied metal ion (80).  The kinetic parameters of these holoforms are comparable 
demonstrating that the GlxII enzyme structure is not stringently selective for activating metal ions.  
The EXAFS analysis shows that metal-ligand distance varies depending on the metal ions bound at 
the binuclear centre, demonstrating a flexibility of the coordination environment supplied by the 
enzyme and associated water molecules (80).  The EPR results reported by Schilling et al. indicate a 
variety of binuclear configurations that can be found in GLX2-2 which include Fe(III)Fe(II), 
Fe(III)Zn(II), and Mn(II)Mn(II) centres.  The result of this investigation does not indicate biased 
metal selectivity for each site in the binuclear centre as declared in the report by Zang et al.  Again 
these findings emphasize the flexible nature of metal binding in the GlxII scaffold, in contrast to the 




Crowder’s research group extended their study of metal loading in GLX2-2 to the analysis of 
recombinant enzyme produced by bacteria cultivated in minimal medium (81).  Their objective was to 
clarify the influence of exogenous metal addition on the types of holoenzymes recovered from 
purification.  The previous use of rich medium tended towards the production of recombinant GLX2-
2 with mixtures of Zn, Fe and Mn in the active site (81).  The metal stoichiometry of GLX2-2 
produced in minimal medium was approximately one metal ion per monomer, with the bulk of the 
metal being Zn or Fe if salts of these respective metals were added to the growth medium (81).  An 
interesting finding is that the substoichiometrically loaded GlxII from minimal growth conditions 
contains a mixture of dinuclear enzyme, and apoenzyme (81).  This data demonstrates that the GlxII 
enzyme has a propensity for binding metals at both sites of the catalytic centre.  In contrast the related 
metallo-β-lactamases have been isolated as both mono- and dimetallated forms from various soil 
bacteria (82).   
Marasinghe et al. published the first detailed characterization of a mitochondrial GlxII 
enzyme from A. thaliana in 2005.  This GlxII enzyme, designated GLX2-5 is isolated following 
expression of the recombinant protein in E. coli as a binuclear FeZn enzyme.  Unlike GLX2-2, 
stoichiometrically significant quantities of Mn are not found associated with the enzyme (2).  The 
EPR analysis of GLX2-5 indicates that the majority of the binuclear holoenzyme was Fe(III)Zn(II) 
occupied although there are some anti-ferromagnetically coupled Fe(II)Fe(II) metal centres detectable 
by this method (2). 
 The 1.74 Å resolution crystal structure of GLX2-5 confirmed the suspected difference in 
metal coordination environments at the active site, given the presence of an Fe(III)Zn(II) centre as 
opposed to the Zn(II) Zn(II) centre observed in human GlxII.  Between these two enzymes 37% 
sequence identity is shared and there is conservation of all of the amino acids ligands (2). Instead of 
the five- and six- coordinate metal centres found in the human enzyme, GLX2-5 has tetrahedrally and 
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trigonal bipyramidal metal centres (2).  Metal site 1 has four ligands supplied by His54, His56, His12 
and a bridging water ligand (Figure 1.18)(2).  Metal site 2 uses Asp58, His59, Asp131, His169 and a 
bridging water ligand to provide a pentacoordinate inner sphere at this location (Figure 1.19) (2).   
 
Figure 1.18: Active site of GLX2-5 (PDB ID: 1XM8). The bridging water ligands are not shown in 
this figure. 
 
1.6.3 Outer Sphere Metal Ligation in GlxII   
In contrast to structural studies of GlxI, the second-sphere or extended bonding network 
associated with the metal sites in GlxII have been characterized as part of the structure determination 
studies.  The extended hydrogen-bonding network around the binuclear metal centre in GlxII is also a 
well-documented architectural feature observed in metallo-β-lactamase enzymes.  The ligands 
associated with the second metal site in particular are observed in connection with outer sphere 
ligands (2).  The second sphere hydrogen bonding interactions for human (GLX2-2) and GLX2-5 are 














may be this difference in extended coordination environment that confers the observed divergence in 
metal selectivity between these two hydrolases (2). 
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Table 1.1:  Ligands in Human GlxII and GLX 2-5 (2) 
 
Human GlxII First 
Sphere Ligands 
 
GLX2-5 First Sphere 
Ligands 
Human GlxII Second 
Sphere Ligands 
GLX2-5 Second Sphere 
Ligands 
His54 (Site 1) His54 (Site 1) Lys143 → His54 Thr53 → His54               
Lys140 → His54 
His56 (Site 1) 
 
His56 (Site 1) Glu146 → H2O → 
His56 
No equiv ligand 
His110 (Site 1) 
 
His112 (Site 1) No equiv ligand Lys140 carbonyl 
No equiv ligand (Site 1) 
 
Bridging water (Site 
1) 
  
Asp134 (Site 1) 
 
No equiv ligand (Site 
2) 
Asp134 carbonyl No equiv ligand 
Asp58 (Site 2) 
 
Asp58 (Site 2)   
His59 (Site 2) His59 (Site 2) No equiv ligand Thr53 → Asp29 → His59 
Asp134 (Site 2) 
 
Asp131 (Site 2)   
His173 (Site 2) 
 
His169 (Site 2) No equiv ligand Lys10 →Asp11→His169 
Also Asp11 → H2O 






1.6.4 Substrate Specificity of GlxII and Active Site Residues 
GlxII enzymes can accept a wide variety of substituted thioester substrates including S-D-
mandeloylglutathione, S-D-acetylglutathione, S-D-acetoacetylglutathione, S-D-formylglutathione, S-D-
glycolylglutathione, and S-D-lactoylglutathione (72).  Despite the broad substrate selectivity, the 
preferred target of hydrolysis is S-D-lactoylglutathione (72).  Early efforts at identifying active site 
residues prior to the availability of GlxII crystal structures were largely conducted by using side chain 
modification reagents and inhibitors.  The presence of an active site amine moiety was inferred from 
the observed inactivation of human liver GlxII by 2,4,6-trinitrobenzenesulphonate (72, 83).  The 
inactivation is a pH dependent effect with a pK of 8.95 (83).  The modification could be abated in the 
presence of the competitive inhibitor N-acetyl-S-(p-bromobenzyl)glutathione, leading to the 
conclusion that an active site amine was being modified by the sulphonate (83). 
  An arginine residue may be involved in GlxII-catalyzed hydrolysis due the observation of 
phenylglyoxal-induced inactivation at pH 8 (83).  The histidine specific chemical modification agent 
diethylpyrocarbonate also inactivates GlxII (rat erythrocyte) at pH 6, providing indirect evidence for 




1.7 Rationale for Continued Characterization of GlxI Enzymes 
Structure-function studies of GlxI enzymes have focused upon resolving the basis for metal activation 
differences in spite of a highly conserved protein structure (52, 53, 57, 71).  This aspect of GlxI 
metalloenzyme chemistry has a substantial foundation in the seminal discovery of non-Zn2+ activation 
in E. coli GlxI (51).  
 The discovery of non-Zn2+-activated, Ni2+/Co2+-activated bacterial (E. coli, P. aeruginosa, N. 
meningitidis, Y. pestis) and parasitic (L. major, T. cruzi) GlxI enzymes represents a recent addition to 
the catalog of known Ni2+-metalloenzymes.  The biochemistry of nickel in proteins is a relatively 
recent area of metalloenzyme research compared to the wealth of information collected on zinc 
metalloproteins (84, 85). There are many unanswered questions about the structural nature of 
divergent metal activation in a conserved protein scaffold exemplified by GlxI.   
Attempts at metal ligand replacement and loop insertion mutagenesis were pursued with E. 
coli GlxI previously.  The intent of these studies was to create a “humanized” chimeric GlxI enzyme 
exhibiting robust activation in by Zn2+.  These experiments are documented in the doctoral and 
master’s dissertations of Dr. Susan Clugston and Nicole Sukdeo respectively.  Briefly, the ligand 
replacement (His5 to Gln5) results in only a weak but detectable shift towards Zn2+-activation.  
Singular insertions of loop regions unique to human GlxI do not shift the selectivity of E. coli GlxI 
towards Zn2+-activation (60).   The addition of multiple loops in an attempt to create a more 
thoroughly “human-like” GlxI scaffold from the E. coli enzyme generates constructs that produce 
modest quantities of the variants as insoluble inclusion bodies.   
Therefore, it can be concluded that the additional secondary structure associated in 
homodimeric Zn2+-activated GlxI enzymes is very specific to this metal activation subclass. Therefore 
the Ni2+/Co2+-activated enzymes are not optimal scaffolds for subtle modification towards Zn2+-
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activation.  However a rational and detailed structural basis for divergent metal activation in GlxI 
remains undefined and hopefully can be resolved with further research. 
The difference in metal selectivity for GlxI enzymes may affect other properties of the 
enzyme, such as the metal stoichiometry in active enzyme, the process for metal insertion into the 
active site and enzyme-substrate interactions. This investigation addresses some of these topics and 
are described in the next section. 
 
1.8 Synopsis of Project 
Several aspects of biochemical research have been addressed in the scope of the doctoral dissertation 
presented herein.  Since the E. coli GlxI enzyme has been characterized and well documented as a 
non-Zn2+-dependent GlxI, it was of considerable interest to ascertain whether E. coli GlxII was also 
divergent in metal selectivity.  Thus the isolation and characterization of E. coli GlxII has been 
carried out and the results are summarized in this document. 
  
1.8.1 Characterization of GlxI Homologs from Pseudomonas aeruginosa 
During the course of this project it became apparent that the genome of Pseudomonas aeruginosa 
strain PAO1 contained three GlxI-encoding homologs.  The enzyme encoded by gloA1 has been 
characterized previously and identified as a Ni2+/Co2+-activated GlxI enzyme.  Interestingly the other 
two homologs in the P. aeruginosa genome appeared to encode one additional Ni2+/Co2+-activated 
GlxI enzyme as well as a Zn2+-dependent enzyme.  At the time, we were not aware of any other 
bacteria possessing multiple genes encoding GlxI, and subsequently characterized these sequences 
confirming that they encode functional forms of the lyase.  Additionally the metal ion requirement 
inferred from sequence comparison was found to be correct from biochemical characterization. 
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1.8.2 Characterization of E. coli GlxII 
The gloB gene from E. coli strain MG1655 was cloned and overexpressed in order to characterize the 
second component of the E. coli Glx system.  We were particularly interested in determining whether 
the metal specificity of the hydrolase would be similar to those of E. coli GlxI, so that the entire Glx 
system in this organism is Ni2+/Co2+-activated. The results of this characterization indicate that E. coli 
GlxII is a Zn2+-metalloenzyme with two Zn atoms occupying its binuclear active site. 
1.8.3 Deuterium Isotope Effects on E. coli GlxI-Catalyzed Isomerization 
In an attempt to address whether the mechanistic attributes of GlxI-catalyzed isomerization are 
retained in the non-Zn2+-activated enzyme, the deuterium isotope effects exhibited by GlxI from E. 
coli have been examined using the substrates phenylglyoxal and α-deuteriophenylglyoxal.  The 
deuterium isotope effects have been determined using Ni2+- and Cd2+-substituted GlxI. The present 
results indicate that the presence of an isotope effect depends to some extent upon the metal present at 
the active site.   
A wealth of kinetic and mechanistic investigation has been conducted on Zn2+-activated GlxI 
enzymes.  The proton transfer mechanism proposed for GlxI was  based upon solvent isotope 
incorporation experiments using the Zn2+-dependent GlxI enzyme of S. cerevisiae (86, 87).  
Stereoselectivity of the GlxI enzymes has also been investigated by quantitating the relative rates of 
turnover of conformationally locked substrates using S. cerevisiae GlxI also (88).  The results of this 
investigation revealed that GlxI exhibits no preference for either diastereomer of the MG-GSH 
hemithioacetal.  Finally the kinetic isotope effects of yeast GlxI were determined using 
perdeuteriomethylglyoxal and α-deuteriomethylglyoxal as proposed by Vander Jagt and Han during 
the 1970’s (86).  These experiments indicate that the proton transfer step is partially rate determining 
for GlxI-catalyzed isomerization (86, 87).  Considering that the GlxI enzymes can be sub-classified 
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on the basis of metal activation, the kinetic and mechanistic aspects of the Zn2+-dependent GlxI-
catalyzed reaction should be re-examined in the Ni2+/Co2+-activated system.   
 
1.8.4 SlyD Metallochaperone and E. coli GlxI Ni2+-Loading in vivo 
The NiFe hydrogenase in E. coli is a well-studied example of a Ni2+-dependent enzyme with a 
cognate set of metallochaperones that assist with co-factor insertion in vivo (89, 90).  In an attempt to 
determine whether E. coli GlxI is subject to metallochaperone-mediated Ni2+-insertion, a comparison 
of GlxI activity in slyD+ versus ∆slyD E. coli strains was performed.  The slyD gene product is a 
peptidylprolyl-cis-trans isomerase that participates in Ni2+ insertion into the NiFe hydrogenase protein 
(6, 91).  Therefore it was of interest to determine whether the presence or absence of this 
metallochaperone would be of consequence to the magnitude of detectable GlxI activity in E. coli cell 
lysates. 
The Zn2+-dependent GlxI enzymes tend to be purified from various sources with Zn2+-
identified in the active site, but not all of them can be re-activated even partially with metal following 
EDTA de-metallation. For example S. cerevisiae GlxI cannot be reconstituted to exhibit any activity 
by addition of exogenous Zn2+ following metal removal with EDTA.  These observations imply that 
the more extended structures of the Zn2+-activated enzymes may reflect differences in the process for 
metallocentre assembly of these GlxI enzymes relative to the Ni2+/Co2+-activated forms.   
1.8.5 Nuclear Magnetic Resonance (NMR) Studies of Metal Binding in E. coli GlxI 
The half-of-the-sites metal activation and metal occupancy in E. coli GlxI is an interesting feature of 
this enzyme, given the homodimeric assembly as well as the availability of two identical active sites 
for metal recruitment .  The one-metal per dimer sufficiency for catalytic activation has also been 
documented for the L. major GlxI and has been observed as an attribute of the holoenzyme crystal 
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structure for this parasitic enzyme.  No structural changes are obvious in the E. coli apoenzyme 
versus the various holoforms as assessed by X-ray crystallography.  To investigate the dynamics of 
metal binding in E. coli, and verify biophysically the enzyme’s propensity for half-of-the-sites 
metallation, 1H15N-heteronuclear single quantum correlation nuclear magnetic resonance (HSQC-
NMR) was performed on 15N -labelled enzyme during incremental titration with Ni2+.  Additional 
investigation of ligand binding effects on the backbone orientation of the E. coli GlxI was conducted 
by titration with an inhibitor. A metal titration on the less active ligand variant H74Q GlxI was 




Chapter 2  Glyoxalase I Homologs in Pseudomonas aeruginosa  
 2.1 Gene Transfer and P. aeruginosa 
The P. aeruginosa genome has been analyzed extensively in an effort to understand how its 
composition of genes evolved. The complete genome sequence for P. aeruginosa strain PAO1 was 
reported in 2000 (92). In this publication Stover et al. reported that 10 regions of the genome, that 
were 3 kB or greater in size exhibited low G+C content (relative to the rest of the genome) and 
unusual codon usage (92). Regions of a genome that have a very different codon usage compared to 
the rest of the bacterial chromosome are typically suspected of originating from another species (93, 
94, 95). The base composition and codon usage may be indicative of genomic regions acquired 
through horizontal gene transfer (92, 93).  Horizontal or lateral gene transfer refers to gene transfer 
between different species; this includes mechanisms such as conjugation, transformation and 
transduction (96). This contrasts with the “vertical” gene transfer, which refers to inheritance of DNA 
from a parental/progenitor organism (96).  
Genomic sequence data and protein sequence data have been used in most cases to postulate 
whether horizontal transfer has shaped the genome of an organism. Some indicators of horizontal 
transfer include the observation of highly similar homologs between two distantly related organisms 
(93). This evidence is most convincing when the homolog has the highest similarity to that of an 
organism in a distant taxon (93).  This attribute is largely dependent on the cutoff values for similarity 
that are chosen when making these comparisons. Horizontal gene transfer may be suspected when a 
cluster orthologous genes in a given organism is highly similar to an organism from a distant 
taxon(93). Conservation of gene order for a set of orthologs between distant taxa may also be 




Analyzing the base composition of bacterial genomes has also been employed for inferring 
that a genomic region might have been laterally acquired.  These regions include genomic islands, 
which are large chromosomal regions call ed genomic islands originating from horizontal transfers 
that are flanked by repeat sequences and situated nearby tRNA-encoding genes (97).  Lateral gene 
transfer has been identified as a mechanism by which P. aeruginosa strains have acquired certain 
virulence determinants. Disseminating genetic material by these mechanisms may also contribute to 
the presence of multiple homologs of a given gene in an organism. 
2.2 Gene Duplication 
The presence of multiple homologs of a gene within a bacterium may indicate that gene transfer or 
gene duplication events have taken place. Duplication of genes may result from whole genome 
duplication, segmental duplication, retrotransposition of mature RNA’s or tandem duplication of 
genes (98) Adaptive evolution may drive gene duplication events depending on the physiological 
requirements of the bacterium. For example comparative genomic studies on Mycobacteria species 
have revealed gene duplications in metabolic pathways that are non-uniform between the species 
examined. (99) For example two genes involved in lysine metabolism are present in multiple copies 
in the genome of Mycobacterium avium ssp.paratuberculosis (99). Marri et al. have suggested that the 
increased biosynthesis of lysine may be required to make the cell wall of this bacterium resistant to 
the acidity of the ruminant gut (99).  A physiological basis for multiple GlxI organisms in P. 
aeruginosa has not yet been identified. 
2.3 pyrC: An Example of Multiple Homologs in the P. aeruginosa Genome 
There is precedent for redundant copies in P. aeruginosa since it contains three homologs for the 
pyrC gene that encodes dihydroorotase (100).  Only two of the gene loci encode functional 
dihydroorotases in contrast to the GlxI homologs which are all functional (100).  Dihydroorotases are 
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Zn2+-dependent enzymes that catalyze the reversible cyclization of carbamoyl L-aspartate to L-
dihydroorotate (100).  In our investigation, we used the P. aeruginosa chromosomal map to determine 
whether the gloA homologs in P. aeruginosa clustered with any of the pyrC homologs, given the 
same number of duplicate genes/pseudogenes.   Only gloA1 was within 2.5 kilobases of the functional 
pyrC homolog designated PA3527 according to the Pseudomonas Genome Database (Figure 2.1).  
Thus it is not likely that the occurrence of multiple pyrC loci in the P. aeruginosa genome arose from 














Figure 2.1:  Chromosomal region surrounding gloA1 gene in strain PAO1. 
2.4 P. aeruginosa has Three GlxI-Encoding Genes 
Although the mechanism by which genes become situated or duplicated in a genome may not always 
be known, it is an interesting exercise to document the existence of homologs in bacterial genomes.  
This genomic context is particularly intriguing, as bacterial genome organization tends to be 
economical in the sense that all genes residing on the chromosome are expressed and contribute to the 
overall cellular physiology of the organism.  The published Pseudomonas aeruginosa PAO1 genome 
indicates the existence of three putative GlxI-encoding open reading frames as delineated by 
hypothetical functions in the PAO1 strain genome database (www.pseudomonas.com) (92, 101). The 
gene designated gloA1 (designated by the locus tag PA3524 in the Pseudomonas Genome Database), 
in this database was initially identified and characterized in our previous comparative studies of 
bacterial GlxI enzymes based on its similarity to the E. coli GlxI (Figure 2.2) (3, 66).  The E. coli 
GlxI polypeptide sequence was employed as a query in selecting candidate homologs for biochemical 
analysis.  GloA1 (gene product of gloA1) has been fully characterized as a non-Zn2+-dependent, 
homodimeric GlxI enzyme with a similar metal activation profile to the E. coli GlxI (Figure 2.2).  




3938 kbp 3949 kbp 
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Additional sequences (gloA2 and gloA3, designated by locus tags PA0710 and PA5111 respectively) 
with predicted lactoylglutathione lyase functions however appeared to be present in the P. aeruginosa 
genome (Figure 2.2). 
 
Figure 2.2:  Sequence alignment of P. aeruginosa GlxI enzymes (GloA1, GloA2 and GloA3; 
NCBI accession numbers are: AAG06912, AAG04099 and AAG08496 respectively) with other 
representative enzymes from both metal activation classes.  The other sequences displayed are 
from E. coli, P. putida and H. sapiens GlxI enzymes (Accession numbers are AAC27133, 
NP_745896 and NP_006699 respectively). Conserved residues directly involved in metal 
coordination are marked with an asterisk. The letters A, B and C denote internal regions of extended 
sequence present in the Zn2+-dependent enzymes that are systematically absent in the non-Zn2+-
dependent GlxI sequences. The alignment was created in CLC Free Workbench (CLC bio A/S) 
version 3.0.1 using the accurate alignment algorithm. 
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P. aeruginosa and S. typhimurium are notable amongst bacteria for having three GlxI 
homologs encoded in its genome. The P. aeruginosa GlxI-encoding genes (gloA1: 3944184 - 
3944570 nucleotides, gloA2: 782570 – 782965 nucleotides, gloA3: 5754144 – 5753614 nucleotides, 
according to annotation in Pseudomonas Genome Database, version 2) are located on chromosomal 
regions distant from each other, hence the gloA genes do not constitute an operon (Figure 2.3) (92, 
100). The genomic organization of P. aeruginosa in general does not exhibit the discrete functional 
clustering observed in the operons of the Enterobacteriaciae (102).  The completed genome sequence 
of strain PAO1 was reported in 2000 and there is little evidence for recent gene duplication events on 
the chromosome (92).  This is indicated by the high G + C content of 66.6.% of the PAO1 
chromosome, with only ten regions possessing a low G + C content and divergent codon usage 
suggestive of recent horizontal gene transfer (92).  None of the GlxI-encoding genes in PAO1 reside 











Figure 2.3:  Chromosomal regions surrounding A) gloA1, B) gloA2 and C) gloA3 genes in PAO1. The 
ORF’s code for hypothetical proteins: PA0705 - probable glycosyl transferase; PA0708 - transcriptional 
regulator; PA0709- hypothetical protein; PA0711 - hypothetical protein; PA0712 - hypothetical protein; 
PA0713 - hypothetical protein; PA0714 - hypothetical protein; PA5108 - hypothetical protein; PA5109 - 
hypothetical protein; PA5113 - hypothetical protein. .cat is a chloramphenicol acetyltransferase -encoding gene, 
toxR codes for transcriptional regulator ToxR, blc is the gene for the Blc outer membrane lipoprotein, fbp codes 
for fructose-1,6-bisphosphatase-encoding gene and estA codes for the EstA esterase. 










In contrast P. aeruginosa only has one copy of a GlxII-encoding gene, as is the case for other 
pseudomonads (sp. Fluorescens, putida, phaseocola, entomophila), E. coli, and all other bacteria 
listed in the TIGR comprehensive microbial resource database (http://cmr.tigr.org/tigr-
scripts/CMR/CmrHomePage.cgi).   This gene resides in a genomic region that appears to be well 
conserved amongst the Pseudomonad genome sequences catalogued in the Pseudomonas Genome 
database. 
 Only one true pseudomonad listed in pseudomonas.com, P. fluorescens possesses a 
methylglyoxal synthase-encoding gene (103). Clearly the physiological context and evolution of 
methylglyoxal metabolism in pseudomonads is complex and not easily deciphered from preliminary 
genomic comparisons.   
Considering the relatedness of the true pseudomonads (related to P. aeruginosa in the DNA-
rRNA homology group I, within the Gammaproteobacteria class) P. aeruginosa stands out as the only 
species relative to P. putida KT2440, P. fluorescens Pf-5 and P. syringae DC3000 (whose genomes 
have all been completely sequenced) with three GlxI homologs in its genome (103, 104, 105, 106).  
The GlxI enzymes in the Pseudomonas species possess GlxI homologs with significant similarity to 
GloA3, representing the Zn2+-dependent class.  Genome region comparisons indicate no conservation 
of the chromosomal regions containing GlxI between the four species (101).  This is not unusual 
considering that genome alignments indicate many chromosomal rearrangements have occurred 
within the distinct species in spite of the conservation of homologs (107).  P. aeruginosa appears to 
diverge from the fluorescens, putida and syringae genomes at a phylogenetic level which may 
account for the higher percent identity between the latter two putative GlxI amino acid sequences as 
opposed the identity shared by P. aeruginosa GloA3 (107). 
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These putative P. aeruginosa GlxI sequences were cloned and characterized to verify whether 
they exhibited lactoylglutathione lyase activity (108).  Interestingly, metal reconstitution studies of 
GloA2 and GloA3 have determined that the former is a non-Zn2+-activated GlxI enzyme while the 
latter is isolated as an active Zn2+-holoenzyme (108). It is clear from the present work that P. 






The reagensts listed below were used in other experiments described in this thesis and are referred to 
accordingly. Nickel (II) chloride hexahydrate (99.9999% pure), 2,6-pyridinedicarboxylic acid 
(dipicolinic acid, DPA, 99% purity) were from Aldrich (Oakville, ON, Canada), cobalt chloride 
hexahydrate (assay, 100%, specification, 98–102%), cadmium chloride (assay, 99.4%), manganous 
chloride tetrahydrate (assay, 98.8%) and zinc chloride (assay, 99.3%) were obtained from J. T. Baker 
(Toronto, ON, Canada), and magnesium chloride hexahydrate (assay, 99.2%) and calcium chloride 
dihydrate (assay, 75.5%) was obtained from BDH (Toronto, ON, Canada). ZnSO4 heptahydrate 
(assay 99%) was obtained from Fisher (Nepean, ON, Canada) and was obtained from Aldrich 
(Milwaukee, WI, USA). Aqueous methylglyoxal (MG) (40% v/v), S-D-lactoylglutathione (SLG), 
reduced glutathione, guanidinium hydrochloride and phenylglyoxal (PG) monohydrate was purchased 
from Sigma (Oakville, ON, Canada). Water used in experiments was purified using a Milli-Q RG 
Ultrapure water system (18 MΩ-cm; Waters Associates, Milford, MA, USA). Tris acid, Tris base, 
solid (NH4)2SO4 , Isopropyl β-D-thiogalactoside (IPTG), HEPES, MOPS and phenylmethylsulfonyl 
fluoride (PMSF) were purchased from Bioshop Canada (Burlington, ON). KCl was obtained from 
EMD Biosciences (Gibbstown, NJ, USA).  Chelex 100 cation exchange resin was obtained from Bio-
Rad (Mississauga, ON, Canada) for the removal of divalent cations from buffer solutions and water. 
Biolyte 4-6 commerical ampholyte (40% stock) was employed for purification of GloA2 and GloA3 
at dilutions in the focusing cell to a final concentration of 1-1.5% v/v. Water used in all experiments 
and purification protocols was purified using a Milli-Q RG Ultrapure water system (18 MΩ-cm; 




2.5.2 Chromatography Resins 
The chromatographic media listed below have been used in other experiments described in this thesis 
and are referred to accordingly. The chromatographic resins Q-Sepharose Fast Flow, Mono-Q anion 
exchange, Phenyl HP Hi Sub, and Superdex 75 were obtained from Amersham Biosciences (Uppsala, 
Sweden). The pre-packed Unosphere-Q anion exchange column was obtained from Bio-Rad 
(Mississauga, ON, Canada). 
2.5.3 Centrifugation 
Centrifugation of volumes exceeding 20 mL was carried out using a Beckman Avanti J-25I centrifuge 
(JA 25.5 rotor used for 20-50 mL volumes, JA 14.4 rotor used for volumes exceeding 50 mL up to 
250 mL, and JA 10 rotor used for volumes exceeding 250 mL up to 500 mL) (Mississauga, ON).  
Centricon® concentrators were spun in a VWR Clinical 100 (Labnet International, Woodbridge NJ, 
USA) clinical centrifuge centrifuge at 3500 rpm.  Centrifugation of volumes suitable for 
microcentrifuge tubes was performed using the Biofuge A microcentrifuge (Heraeus Sepatech GmbH, 
Germany).  The microcentrifuge was used at speeds of 13 000 rpm for pelleting of cells for SDS-




2.5.4 Chromatographic Systems 
Fast peptide and protein liquid chromatography (FPLC®) on cell lysate was performed using a 
Pharmacia (now Amersham Biosciences, Uppsala, Sweden) Biotech system consisting of the 
following components: LCC-500 chromatography controller, two P-500 pumps, MV-7 motor valve, 
UV-M monitor. A Waters high-pressure liquid chromatography (HPLC) system was also used for 
protein purification. This system consisted of a Waters 600S Controller, Waters 626 Pump amd 
the2996 Photodiode Array detector. The EmpowerTM software suite was used for data collection and 
chromatogram generation with this system. 
2.5.5 Preparative Isoelectric Focusing 
The Rotofor® preparative isoelectric focusing apparatus from Bio-Rad (Missisauga, ON, Canada) was 
used for the preparation of apo-GlxI enzymes from E. coli and GloA2 of  P. aeruginosa. 
2.5.6 Incubators  
Either a Gyrotory® Model G76 (New Brunswick Scientific, Edison, NJ) water bath shaker at a speed 
setting of 5, or a Series 25 (also New Brunswick Scientific) controlled environment incubator shaker 
at 200 rpm was employed for growing bacterial broth cultures.  Standing broth cultures or plated 
bacterial cultures were grown in a Precision® gravity convection incubator from Precision Scientific, 
Inc. (Chicago, IL). 
2.5.7 Protein Concentration and Buffer Exchange 
Concentration of purified protein and exchange into storage buffer was achieved using either 
Centricon® YM10 centrifugal concentrators (0.5 mL – 2 mL volumes), Vivaspin 10 (Sartorius, 
Gottingen, Germany) centrifugal concentrators (0.5 mL – 2 mL volumes), Nanosep microcentrifugal 
concentrators (10 kDa cutoff membrane for 40 µL – 400 µL volumes) (Pall Life Sciences, , Ann 
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Arbor, MI, U.S.A.), Amicon® ultrafiltration cells (50mL or 10mL volume), using Millipore YM10 
membranes (Millipore, Billerica, MA).  
2.5.8 Spectrophotometry 
Protein quantitation and spectrophotometric assays of GlxI activity were performed using a Varian 
Cary 3 (Mississauga, ON) spectrophotometer, using the Cary WinUv software, version 3  (Varian 
Instruments Walnut Creek, CA, USA) for instrument control and data collection.   
2.6 General Methods for GlxI Characterization 
This section describes methods that have been used in the isolation and characterization of GlxI 
enzymes for several of the studies described within this thesis. The use of methods in this section will 
be referred to accordingly. 
2.6.1 Assay for GlxI Enzymatic Activity 
The glyoxalase I enzyme assay employed in these studies was performed according to the procedure 
documented by (109).  A solution of the hemithioacetal substrate at a given concentration was made 
by the addition of methylglyoxal (MG) and GSH to degassed 50 mM potassium phosphate buffer, pH 
6.6.  The mixture was equilibrated after mixing at room temperature for 15 minutes prior to ensure 
hemithioacetal formation to occur.  The free GSH was maintained at 0.1 mM to prevent enzyme 
inhibition (110).  Hemithioacetal concentrations were calculated using the dissociation constant for 
the species at pH 6.6, such that Kdiss = 3.1 mM (111).   
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The equilibrium equation for hemithioacetal concentration used in these calculations is as follows:   
Kdiss = [MGtotal – MGcomplex] [GSHtotal – GSHcomplex] 
          MG-GSHcomplex] 
Note: [GSHfree] = [GSHtotal – GSHcomplex] = 0.1 mM 
  
 Enzyme activity was measure spectrophotometrically by observing formation of S-D-
lactoylglutathione at 240 nm (112).  The reaction was monitored in quartz cuvettes with a pathlength 
of 10 mm, and the rate of thioester formation was calculated using the extinction coeffecient of 2860 
M-1cm-1 (112). Initial rate data was fitted by non-linear regression analysis using the software GraFit 
version 3.01 (Erithacus Software). 
2.6.2 Methylglyoxal (MG): Distillation and Concentration Determination 
Distillation of aliquots MG (40% aqueous solution) was performed prior to usage as a working stock 
to remove polymers and other contaminants.  The MG was distilled at atmospheric pressure, and the 
distillate was collected between 92 – 96 °C (Vince et al. 1971).  This purified stock was stored at 4 °C 
for up to six months.   
 The concentration of the distilled MG was determined on a periodic basis (once a month 
during useful lifetime) utilizing a method based on the spectrophotometric glyoxalase I assay (113).  
Essentially the enzyme assay was run in triplicate using a sufficiently dilute MG concentration and 
excessive GSH concentration, ensuring all MG was consumed during the reaction.  The MG stock 
concentration was subsequently determined from the amount of S-D-lactoylglutathione detected by 
∆A240 using the extinction coefficient 2860 M-1 cm-1.   
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The procedure for MG calibration is as follows.  Matched 1 mL cuvettes were filled with 100 
mM potassium phosphate buffer, pH 6.8.  To this buffer, GSH was added to a final concentration of 
0.5-1.0 mM and approximately 0.1 units of purified E. coli GlxI or yeast GlxI grade IV from Sigma 
was also added (where one unit of enzyme = enzyme quantity producing 1 mmol of S-D-
lactoylglutathione per minute).  The initiation of the GlxI reaction was achieved by addition of 
distilled MG that was diluted 150-fold, such that the final concentration of this substrate constituent 
was 0.2-1.0 mM. 
2.6.4 Determination of Glutathione (GSH) Concentration 
A precise determination of GSH concentration is required for quantitative preparation of MG-GSH 
hemithioacetal solutions.  GSH titration with 5,5’dithio-bis(2-nitrobenzoic acid) (DTNB) was used 
for [GSH] determination by the method of Ellman (114).  As for other assays a 50 mg/mL GSH 
working stock was prepared in assay buffer (degassed).  An aliquot of this stock was diluted 60-fold 
in 100 mM potassium phosphate buffer pH 7.4, and basified with sodium carbonate to pH 7.5-8.0.  In 
a sample cuvette the diluted, basified GSH was added to 100 mM potassium phosphate buffer pH 7.4 
for a final volume of 1 mL, such that the final GSH concentration was around 0.05 mM.  DTNB as a 
1-2 mg/mL stock in HPLC grade methanol, was titrated into sample and reference cuvettes while 
monitoring the absorbance at 412 nm until no further increase in absorbance was observed.  The 
overall change in absorbance was used to calculate the GSH stock concentration, based on the molar 
extinction coefficient of the DTNB-GSH disulfide complex (14 150 M-1 cm-1) (115).   
2.6.5 Removal of Activating Metals from Buffers and Plasticware 
To store purified apoGlxI storage buffers and plastic containers should be free of re-activating metal 
ions.  Such buffers and containers should also be used for the preparation of metal chloride stock 
solutions and for preparations of metal-reconstituted GlxI.  Divalent metals were removed from 
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buffers and/or water with a cation exchange resin. Specifically, 5-6 grams of Chelex 100 resin was 
used to treat approximately one liter of solution.  Plastic containers were treated to remove metal ions 
by soaking in 10% HNO3 (v/v) for 15-20 minutes, followed by numerous rinses with distilled 
deionized water, and several rinses of Chelex treated water, or rinsing of a buffer storage vessel with 
aliquots of Chelex treated buffer. 
2.6.6 Preparation of Protein Samples for Mass Spectrometry   
Purified GlxI samples were desalted prior to injection into an electrospray ionization mass 
spectrometer.  Protein samples were dialyzed to exchange buffer for Milli-Q grade water, with one 
change of solution between three and six hour periods of stirring respectively.  Each dialysis chamber 
was scaled to permit approximately a 10 000-fold dilution of the buffer constituents in the GlxI 
sample, i.e 50 µL of purified GlxI in 50 mM MOPS pH 7.0 against 500 mL water. 
2.6.7 Microbiological Media 
All microbiological media was prepared using deionized-distilled water.  
Luria-Bertani (LB) media was used for the growth of E. coli except where indicated. The composition 
of this medium consists of 10g tryptone (EMD Biosciences, Gibbstown, NJ, USA), 10g NaCl (EMD 
Biosciences, Gibbstown, NJ, USA) and 5g yeast extract (EMD Biosciences, Gibbstown, NJ, USA) 
per liter of media. The media is adjusted to pH 7.0 with NaOH. LB media was also used as a solid 
growth medium by adding agar (EMD Biosciences, Gibbstown, NJ, USA) to the prepared broth for a 
final concentration of 3% w/v. 
 Terrific Broth (TB) was also used as a growth medium for E. coli where indicated. The 
composition of TB per liter of media is 12g tryptone (EMD Biosciences, Gibbstown, NJ, USA), 24g 
yeast extract (EMD Biosciences, Gibbstown, NJ, USA), 4mL glycerol (EMD Biosciences, 
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Gibbstown, NJ, USA), 17mM KH2PO4 (from EMD Biosciences, Gibbstown, NJ, USA) and 7.2 mM 
K2HPO4 (EMD Biosciences, Gibbstown, NJ, USA). The potassium salts are added as a 100 mL 
solution of 0.17M KH2PO4 and 0.72M K2HPO4 to the other media constituents, which have been 
dissolved in 900 mL of water. 
M9 minimal salts media was used to grow E. coli in liquid cultures where indicated. The 
concentrated M9 minimal salts solution consists, per liter of: 64g Na2HPO4-7H2O (Bioshop Canada, 
Burlington, ON, Canada), 15g KH2PO4, 2.5g NaCl and 5.0g NH4Cl (BDH, Toronto, ON, Canada). 
 
One liter of prepared M9 minimal salts medium consists of: 
 
•    200 mL of M9 salts  
•   2 mL of 1M MgSO4 (sterile)  
•   20 mL of 20% glucose (v/v) (Fisher, Nepean, ON, Canada) 
•   100 µL of 1M CaCl2 (sterile)  
•   100 µL of 0.5% thiamine HCl (v/v) (Sigma, Oakville, ON, Canada) 
 
2.7 Isolation and Characterization of GloA2 and GloA3 
2.7.1 Bacterial Strains and Sources of Template DNA   
E. coli strains BL21(λDE3) (F-, ompT, hsdS(r-B, m-B), gal, dcm, λDE3(lacI, lacUV5-T7 gene 1, 
ind1, sam7, nin5) and DH5α (φ80dlacZ∆M15, recA1, endA1, gyrAB, thi-1, hsdR17(rK-, mK+), 
supE44, relA1, deoR, ∆(lacZYA-argF) U169, phoA) were used as GlxI overexpression and plasmid 
propagation hosts respectively. Genomic DNA was isolated from wild-type P. aeruginosa strain 
PAO1 (wild type strain). This strain was obtained as a gift from Dr J. Lam of the University of 
Guelph (Ontario, Canada). Oligonucleotides and DNA sequencing - DNA primers for isolating gloA2 
and gloA3 were obtained from Sigma Genosys (Oakville, Ontario, Canada). Sequencing of the 
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plasmid constructs for overexpression was performed by MOBIX (McMaster University, Hamilton, 
Ontario, Canada). 
2.7.2 Cloning of P. aeruginosa Genes gloA2 and gloA3  
The putative GlxI DNA sequences used to design oligonucleotide primers were based upon the 
nucleotide sequences for the gloA2- and gloA3-encoding genes as indexed in the Pseudomonas 
Genome database at (www.pseudomonas.com). The gloA2 gene was amplified from the 
aforementioned template DNA by PCR, using the following primer pair: 
(+)5′CCAGTCGACCATATGCGAATCCTGCACAGCATGC3′, 
(−)5’CGTGGATCCTCAATCGAACTGGGTGCCCTTCTGG3′ . The gloA3 gene was amplified 
from the aforementioned template DNA by PCR, using the following primer pair:  
(+)5′ CCAGAATTCCATATGAGTTTCAACACCGAAGTACAGC3′,  
(−)5′CCAGAATTCTCTCAGCCGCGTCCCATCTCGCCG 3′. 
The thermal cycle profile used for amplification of gloA2 and gloA3 was as follows: 
1) Initial denaturation @ 95°C for 30 s 
2) Hot start @ 85°C  
3) 10 cycles of: 
Denaturation @ 95°C for 30 s 
Primer annealing @ 59°C (for gloa3 amplification) or 63°C (for gloA2 amplification) 
Extension @ 72°C for 45 s 
4) 15 cycles of: 
Denaturation @ 95°C for 30 s 
Primer annealing @ 59°C (for gloa3 amplification) or 63°C (for gloA2 amplification) 
Extension @ 72°C for 45 s with 5 s time extension per cycle 
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5) Final Extension @ 72°C for 10 min 
 
For both gloA2 and gloA3 amplification, primer concentration used was 300nM, the 
dinucleotide triphosphate concentration was 0.2 mM and the amount of template DNA was 300ng in 
a 100 µL reaction. Optimal MgSO4 concentrations were 2.0 mM and 2.5 mM for gloA3 amplification 
and 1.5 mM for gloA2 amplification. 
The gloA2 amplification product was ligated into the pET22b expression vector (ampR, T7 
lac promoter, f1origin of replication; Novagen, Madison, WI, USA), which was prepared by 
restriction endonuclease digestion with NdeI and BamHI. The digestion products were subsequently 
ligated to generate the over-expression constructs designated pPAG4. The gloA3 amplification 
product was ligated into pET22b following restriction endonuclease digestion with NdeI and EcoRI, 
which generated the overexpression plasmid called pPAG3. All three plasmid constructs were 
transformed into E. coli BL21(λDE3) cells, yielding the final overexpression systems for these GlxI 
enzymes. 
2.7.3 Growth and Induction of gloA2- and gloA3-overexpressing E. coli Cells   
The protocol for induction of GloA2 (using E. coli  BL21-(λDE3)/pPAG4)  was similar to that used 
for induction of the E. coli GlxI-overexpression system, except that no NiCl2 was added to the growth 
medium and the cells were induced with 0.5 mM isopropyl β-D-thiogalactoside (IPTG) for 4 hours as 
opposed to the 6 hour induction for E. coli MG1655/pGL10(51).  For overproduction of GloA3, E. 
coli BL21-(λDE3)/pPAG3 was grown in 0.5 or 1 L of Terrific Broth (TB) containing  a range of 0 - 1 
mM ZnSO4. The absence or presence of ZnSO4 in the media did not appear to alter the activity of the 
isolated holoenzyme. At an optical density of 0.5 at 600 nm, induction of protein production was 




2.7.4 Purification of GloA2 and GloA3   
BL21(λDE3)/pPAG3 or BL21(λDE3)/pPAG4 cells were re-suspended in 20 mM Tris pH 7.5, and 
disrupted by sonication.  For GloA3 purification, 15 mM DL-methionine or 10 mM dithiothreitol 
(DTT) was present in purification buffers to attenuate methionine and cysteine oxidation.  Glycerol 
and phenylmethylsulphonyl fluoride PMSF (1M stock in HPLC-grade acetone) were added to the 
lysates so that the final concentrations were 10% v/v and 1 mM respectively. The lysates were 
clarified by centrifugation at 48 434 x g for 15 minutes at 4 ºC.  Lysates were filtered through a 0.2 
µm filter and loaded onto a 10/30 Q-Sepharose Fast Flow column (Amersham Biosciences) at 1 
mL/min. The protein was eluted from the column using a 100 minute gradient with a 1%/min change 
in percent salt concentration [from: 20 mM Tris/HCl, 10% (v/v) glycerol, pH  7.5; to: buffer + 1 M 
KCl].  The GlxI-containing fractions were pooled and dialysed against 20 mM Tris, pH 8.0 for 
GloA2, and against 20 mM Tris, pH 7.5 for GloA3, then applied to a Mono-Q (Amersham 
Biosciences) column. A similar KCl gradient to that used on the Q-Sepharose column was applied for 
this purification step using the Tris buffers at their respective pH’s. GloA2-containing fractions were 
pooled and dialyzed into 20 mM MOPS, 150 mM KCl, pH 7.0 and applied to a 10/30 Superdex 75 
gel filtration column for purification.   
The GloA2-containing fractions from this chromatographic step were pooled and dialyzed 
into 10% glycerol prior to loading into the Rotofor (Bio-Rad, Hercules, CA) preparative isoelectric 
focusing cell for preparation of apoenzyme at 12 W constant power for 4-6 hours. The cell was 
maintained with constant cooling by a re-circulating water bath at 4 °C.  The focusing medium used 
in this preparation was the ampholyte solution indicated in the materials section at the specified 
concentration.  Purified apo-GloA2 was concentrated and stored in 50 mM Chelex-treated MOPS, 
pH 7.0, in acid-treated plasticware at 4 °C.  GloA3-containing MonoQ fractions were dialyzed into 50 
mM potassium phosphate buffer, pH 6.6 and solid (NH4)2SO4 was added to the dialysed sample to a 
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final concentration of 1.7 M. The sample was filtered with a 0.2 µm filter and loaded onto a 1 mL 
Phenyl HP High Sub column (Amersham Biosciences) at 1 mL/min with 50 mM potassium 
phosphate, 1.7 M (NH4)2SO4, pH 6.6. The protein was eluted with a decreasing gradient of (NH4)2SO4 
and purified GloA3 was collected as a single peak. The protein was exchanged into 50 mM MOPS, 
pH 7.0 (Chelex-treated) and stored at 4 °C. 
2.7.5 Molecular-Mass Determination  
 Electrospray ionization mass spectrometry (ESMS) was used to confirm the molecular mass of the 
overproduced bacterial GlxI enzymes in purified samples. Analysis was performed on protein 
samples using a Micromass quadrupole time-of-flight (Q-TOF) Ultima Global (Manchester, U.K.) 
mass spectrometer at the Waterloo Chemical Analysis Facility, University of Waterloo. Samples 
made up in Milli-Q grade water were introduced using eluants consisting of 1:1 water/acetonitrile 
plus 0.2% formic acid. Electrospray ionization was performed in positive ion mode.  
2.7.6 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS/PAGE) 
 SDS/PAGE was employed to select for GloA2 and GloA3-containing fractions during 
chromatographic purification. Separation (using pre-cast gels with acrylamide gradients ranging from 
10-15%, or 8-25%) and visualization (Coomassie Brilliant Blue staining) of protein samples by 
SDS/PAGE was performed using a PhastSystem™ (Amersham Biosciences). 
2.7.8 Metal Analysis   
Metal-free water was prepared by passing Milli-Q grade water through Chelex 100 resin (Bio-Rad, 
Mississauga, ON, Canada). Purified GloA3 was exchanged into metal-free water by using a 
Vivaspin10 centrifugal ulttrafiltration device. Approximately 0.38 - 2 mg of GloA3 was submitted for 
metal quantitation in a nitric acid treated plastic tube. The final volume of the sample was 20mL. 
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Metal content was determined at EnviroTest (now ALS Laboratories Waterloo, ON, Canada) by 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS).  The following elements were quantitated 
in the sample: Al, Sb, As, Ba, Be, Bi, B, Cd, Ca, Cr, Co, Cu, Fe, Pb, Mg, Mn, Mo, Ni, P, K, Se, Si, 
Ag, Na, Sr, Tl, Sn, Ti, W, U, V, Zn, Zr. Quantitation of metal in GloA3 was based on three replicates 
of metal analysis on purified enzyme. 
2.7.9 Gel-Filtration Chromatography  
Purified GloA2 or GloA3 in 50 mM MOPS, 150 mM KCl, pH 7.0 were applied to a Superdex 75 
10/30 column equilibrated with the same buffer at 0.4 mL/min. The column was calibrated using  
protein standards from Bio-Rad (ovalbumin, myoglobin, and vitamin B12) and Sigma (bovine 
albumin and carbonic anhydrase). The void volume of the column was determined by  injections of 
Blue Dextran (Sigma) solution. All injections were performed in triplicate using GlxI samples 
2.7.10 GlxI Enzyme Assay  
The assays and assay conditions used for quantification of GlxI activity were identical with those 
described for the characterization of E. coli GlxI (51).  
2.7.11 Metal Activation Profile for GloA2    
The purified GloA2 enzyme was confirmed to be active as a homodimer by gel-filtration 
chromatography (results not shown).  Profiles for metal activation GloA2 with various divalent metal 
chlorides were assessed by means of the GlxI spectrophotometric assay (51). Samples of a particular 
apo-GlxI were diluted in 50 mM Chelex-treated MOPS, pH 7.0, and pre-incubated at ambient 
temperature with 2.5 molar equivalents of metal chloride per dimeric enzyme for at least 10 minutes 
prior to assay.  Enzyme activity was assayed at a 0.5 mM MG-GSH concentration in triplicate. 
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Amounts of GlxI used per assay were 0.15 µg. Activation was assessed using the following metal 
chlorides: Mg2+, Ca2+, Zn2+, Cd2+, Mn2+, Co2+ and Ni2+. 
2.7.12 Determination of Kinetic Parameters   
The Michaelis–Menten constants (Km) and maximal enzyme velocities (Vmax) for GloA2 and GloA3 
enzymes were determined experimentally by measurement of initial reaction rate. Rate data was 
collected at 11 substrate concentrations between the range of 0.01 and 0.5 mM of MG-GSH. For 
GloA2, stock enzyme was diluted with 50 mM Chelex-treated MOPS pH 7.0 and 2.5 molar 
equivalents of NiCl2 or CoCl2, per dimeric enzyme. Enzyme activity at each concentration was 
measured in triplicate. The entire set of triplicates was measured twice, and the values from the 
duplicate experiments were averaged to obtain the final parameter values. For GloA3, the purified 
holoenzyme was diluted to 0.1 mg per mL and assayed under the same conditions as for GloA2, with 
rate data collected at 11 substrate concentrations ranging between 0.1 to 2 mM MG-GSH.  The same 
number of replicates was used to calculate kinetic parameter values for GloA3 as for GloA2. 
2.7.13 Metal Reconstitution of GloA3   
Purified GloA3 (1.9 mg) was incubated in 50 mM MOPS containing 50 mM dipicolinic acid (DPA) 
(final dimeric enzyme concentration of 31.9 µM) with stirring for 4 hrs at 4 °C.  DPA was removed 
from the protein sample by passage through a Nanosep centrifugal ultrafiltration device (molecular 
mass cut-off of 10 kDa) so that the GloA3 sample was changed over to Chelex-treated MOPS, 50 
mM, pH 7.0.  The final concentration of the GloA3 sample obtained following ultrafiltration was 19.7 
µM dimeric enzyme.  To reconstitute the demetallated enzyme, metal chloride (final concentration 25 
µM) was added to a dilution of GloA3 (final concentration 5 µM, 5 equivalents of metal chloride per 
dimeric enzyme) in Chelex treated MOPS pH 7.0. The enzyme was incubated with metal for 48 hours 
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at 4 °C.  Samples were then assayed in 1 mL of 0.5 mM MG-GSH in 50 mM KPB pH 6.6 to obtain 
relative activation levels. 
2.8 Results 
Cloning of the gloA2 and gloA3 genes into the aforementioned expression constructs yielded systems 
producing soluble enzyme that exhibited robust levels of activity in the lysate as determined by 
spectrophotometric assay. Electrospray mass spectra obtained for both purified enzymes were in 
agreement with the predicted molecular mass from ExPASy (Figure 2.4) 
(http://www.expasy.org/tools/protpar-ref.html; Geneva, Switzerland) (116).  Both GloA2 and GloA3 
were identified as dimers in solution by gel filtration chromatography on purified enzyme samples 
(Table 2.1, Figure 2.5).  The apparent molecular weights of GloA2 and GloA3 were 28 kDa and 38 
kDa respectively. The elution volumes for both enzymes were lower than the observed elution 
volume for the 17 kDa myoglobin standard (Table 2.1, Figure 2.5). No additional GloA2- or GloA3- 




     
Figure 2.4: Electrospray ionization mass spectra of A) GloA2 and B) GloA3. The observed mass 
of 14923 Da corresponds well to the calculated mass of 14925 Da for the GloA2 monomer. The 
observed mass of 20082 Da corresponds with the expected mass of the GloA3 with the N-terminal 
methionine residue truncated during heterologous production (20084 Da expected for the monomer 
without N-terminal methionine). 
 
 
Table 2.1: Molecular Weights of Superdex 75 Standards, GloA2‡ and GloA3‡ 
 
Protein Molecular Weight (MW) (Da) Log MW Ve/Vo
* 
 
A) Bovine Albumin† 66000 4.82 1.21 
B) Ovalbumin 44000 4.64 1.37 
C) Carbonic Anhydrase 29000 4.46 1.50 
D) Myoglobin 17000 4.23 1.69 
E) Vitamin B-12 1350 3.13 2.53 
GloA2  24000‡ 4.38 1.56 
GloA3 38000‡ 4.58 1.41 
*Vo was determined by injections of Blue Dextran 
† Proteins A-E were used to standardize the column 









Figure 2.5: Standard curve from Superdex75 chromatography. The lettered data points 
correspond to the standard proteins in the above table.  
 
Preliminary screens on cell free extracts indicated that GloA2 could convert MG-GSH to S-D-
lactoylglutathione as indicated by the standard assay (0.5 mM MG-GSH, 50 mM potassium 
phosphate pH 6.6). This activity was increased with addition of Ni2+ and Co2+ to the assay buffer, but 
not increased with addition of Zn2+. Clearly, this initial profile mirrors the characteristic metal 
activation of the non-Zn2+- activated enzymes from E. coli, and P. aeruginosa GloA1 . GloA3 
extracts by comparison exhibited detectable levels of GlxI activity that was not modifiable by the  
addition of Ni2+, Co2+ or Zn2+.  The enzyme activity detected in these lysates did not vary with the 
presence of ZnSO4 in the growth medium.  Differentiation of the activating metal in GloA3 was 
assessed initially by comparing the second-derivative spectra of 4-(2-pyridylazo)resorcinol-metal 
(PAR) complexes obtained with denatured enzyme to the spectra of PAR with NiCl2 and ZnCl2 
standards indicating the presence of Zn2+ (Figure 2.6) (117, 118). Purified, recombinant GloA3 was 
found to contain Zn2+ by inductively coupled plasma mass spectrometry (ICP-MS) with a Zn2+:dimer 
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ratio of 1:1.  There is precedent for observed mono-metallation in fully active GlxI enzymes from E. 
coli and L. major GlxI enzymes.   
 
 
Figure 2.6:  A) PAR-metal complex absorption spectra for purified GloA3 and indicated metal 
standards B) 2
nd
 derivative of the spectra in A) 
  
GloA2 is therefore similar to the non-Zn2+-dependent GlxI enzymes previously characterized 
based on its metal activation profile and the relative ease with which metal can be removed from the 
holoform.  Isoelectric focusing has been successfully employed demetallating GlxI from E. coli, Y. 
pestis, N. meningitidis and P. aeruginosa (GloA1)(3, 51). Apo-GloA2 was obtained through this 
A 
B 
GloA3 6 µM 
ZnCl2 6 µM 
NiCl2 6 µM 
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method for kinetic characterization and metal reconstitution studies. For GloA2 and the 
aforementioned GlxI enzymes, isoelectric focusing produces enzyme with less than 5% specific 
activity relative to the Ni2+-reconstituted holoform (in the absence of activating metals). These 
activity levels are highly suggestive of an enzyme preparation that predominantly contains apo-GlxI. 
GloA2 appears strongly selective for Ni2+- over Co2+-activation compared to the other bacterial GlxI 
enzymes that we have previously characterized (Figure 2.7). 
 
Figure 2.7: A) Metal activation for GloA1 (3) B) Metal activation for GloA2. The relative 
activities shown are normalized by subtraction of the residual specific activity (1.4% of the Ni2+-
GloA2 specific activity) observed for the apo-control.  Relative activity levels for the Co2+- and Ni2+-
substituted enzyme were obtained from the experimental Vmax values determined for Ni
2+-GloA2. The 
activity of the Ni2+-bound GloA2 is set as the maximal activity (100%) in the metal activation profile 







The metal binding properties of GloA3 are quite different from GloA2.  The apo-form of 
GloA3 could not be obtained by isoelectric focusing, so that fractions isolated from this purification 
process were still highly active when assayed.  Clearly this differs from our observations of non-Zn2+-
activated GlxI enzymes to date, wherein isoelectric focusing results in apoenzyme formation.  Several 
attempts were made at removing the activating metal from GloA3 for the purpose of determining 
metal selectivity.  Incubation of the enzyme with 30 mM EDTA in 50 mM MOPS pH 7.0 for 48-72 
hours (similar condition for preparation of P. putida apo-GlxI (59)), was unsuccessful in deactivating 
this enzyme.  Partial denaturation at pH 3.8 along with EDTA present at 100 mM in sodium acetate 
has been used to generate apo-superoxide dismutase previously.  However subjecting GloA3 to 
similar conditions only resulted in aggregation and precipitation of the enzyme, which could not be 
reversed by dialysis into 50 mM MOPS pH 7.0. The chelator 1,10-phenanthroline could produce a 
detectable decrease in enzyme activity with short-term incubation (20 minutes) but 2,6-
pyridinedicarboxylic acid (dipicolinic acid, DPA) produced the greatest loss of activity under the 
same conditions.  Preparations of partially demetallated enzyme were prepared by removing the 
chelator with a centrifugal ultrafiltration device, generating GloA3 that could be re-metallated with 
different metal chlorides.  The 4-hour incubation in DPA reduced activity to 16% of that observed for 
non-treated enzyme. Partial reactivation of GloA3 was observed with Mg2+, Zn2+ and Cd2+ 
reconstitution (26%, 76% and 87% activity of untreated enzyme, respectively) while apparent hyper-
reactivation was observed with Co2+, Ni2+ and Mn2+ re-constitution (115%, 146% and 146% activity 





Figure 2.8: Metal activation of DPA-treated GloA3. Percentage of observed enzyme activity 
relative to non-DPA treated GloA3 (100%) is shown ± standard deviation. GloA3 was de-metallated 
and reconstituted as described in Experimental Procedures. 
 
Kinetic parameters of GloA2 are very similar to those of P. aeruginosa GloA1 and E. coli 
GlxI (Table 2.2).  The catalytic efficiency of GloA2 approaches the value observed for the E. coli 
enzyme but the selectivity of Ni2+ activation over Co2+ re-constitution is much more pronounced for 
GloA2 compared to the non-Zn2+-dependent bacterial GlxI enzymes characterized previously (E. coli, 
P. aeruginosa GloA1, N. meningitidis, Y. pestis).  GloA3 is comparable in efficiency to the other GlxI 
enzymes in P. aeruginosa, confirming that all three homologs are fully functional GlxI enzymes with 
wild type activity levels (Table 2.2).  In comparison to dimeric P. putida GlxI, GloA3 has a higher 
rate for substrate turnover (kcat for GloA3 ≈ 787 s-1, kcat for P. putida GlxI ≈ 115 s-1  and the catalytic 







Table 2.2: Kinetic Parameters for P. aeruginosa GlxI Enzymes  
 







GloA1* Ni2+ : 32 ± 2 
 
Co2+: 16 ± 3 
 
Ni2+: 571 ± 28 
 







GloA2 Ni2+: 21 ± 0 
 
Co2+: 24 ± 11 
 
Ni2+: 497 ± 8 
 




Ni2+: 1.2 x 107 
 
Co2+: 1.6 x 106 
GloA3 287 ± 47 1176 ± 4 787 2.8 x 106 
 
*Kinetic parameters for GloA1 are as described previously (3). 
 
2.9 Discussion 
Previous research has determined the existence of two biochemically distinct classes of GlxI 
enzymes, a Zn2+-activated and a non-Zn2+-activated (but Ni2+/Co2+ activated) class (3). Two distinct 
classes of GlxI have now been identified and investigated in P. aeruginosa.  The GlxI homologs 
encoded in the P. aeruginosa genome provided an opportunity to  investigate both metal activation 
classes of this enzyme.  GloA2 mirrors the kinetic characteristics and metal selectivity of previously 
characterized non-Zn2+-dependent GlxI enzymes very closely. Not only are the holoforms in this class 
very similar, but the relative ease of obtaining apoenzyme preparations of the non-Zn2+-dependent 
GlxI enzymes is also observed.  GloA3 in contrast, is expressed as a highly active Zn2+-holoenzyme 
from which the activating metal is quite difficult to remove. Difficulty in demetallating the 
Zn2+dependent GlxI enzymes has been observed with other GlxI in this metal activation class.  For 
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example P. putida GlxI as characterized by St. Jean et al. required dialysis against 30 mM EDTA for 
96 hours in order to obtain inactive enzyme. In addition the yeast GlxI enzyme cannot be re-
constituted following extraction of its active site metal ion .  In contrast to non-Zn2+-activated GlxI 
enzymes, GloA3 can be reconstituted with Ni2+ as well as Zn2+ which has been observed with rat liver 
and sheep liver GlxI (also Zn2+-dependent).  Another observable characteristic of the Zn2+-activated 
enzymes is that Mg2+ reconstitution is possible with the Zn2+-dependent class members including 
GloA3, but is not a characteristic of non-Zn2+-dependent GlxI enzymes (119).  
An alignment comparison of all three P. aeruginosa GlxI enzymes indicates several 
interstitial regions present in the extended enzymes, but systematically absent in the shorter non-Zn2+-
dependent forms (Figure 2.9).  The additional structural elements in the Zn2+-dependent GlxI enzymes 
may also account for the observed recalcitrance of GloA3 to metal removal. For example, region A in 
Figure 2.8 corresponds to an α-helix turn proximal to the metal ligands as observed in the crystal 
structure for the human GlxI enzyme, a member of the Zn2+-dependent class of this enzyme.   It is 
possible that the active site of the Zn2+-dependent GlxI enzymes is less open and more tightly 





Figure 2.9: Sequence alignment of P. aeruginosa GlxI enzymes (GloA1, GloA2 and GloA3; 
Accession Numbers are: AAG06912, AAG04099 and AAG08496 respectively) with other 
representative enzymes from both metal activation classes.  Regions A-C  are sequences that are 
not found in Ni2+-activated GlxI enzyme. 
 
P. aeruginosa as a multihost pathogen may be better endowed for successful colonization and 
propagation due to the presence of several MG detoxifying enzymes. A hypothetical basis for 
enhanced virulence could be functional under a broader set of divalent metal limiting conditions in 
vivo. Based on our own previous work with respect to Ni2+ activation of the E. coli enzyme and 
previously reported work (by Mannervik et al. ) on the human Glx I which is Zn2+ activated, each of 
these metals are found by X-ray crystallography and by enzyme activity assays, that their importance 
lies in their active site binding and enzyme activation, as opposed to a structural role (50, 51, 52, 53, 
60, 61, 120).  In fact the current mechanism appears to indicate that the interaction of the substrate 
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with  the active site metal  is  critical for catalysis (121, 122, 123).  All the GlxI enzymes listed above 
are inactive when there is no metal ion in the active site.  Additionally the E. coli enzyme shows no 
structural change in the protein in the absence of metal, indicating that the metal does not appear to 
control solely structural aspects of the enzymes (51, 52).  Further characterization of GlxI expression 
in P. aeruginosa and the effect metal availability has on expression would be valuable for 
quantitating the proportion of each homolog as a contributor to MG detoxification in this bacterial 
species. 
2.9.1 Putatative GlxI Homologs in Salmonella typhimurium 
Campos-Bermudez et al.’s  have reported the presence of three GlxI-encoding genes in the genome of 
Salmonella typhimurium (4, 124).  Therefore it was of interest to determine how related each of the S. 
typhimurium GlxI homologs were to canonical GlxI sequences.  The lactoylglutathione lyase-
encoding gene gloA from this organism, designated STM1435 encodes a GlxI enzyme sharing 91% 
amino acid identity to E. coli GlxI (124).  This gene likely encodes a GlxI enzyme for MG 
detoxification in S. typhimurium.  The additional GlxI-like sequences are encoded by STM0235 
(yaeR) and STM3117 (124).  The STM3117 locus has been identified in previous studies as a gene 
that is upregulated in murine macrophage infections with S. typhimurium (43).  Colonization of these 
host immune cells involves the formation of a Salmonella-containing vacuole that provides a 
hospitable environment for establishing infection although it is a nutrient limited compartment (43).  
STM3117 is subject to upregulation as part of the gene expression profile for S. typhimurium during 
macrophage colonization (43).   
 The protein encoded by yaeR aligns with glyoxalase family proteins in a BLASTP search of 
the non-redundant protein database at NCBI.  Alignment with confirmed GlxI sequences from E. coli 
and P. aeruginosa indicates that all of the putative metal ligands are conserved in the yaeR gene 
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product.  In fact the S. typhimurium yaeR gene product shares 88% identity with the same gene 
product in E. coli.  The yaeR genes share 78% sequence identity at the nucleotide level. Additionally 
the chromosomal location of the yaeR locus appears conserved between E. coli, S. typhimurium and 
Shigella flexneri where it is situated between a lysine decarboxyalase encoding gene and a cell cycle 
control locus in all three genomic contexts.  An alignment of the YaeR protein against E. coli GlxI 
reveals that all four metal ligands are conserved and given the presence of a yaeR gene in E. coli there 
is the potential for at least two functional GlxI enzymes in this species as well as S. typhimurium. 
 Based on genomic analysis the locus designated STM1435 is likely to encode a GlxI-enzyme.  
However phenotypic analyses of mutants for STM3117 and yaeR would be interesting to determine 
whether abolishing expression of these gene products enhances MG (Figure 2.9). 
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    E. coli  (AAC27133)   M----------------------------------RLLHTMLRVGDLQ RSIDFYTKVLGM 
STM1435 M----------------------------------RLLHTMLRVGDLQRS IAFYTNVLGM 
Y. pestis  (CAL21009) M----------------------------------RLLHTMLRVGDLQRS IDFYTKVLGM 
GLOA1 M----------------------------------RILHTMIRVGNIDRS IDFYTRVLGM 
     GLOA2   M----------------------------------RILHSMLRVADLE AALEFYTRALDM 
     L. major (AY604654)   M-------------------------------PSRRMLHTMIRVGDLD RSIKFYTERLGM 
GLOA3 M--------SFNTEVQPGICMEPDAITQEYV-----FNHTMLRVKDPKRS LDFYSRVLGM 
P. putida (NP_745896) M-------SLHDLQTLPGVTAQPDAATAQFV-----FNHTMLRVKDIEKS LDFYTRVLGF 
H. sapiens (NP_006699) MAEPQPPSGGLTDEAALSCCSDADPSTKDFL-----LQQTMLRVKDPKKSLDFYTRVLGM 
STM0235 M------------------------------LGLKQVHHIAIIATDYAVS KAFYCDILGF 
     STM3117   M-------------LFFNVASLKYKHHESIQMIIDRIDHLVLTVSDIS TTIRFYEEVLGF 
 
 
E. coli KLLRTSENPEY---KYSLAFVGYGPETE---------------EAVIELT YNWGVDK--- 
     STM1435   KLLRTSENPEY---KYSLAFVGYGPETE---------------EAVIE LTYNWGVES--- 
Y. pestis RLLRTSENTEY---KYSLAFVGYSDESK---------------GSVIELTY NWGVDQ--- 
GLOA1 TLLRKNDYPDG---QFTLAFVGYGNEAD---------------SAVIELT HNWGVDA--- 
GLOA2 RLLRRRDYPEG---RFTLAFVGYQDERA---------------AAALELT HNWDRDG--- 
L. major KLLSRKDFEEA---KFSLYFLSF-PKDDIPKNKNGEPD-VFSAHGVLELTHNWGTEKNPD 
GLOA3 KLLSRKDFEEA---KYTLVFLGYGPEMS---------------STVLELT YNYGVTS--- 
P. putida RLVDKRDFPEA---AFSLYFLALVDPAQIPADDTARHQWMKSIPGVLELTHNHGTENDAD 
H. sapiens TLIQKCDFPIM---KFSLYFLAYEDKNDIPKEKDEKIAWALSRKATLELTHNWGTEDDET 
STM0235 DLLSEVWREERDSWKGDLALNG---------------------QYVIELF S--------- 
STM3117 SAVT---FKQN---RKALIFGAQKINLH---------------QQEME-- ---------- 
 
 
E. coli --YELGT---------AYGHIAL-SVDNAAEACEKIRQNGGNVTREAGPV KG----GTTV 
STM1435 --YDMGN---------AYGHIAL-SVDNAAEACERIRQNGGNVTREAGPV KG----GSTI 
Y. pestis --YDMGT---------AFGHLAL-GVDDVAATCDQIRQAGGKVTREAGPV KG----GNTI 
GLOA1 --YEIGT---------GYGHIAI-EVDDAYQACDDIRYNGGQVTREAGPM KH----GTTV 
GLOA2 --YTQGD---------GYGHLAI-EVEDAAVTCARARALGYRVTREAGLM QH----GRSV 
L. major --YKHDE---------AYGHIAI-GVEDVKELVADMRKHDVPIDYE---- -D----ESGF 
    GLOA3   SQYHNGNQDP-R----GFGHICF-SVPDLVAACERFETLGVNFVK--- PLDR----GMKN 
P. putida  FAYHNGNTDP-R----GFGHICI-SVPDVRAACARFEELEVPFQKR--L QDG----RMNH 
H. sapiens QSYHNGNSDP-R----GFGHIGI-AVPDVYSACKRFEELGVKFVKK--PD G----KMKG 
STM0235 --FPFPPARPSRPEACGLRHLAF-SVENVENAVAHLEKHQVKCE----PIRIDPY-TGKR 
STM3117 --FEPKASRPTP----GSADLCFITSTPINDVVSEILQAGISIVEG--PV ERTGATGEIM 
 
 
E. coli IAFVEDPDGYKIELIEEKDAGRGLGN------------------------ ---------- 
STM1435 IAFVEDPDGYKIELIEAKDAGRGLGN------------------------ ---------- 
Y. pestis IAFVEDPDGYKIELIENKSAGDCLGN------------------------ ---------- 
GLOA1 IAFVTDPDGYKIELIQKSS------------------------------- ---------- 
GLOA2 IAFLEDPDGYKVELIQKGTQFD---------------------------- ---------- 
L. major MAFVVDPDGYYIELLNEKTMMEKAEAD----------------------- ---------- 
GLOA3 VAFISDPDGYWVEIVQASLNGEMGRG------------------------ ---------- 
P. putida LAFVKDPDGYWVEVIQPTELEG---------------------------- ---------- 
H. sapiens LAFIQDPDGYWIEILNPNKMATLM-------------------------- ---------- 
STM0235 FTFFNDPDGLPLELYEQ--------------------------------- ---------- 
STM3117 SIYIRDPDGNLIEISQYV-------------------------------- ---------- 
         
Figure 2.10: Alignment of S. typhimurium GlxI homologs. STM numbers identify the GlxI 
homologs from S. typhimurium as indexed in The Insitiute for Genomic Research (TIGR) microbial 
database. NCBI accession numbers for for E. coli, Y. pestis, L. major, P. putida and H. sapiens GlxI 




Chapter 3 Characterization of Escherichia coli Glyoxalase II 
Escherichia coli GlxI is the first non-Zn2+-activated GlxI enzyme reported upon in the biochemical 
literature (51).  Non-Zn2+-dependent GlxI enzymes constitute a second metal activation class of this 
enzyme (the first being Zn2+-dependent GlxI enzymes), based on the prevalence of this metal 
activation profile amongst GlxI enzymes from bacteria and parasites (Leishmanial and 
Trypanosomal) (3, 67, 69).   
 For organisms with non-Zn2+-dependent GlxI, it is worth investigating whether the GlxII 
enzyme in this system mirrors the metal activation requirements of the first enzyme.  If both proteins 
in a given Glx system have the same metal ion requirement, the system could be subject to regulation 
based on availability of the activating metal.  It is also possible that the upregulation of Glx system 
enzymes may in turn affect the regulation of systems that affect the transport of metal ions required to 
assemble these proteins in their fully functional states.  Firstly it is important to test that both GlxI and 
GlxII in a given organism require the same metal ion for activation. 
 Most of the GlxII enzymes characterized to date have been obtained from eukaryotic 
organisms, notably Homo sapiens and Arabidopsis thaliana.  Chapter One outlines structural features 
of this enzyme in detail that are briefly summarized here.   GlxII enzymes are monomers that are 
members of the Zn2+-metallohydrolase family with a conserved fold that is observed in metallo-β-
lactamase enzymes (77).  Crystal structures indicate that the active sites of both GlxII and metallo-β-
lactamase enzymes indicate that the active sites typically contain a binuclear metal centre (77).  Initial 
characterization of A. thaliana GlxII led Ridderstrom and Mannervik to conclude that the enzyme was 
metal-independent because the activity was unchanged with the addition of Zn2+ or Mg2+ ions to the 
growth medium during expression (75).  However the Zn2+ activation of cytoplasmic A. thaliana 
GlxII was finally confirmed based on inductively coupled plasma atomic emission spectroscopy 
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(ICP-AES) analysis by Crowder et al (76).  Active forms of the A. thaliana GlxII have been isolated 
with heterogeneously metallated active sites (79, 80). The cytoplasmic GlxII enzyme from A. thaliana 
is produced in E. coli with a binuclear iron/zinc active site (79, 80).  The metal content of 
recombinant A. thaliana GlxII metal content can be biased depending on the metal chloride supplied 
to the host E. coli cells during growth in minimal medium (80).  The kinetic parameters are 
comparabable for A. thaliana GlxII loaded with Mn2+, Fe2+ or Zn2+ by metal supplementation in 
minimal medium during growth and induction (80).The GlxI- and GlxII-encoding genes in E. coli are 
designated gloA and gloB respectively. These genes are not clustered in an operon, but are situated at 
discrete locations on the E. coli chromosome. The map position of the gloA  is 1,725,861-1,726,268 
nucleotides while  gloB is encoded between nucleotides 234,027-234,782 as indicated in the EcoCyc 
database (125).  Therefore there is no evidence of coordinated gene expression for these two 
enzymes.  As mentioned previously, the GlxI enzyme from E. coli is not Zn2+-activated. However the 
GlxII enzyme from an organism with a non-Zn2+-dependent GlxI enzyme has not been characterized 
previously.  In this chapter the isolation and biochemical characterization of E. coli GlxII is described 
(126). The bulk of this research was conducted by Jason O’Young, who was an undergraduate 
member of the Honek laboratory at the time (126).  This work demonstrates that GlxII has been 
conserved as a binuclear monomeric Zn2+-metallohydrolase, possessing the conserved active site 
consensus sequence for metal binding (126). 
 
3.1 Materials and Methods  
3.1.1 Materials 
See Chapter 2, section 2.5 for materials referred to in the described methods. 
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3.1.2 Theoretical Calculations 
Calculations to determine theoretical molecular mass and pI were performed using ProtParam on the 
ExPASy Proteomics Server (http://www.expasy.org/tools/protpar-ref.html; Geneva, Switzerland) 
(116). 
3.1.3 DNA Manipulation and Plasmid Construction 
All manipulation of DNA and plasmid isolation was performed according to the protocols of 
Sambrook and Russell (127). The putative Glyoxalase II gene sequence (GeneID 944902) was 





 Primers were obtained from Sigma Genosys (Oakville, ON, Canada). Thermal cycling was 
performed on a thermal cycler from Techne (Staffordshire, UK). The desired PCR products were 
excised from a 1.5% agarose gel following electrophoretic analysis and purified using an ELU-QUIK 
DNA purification kit from Scheleicher and Schuell (Keene, NH, USA) and subjected to NdeI and 
BamHI (New England Biolabs, Ipswich, MA, USA) restriction endonuclease digestion. The digestion 
products were subsequently ligated into a pET22b expression vector (ampr, T7 lac promoter, f1 origin 
of replication; Novagen, Madison, WI, USA), which had also been digested with the above restriction 
endonucleases to generate construct pGloB. Sequencing of plasmid constructs was performed by 
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MOBIX (Hamilton, Ontario, Canada).  The cloned gloB gene was sequenced in the 5’ to 3’ and 3’ to 
5’ directions using the T7 forward and reverses primers respectively.  pGloB was propagated in E. 
coli strain DH5α, isolated, and transformed by heat shock into CaCl2-treated E. coli  BL21(λDE3) 
competent cells for recombinant protein production. 
3.1.4 Expression and Purification of E. coli GlxII 
A one liter LB culture of BL21(λDE3)/pGloB supplemented with 50 mg/L of carbenicillin was grown 
to an optical density (OD600nm) of 0.7 before induction of gloB expression with IPTG at a final 
concentration of 0.5 mM. Induction of the culture was allowed to proceed for 4 h before recovery of 
the cells by centrifugation at 6000g for 15 min. The cells were resuspended in 50 mM Tris buffer, pH 
8.0, and re-pelleted at 6000g for 15 min and flash frozen in liquid N2 for storage at −80 °C. 
Frozen BL21(λDE3)/pGloB cells (1 g) were suspended in 50 mM Tris, pH 8.0, buffer (5 mL) 
and the suspension was disrupted by sonication followed by the addition of phenylmethylsulfonyl 
fluoride (PMSF) to 1 mM final concentration (added from a 1 M stock), and glycerol to 10% (v/v). 
Cellular debris was removed by centrifugation at 48,300g for 15 min at 4 °C. The recovered 
supernatant was filtered through a 0.2 µM filter (Acrodisc Ion Chromatography filter, Pall Life 
Sciences, Ann Arbor, MI) then loaded onto a 10/30 Q-Sepharose column (Amersham Biosciences, 
Uppsala, Sweden) with elution utilizing a gradient of 0–1 M KCl (in 50 mM Tris, pH 8.0) over a 
100 min interval (flow rate of 0.8 mL/min). Fractions identified by SDS–PAGE analysis and kinetic 
assay (corresponding to 50–60% KCl) were pooled and dialyzed against 50 mM Tris, pH 6.5, 
overnight at 4 °C. The dialyzed sample was diluted to 5 mL and filtered using a 0.2 µm filter prior to 
loading onto a 5/5 Mono-Q column. Elution was accomplished by applying a gradient of 0–1 M KCl 
(in 50 mM Tris, pH 6.5) over a 100 min interval (flow rate of 0.5 mL/min). Fractions identified by 
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SDS–PAGE analysis and kinetic assay (corresponding to 25–30% KCl) were pooled and dialyzed at 
4 °C against 50 mM phosphate buffer, pH 6.5, overnight. 
Solid (NH4)2SO4 was added to the dialyzed sample, for a final concentration of 1.7 M and the 
resulting solution after filtration (0.2 µm filter, Pall, ) was loaded onto a Phenyl HP Hi Sub column 
(1 mL). The sample was loaded onto the column with 1.7 M (NH4)2SO4 in 50 mM potassium 
phosphate buffer (pH 6.5). Elution was accomplished utilizing a gradient of 1.1–0 M ammonium 
sulfate in 50 mM potassium phosphate buffer (pH 6.5) applied over a 20 min period (flow rate of 
0.5 mL/min). Fractions identified by SDS–PAGE analysis and kinetic assay (corresponding to 
approximately 0.25–0.5 M (NH4)2SO4) were pooled and dialyzed at 4 °C against 50 mM Tris, 
100 mM KCl, pH 7.5, overnight. The dialyzed sample was filtered (0.2 µm) and loaded onto a 
Superdex 75 column utilizing 50 mM Tris, 100 mM KCl, pH 7.5, as eluting buffer. Fractions were 
analyzed by SDS–PAGE, where E. coli GlxII was identified as a band migrating approximately the 
same distance as the 30 kDa marker (carbonic anhydrase) in the size standard. The enzyme was stored 
in 50 mM Tris, pH 7.5, at 4 °C. The enzyme appeared homogeneous in purity after gel filtration as 
determined by SDS–PAGE with Coomassie brilliant blue staining of protein (data not shown). 
3.1.5 Molecular Mass Determination and Mass Determination for Native GlxII 
The molecular mass of the recombinant E. coli GlxII was determined utilizing electrospray ionization 
mass spectrometry. Samples were introduced into a Micromass Q-TOF Global Ultima mass 
spectrometer using an eluant of 50:50 H2O:acetonitrile plus 0.2% formic acid. Samples were run in 
positive ion mode and m/z ratios were deconvoluted using the MaxEnt1 algorithm in the MassLynx 
(V4.0, Micromass Limited/Waters, Milford, MA) software. SDS–PAGE was utilized to screen for 
GlxII during purification. Separation of purification fractions was performed on a PhastSystem 
electrophoresis unit using 10–15% gradient gels (Amersham Biosciences, Uppsala, Sweden). Proteins 
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were visualized on the gels by Coomassie brilliant blue staining. The quaternary structure of GlxII 
was determined by gel filtration using a 10/30 Superdex 75 (Amersham Biosciences, Uppsala, 
Sweden) column as described above, employing the appropriate protein standards. Injections were 
performed in triplicate for native molecular mass determination. 
3.1.6 Glx II Enzyme Assay 
Glyoxalase II enzymatic activity was determined as previously reported by Marasinghe et al. in 
50 mM MOPS, pH 7.1 buffer (based upon pH optimization for activity assay) (2). S-
lactoylglutathione (SLG) was utilized as the substrate in these assays. The decrease in absorbance due 
to hydrolysis of the SLG (ε = 3.1 mM−1 cm−1) was monitored at 240 nm (2). The activity assay for 
identification of column fractions was performed at a substrate concentration of 500 µM. All activity 
assays for E. coli GlxII were performed using a Cary 3 UV–vis spectrophotometer (Varian, 
Mississauga, ON) with assays conducted at 25 °C (Pelletier cooling), and data were collected using 
the Kinetics module of CaryWinUV version 3.0 (Varian, Mississauga, ON). 
3.1.7 Kinetic Analysis 
Determination of the Michaelis constant, Km, and the maximal enzyme velocity, Vmax, for E. coli GlxII 
involved measurement of the initial reaction rate utilizing 10 substrate concentrations ranging 
between 50 and 500 µM. Assays were performed in 1 mL of substrate with 0.002 mg of GlxII added 
per replicate. The enzyme stock was diluted with 50 mM MOPS, pH 7.1. Data were fitted by least 
squares linear regression using GraFit version 3.01 (Erithacus Software). 
3.1.8 Metal Analysis 
Metal-free water was prepared by passing Milli-Q grade water through Chelex 100 resin obtained 
from Bio-Rad (Mississauga, Ontario, Canada). Purified enzyme solution was exchanged into metal-
 
 85 
free water by utilizing a Centricon® (Millipore) ultrafiltration device with a 10 kDa cut off 
membrane,. All plastic containers were presoaked with nitric acid (10% v/v) and rinsed with Chelex-
treated water. Metal content of purified GlxII was determined using Inductively Coupled Plasma 
Mass Spectrometry (ICP-MS). This analysis was performed at the EnviroTest Laboratory, which is 
now the Waterloo branch of ALS Laboratories (Waterloo, Canada)  The following elements were 
analyzed for using this method: Al, Sb, As, Ba, Be, Bi, B, Cd, Ca, Cr, Co, Cu, Fe, Pb, Mg, Mn, Mo, 
Ni, P, K, Se, Si, Ag, Na, Sr, Tl, Sn, Ti, W, U, V, Zn, and Zr. 
3.1.9 Metal activation Studies 
Purified E. coli GlxII was incubated (final concentration of 27.8 µM) with 50 mM dipicolinic acid 
DPA in 50 mM MOPS, pH 7.0, for 4 h at 4 °C. The DPA was removed from the GlxII sample by 
centrifugal ultrafiltration with a 10 kDa cut-off Nanosep device (Pall Life Sciences, Ann Arbor, MI, 
USA). This ultrafiltration step was used to change the GlxII buffer to 50 mM MOPS, pH 7.0. The 
MOPS buffer was treated prior to usage with Chelex 100 (Bio-Rad, Mississauga, Ontario, Canada) 
resin to remove any potentially contaminating and re-activating divalent metal ions. The final 
concentration of DPA-treated GlxII was determined by the method of Bradford to be 36.9 µM (≈ 1.04 
mg/mL which is within the range of detection by this protein quantitation method). This enzyme 
stock was used to set up metal reconstitution incubations containing 5 µM GlxII, 6 equivalents of 
MnCl2, NiCl2, ZnCl2, and CoCl2 (final concentration 30 µM), in 50 mM MOPS, pH 7.0 (Chelex-
treated). The enzyme was incubated with metal for 16 h prior to assay in 0.5 mM SLG (dissolved in 
50 mM MOPS, pH 7.1). The assay was performed in triplicate using 500 µL of substrate, using 




The gloB gene in E. coli codes for a GlxII enzyme 251 amino acids in length with a predicted 
molecular mass of 28434 Da. Sequence alignment of the E. coli GlxII enzyme with other 
characterized GlxII sequences reveals that it possesses the typical conserved residues associated with 
Zn2+-binding including the T-H-X-H-X-D-H motif (Figure 4.1) (77).  The cloning of E. coli gloB into 





Figure 3.1: Alignment of GlxII amino acid sequences. E. coli GlxII is indexed with the NCBI accession 
number: AAC73317. The other GlxII sequences include H. sapiens, A. thaliana cytoplasmic and mitochondrial 
(pre-protein sequence shown), P. falciparum GlxII pre-protein, and S. cerevisiae isoforms of GlxII (NCBI 
Accession numbers are: CAA62483, NP_187696, NP_565999, AAQ05976, CAA58065, CAA71335 
respectively). The % identity of these GlxII relative to the E. coli enzyme are 34%, 36%, 38%, 28%, 30% and 
33%, respectively.  The box indicates the THxHxDH active site motif and asterisks indicate other metal binding 
histidine residues. The alignment was created in CLC Free Workbench (CLC bio A/S) version 3.0.1 using the 




IPTG-induced cultures of BL21(λDE3)/pGloB produce significant levels of soluble GlxII 
within four hours of induction.  Active holo-GlxII could be recovered from lysates of induced cells 
following anion exchange, hydrophobic interaction and gel filtration chromatographic steps 
respectively.  The molecular mass of the recombinant protein is in accordance with the predicted 
mass as assessed by ESMS (Figure 3.2). The purified enzyme from these enrichment steps is 
approximately 85% pure as assessed from SDS-PAGE with Coomassie Brilliant Blue staining (Figure 
3.3).   ICP-MS analysis of purified E. coli GlxII indicates the presence of Zn2+ in the protein at a ratio 
of 1.7 equivalents per mol monomeric enzyme (native protein size confirmed by analytical size 
exclusion chromatography).  The metal:enzyme ratio was also confirmed by subjecting the GlxII to a 
denaturing colorimetric PAR assay (118).  These two methods of metal analysis are in agreement 
with recombinant E. coli GlxII being produced as a binuclear zinc holoenzyme.   
 
 
Figure 3.2: ESMS for purified E. coli GlxII.  The peak for GlxII is labelled with the observed 






Figure 3.3: SDS-PAGE purification summary for E. coli GlxII.  L = lysate, Q = fractions from Q-
Sepharose Fast Flow, M = fractions from MonoQ, P = fractions from Phenyl HP High Sub, LMW= 
low molecular weight marker.  Marker sizes are indicated to the right of the figure and the arrow 
points to the band identifiable as E. coli GlxII. 
 
Prior to kinetic characterization of E. coli GlxII, an initial pH profile (pH range surveyed was 
5.5-9.5) was constructed by assaying for activity at concentrations of SLG exceeding typical Km 
values for the enzyme.  From this profile it was established that kinetic parameters for E. coli GlxII 
would be obtained at a pH of 7.1. 
 The kinetic parameters obtained for the overproduced Zn2+-GlxII are comparable to the 
values for previously characterized enzymes from other sources.  Kinetic constants determined on the 
purified protein using SLG are listed in Table 3.1. Catalytic efficiency of E. coli GlxII most closely 
resembles that of the Plasmodium falciparum tGloII and C. albicans enzymes (Table 3.1) (128, 129). 
The E. coli GlxII falls well within the range of catalytic efficiencies for other GlxII enzymes such as 












Table 3.1: Kinetic Parameters for Various GlxII Enzymes
* 
 


















E. coli (126) 
 
53 ± 11 
 
















1.19 x 106 
 






4.17 x 106 
 





















1.9 x 106 
































Human GlxII has been studied to characterize refolding and zinc activation after guanidinium 
HCl denaturation of the enzyme in the presence of EDTA (131).  This approach was attempted in our 
lab for preparation of apo-E. coli GlxII.  The unfolding/refolding protocol developed for 
Pseudomonas aeruginosa alkaline protease in the Honek laboratory was adapted to E. coli GlxII for 
this purpose (132).  Unfortunately, the final yield of protein was insufficient for quantitation and in 
some cases was so poor that no measurable GlxII activity was detected in the prepared samples.  For a 
survey of metal specificity, a demetallated E. coli GlxII preparation was obtained by incubating the 
enzyme with 2,6-pyridinedicarboxylic acid (DPA). The chelator was removed from the protein 
sample by ultrafiltration.  Several equivalents of the metal chloride were added to the DPA-treated 
GlxII and activity was screened for in 0.5 mM S-lactoylglutathione in 50 mM MOPS pH 7.0. 
Interestingly, reconstitution with ZnCl2 did not enhance the activity of the DPA-treated 
enzyme (Figure 3.4).  Addition of ZnCl2 to the active holoenzyme has no additive or detrimental 
effect on the observed catalytic activity of E. coli GlxII (data not shown).  This is intriguing since the 
recombinant holoenzyme was found to contain Zn2+.  Analysis of the E. coli GlxII sequence revealed 
the presence of several cysteine residues. It is possible that the DPA-demetallated GlxII is rendered 
inactive by Zn2+ mismetallation that occludes the active site of the enzyme (which may or may not be 
appropriately metallated).  It is also possible that the mismetallated GlxII has assumed an inactive 
conformation.   Importantly adding Ni2+ ions to the DPA-treated enzyme does not increase activity 
(Figure 3.4).  This together with the metal analysis confirms that the E. coli GlxII is conserved in 
nature as a Zn2+-activated metallohydrolase.  Furthermore this finding clarifies that the Glx system in 
E. coli does not have a uniform Ni2+ ion requirement.  It is only the first enzyme of the pathway that 
has diverged in metal selectivity.  The reconstitution of DPA-treated GlxII with Mn2+ and Co2+ was 
particularly efficacious indicating the relaxed metal selectivity of E. coli GlxII in contrast to the GlxI 





Figure 3.4: Relative re-activation of DPA-treated E. coli GlxII with various divalent metal ions. 
The bar labeled Pre-DPA denotes the activity of the recombinant GlxII holoenzyme after purification. 
This activity represents the maximal activity (100%) observable for the native enzyme. All other 
enzyme activity percentages in this figure are relative to this holoenzyme activity. The bar labeled 
Post-DPA denotes the activity of DPA-treated GlxII without the addition of any re-activating metal 
chlorides. The bars labeled Mn(II), Co(II), Ni(II), and Zn(II), represent relative activities of DPA-
treated enzyme following addition of activating metal chlorides as indicated in the experimental 
procedure. The error bars represent the standard deviation for the activity of the triplicate assays. 
3.3  Discussion 
The characterization of E. coli GlxII described herein is sufficient to confirm that it is a Zn2+-
dependent hydrolase. Our investigation did not examine how the metal content of the enzyme can be 
changed with different supplemental metals during growth as with the studies of A. thaliana GlxII.  
Differential metal incorporation into E. coli GlxII was not part of the scope of research for this 
investigation, but should be revisited in light of the various holoforms recently characterized for the 
highly related Salmonella typhimurium GlxII. 
This recent report of promiscuous metal selectivity in GlxII comes from the published 
characterization of the enzyme from Salmonella typhimurium (4), published subsequent to our 
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reported findings on the GlxII enzyme from E. coli (126).  The GlxII from this Gram-negative species 
is 78% identical and 89% similar to the E. coli enzyme at the amino acid level.   
The recombinant S. typhimurium GlxII as expressed in E. coli contains 1.15 equivalents of 
metal per monomeric enzyme, with Mn2+, Fe2+ and Zn2+ as the contributing metal ions in the sample 
(4).  When S. typhimurium GlxII is produced in E. coli under minimal medium growth conditions 
with specific metal supplementation (Mn2+, Fe2+ and Zn2+) the metal content of the enzyme reflects 
the ions present during overproduction (4).  This is similar to the results obtained for differential 
metal loading of recombinant A. thaliana GlxII under minimal medium growth conditions as 
described in Chapter 1 (80).   
Sub-stoichiometric amounts of metal are present in the S. typhimurium GlxII enzyme whether 
it is produced in rich medium or minimal medium with metal supplementation (4).  The reason for 
this < 2 metal per monomer ratio is attributed to loss of metal ions from the active site during 
purification (4).  Catalytic efficiency values for the enzyme either from rich media or loaded with 
Mn2+, Fe2+ and Zn2+ are comparable reflecting a relaxed stringency for metal utilization in GlxII, 
which has been observed with the A. thaliana enzyme (4).  
Electron paramagnetic resonance (EPR) studies have been conducted on the S. typhimurium GlxII 
enzyme, revealing that a range of metal centres can be observed for this enzyme including 
magnetically coupled Fe(III) and magnetically uncoupled Fe(II)/Fe(III) (4).  The observation of 
mixed metallation in A. thaliana and S. typhimurium GlxII enzymes contrasts significantly with other 
enzymes of the Zn-metallohydrolase superfamily, including human GlxII which have been observed 
to be exclusively dinuclear Zn2+-holoenzymes (4, 77, 81).   
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The crystal structure of S. typhimurium GlxII has been solved to 1.4 Å resolution (Figure 3.5) (4).  
Given the conservation of sequence and metal binding motifs, it is not surprising that the overall 
topology mirrors other GlxII enzymes and the metallo-β-lactamases (Figure 3.5).   
 
Figure 3.5: Structure of S. typhimurium GlxII.  The black spheres indicate the metal ions bound to 
the holoenzyme (PDB ID: 2QED) (4).   
 
 
Binuclear metallation of the enzyme is observed in the crystal structure, although the identity 
of the metals was not assigned in the crystal structure (Figure 3.5).  The active site residues that ligate 
to both metal ions are well conserved also.  Metal site 1 contains the ligands His53, His55, and 
His110.  The ligands associated with metal site 2 are Asp57, His58, and His165 (Figure 3.6) (4).  The 
metal ligands listed are conserved in the E. coli GlxII sequence (Figure 3.7). 
Second sphere ligands play a role in the positioning of the primary metal ligands in S. 
typhimurium as has been observed previously in human GlxII and A. thaliana GLX2-5.  The 
positioning of active site histidines is influenced by hydrogen bonds with the non-ligating nitrogen 
atoms in the His imidazole rings (Figure 3.6) (4).  Given the overt structural similarity to the 
aforementioned GlxII enzymes, it is also not surprising that second sphere interactions are also 
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conserved in the S. typhimurium hydrolase.  For example the Thr52→Asp28→His58 hydrogen 
bonding interaction is analogous to the Thr53 → Asp29 → His59 interaction in A. thaliana GLX2-5 
(Figure 3.6)  (4).  The second sphere interaction of Thr52 with His53 is also analogous to the Thr53 
hydrogen bonding interaction with His54 in A. thaliana GLX2-5 (Figure 3.6) (4).  Other conserved 
His ligand interactions include Arg136 carbonyl→ His110 (conserved GLX2-5 as Lys140 carbonyl 
→ His110), Glu139 → H2O → His55 (conserved human GlxII as Glu146 → H2O → His56) and 
Asp11→His165 (conserved in GLX2-5 as Asp11→His169) (Figure 3.6)  (4).  All of the 
aforementioned second sphere ligands are conserved in the E. coli GlxII sequence (Figure 3.7).  
 
 
Figure 3.6: Active site of S. typhimurium GlxII.  Grey stick forms represent inner sphere metal 
ligands and second sphere ligands are depicted as black stick forms.  The numbered black spheres 
indicate the metal ions and water ligands are designated with the letter “W.”  The grey dashed lines 
indicate coordination to the metal ions and the second sphere hydrogen-bonding interactions are 




EC MNLNSIPAFDDNYIWVLNDEAGRCLIVDPGDAEPVLNAIAANNWQPEAIFLTHHHHDHVG  60 
 




EC GVKELVEKFPQIVVYGPQETQDKGTTQVVKDGETAFVLGHEFSVIATPGH LGHICYFSK  120 
 




EC PYLFCGDTLFSGGCGRLFEGTASQMYQSLKKLSALPDDTLVCCAHEYTLSNMKFALSILP  180 
 




EC HDLSINDYYRKVKELRAKNQITLPVILKNERQINVFLRTEDIDLINVINEETLLQQPEER  240 
 




EC FAWLRSKKDRF  251 
 
ST FAWLRSKKDTF  251 
 
Figure 3.7: Amino acid sequence alignment of E. coli (EC, NCBI accession number U57363) and 
S. typhimurium (ST, NCBI accession number NP_459259) GlxII enzymes.  Residues highlighted 
in grey are metal ligands.  Second sphere ligands are highlighted in black.  The conserved T-H-X-H-
X-D-H motif is underlined in the alignment. 
 
In contrast to the S. typhimurium GlxII enzyme, the E. coli GlxII has been characterized and 
isolated from rich media propagated host cells as a binuclear Zn enzyme, as inferred from containing 
1.7 equivalents zinc per monomer.  The S. typhimurium GlxII produced in E. coli grown in LB 
medium contained 0.21 equivalents zinc, 0.64 equivalents iron and 0.30 equivalents manganese for a 
total metal content of 1.15 equivalents per monomer (4).  Possible reasons for the difference in 
metallation of the enzyme may include the difference in endogenous metallochaperones involved in 
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assembling GlxII in E. coli versus S. typhimurium.  Also the E. coli enzyme may have been in the 
presence of more exogenous zinc during the stages of purification such that the second site may have 
obtained metal occupancy as a consequence of different buffer exchanges. Further metal analyses of 
E. coli GlxII recombinantly expressed in rich media or metal supplemented minimal media would be 
valuable in providing an assessment as to whether this bacterial GlxII parallels the S. typhimurium 




Kinetics of Phenylglyoxal-Glutathione Isomerization and 
Determination of Deuterium Isotope Effects in E. coli Glyoxalase I 
The mechanistic details of the GlxI-catalyzed reaction have been a subject of investigation since the 
1950’s (133, 134, 135).  This enzyme catalyzes a 1,2-proton transfer via a cis-enediolate intermediate 
analogous to the reaction catalyzed by triosephosphate isomerase (122).  There is continued interest in 
examining the mechanistic intricacies of the GlxI-catalyzed isomerization because it will improve our 
understanding of metalloenzyme-catalyzed 1,2-proton transfers (122).  Several other metal-dependent 
enzymes are thought to catalyze similar reactions via the cis-enediol intermediate.  These include 
fucose isomerase, fuculose-1-phosphate aldolase (class II), phosphoglucose isomerase and uronate 
isomerase (136, 137, 138, 139).     
Molecular dynamics and density functional theory approaches have been used to evaluate the 
proposed GlxI mechanism and the energetics of the rate-limiting proton transfer step. The proposed 
role of the Zn2+ centre, based upon the modeling study of Himo et al. was to increase the C1 proton’s 
acidity via coordination of the substrate to the active site metal (140).  The calculated energy barrier 
for proton transfer (14.4 kcal/mol) from their model corresponds well with the value calculated (14 
kcal/mol) from the observed reaction rate (kcat ≈ 1500 s-1 for human GlxI (140). The Lewis acid 
properties of divalent transition metal ions such as Zn2+ or Ni2+, may be a preferred element in 
enzyme active sites to facilitate proton transfer in the aforementioned isomerases. 
 The currently accepted proton transfer mechanism for GlxI is based on data from several 
experimental approaches. Initial attempts at postulating the nature of enzymatic MG-GSH 
hemithioacetal isomerization were put forth in the 1950’s, by means of detecting solvent deuterium 
incorporation into the substrate by NMR methods.  NMR screening of the yeast GlxI reaction in 2H2O 
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and 3H2O solvent systems supported a hydride transfer mechanism (Figure 4.1) (133, 134, 135). This 
mechanism was proposed because no deuterated or tritiated lactic acid product (from GlxII-catalyzed 
thioester hydrolysis) could be detected (133, 134, 135).  This mechanism was re-evaluated using the 
same experimental methodology by Hall, Doweyko and Jordan (141).  They concluded that the 
observed 15% deuterium incorporation into the product at 25ºC in 2H2O and 22% incorporation at 
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Figure 4.2: Enediol mechanism (proton transfer) for GlxI-catalyzed reaction 
 
 100 
Partition analysis of the yeast GlxI-catalyzed isomerization of fluoromethylglyoxal 
(fluoroMG) has been performed and also produced data supporting a proton transfer mechanism.  
GlxI isomerization of the fluoroMG-GSH hemithioacetal partitions products into S-fluorolactoylGSH 































Figure 4.3: Products of GlxI-catalyzed reaction with fluoroMG 
 
The ratio of partitioning can be influenced by the presence of deuterium on C1 of fluoroMG.  Chari 
and Kozarich were able to use the ratio of fluorinated thioester versus fluoride elimination product 
(Figure 4.3) as a diagnostic for the likelihood of proton transfer by considering the effect of the 
deuterium on the substrate (87).  This is required because the observation of deuterium incorporation 
into substrate as well as fluoroMG partitioning can be explained as a hydride migration accompanied 
by a non-catalytic base-dependent exchange of fluoride or proton (87).  In either case the rate of 
product release should remain constant.  Chari and Kozarich observed a deuterium isotope effect that 
influenced the partitioning ratio, such that fluoride elimination was increased when deuterated (H-
atom on C1 substituted) fluoroMG was used as a substrate for GlxI (87).   If the reaction were to 
proceed via a proton transfer then the rate of fluoride elimination would be re-protonation of the 
substrate  (Figure 4.4) (87).  The corresponding decrease in fluorothioester formation (Figure 4.5) 
would increase the partitioning towards fluoride elimination as observed in this study (87).  Therefore 
a proton transfer contribution to GlxI catalysis does support hemithioacetal to thioester conversion via 




that deuteride migration would decrease fluoride elimination via an isotope effect for this process, 
























































































Figure 4.5: Enediol mechanism for GlxI catalyzed fluoro-MG-GSH isomerization without 








































The rate of deuterated substrate turnover by GlxI has been examined using the yeast enzyme 
to assess the degree of rate dependence on the proton transfer step during catalysis (86).  These 
deuterium isotope effect experiments rely on the observable perturbation of a reaction rate as a 
consequence of chemical bond energy being changed by isotopic substitution.  In turn the isotope-
dependent effect on reaction rate can aid in determining whether a particular enzymatic step is a 
contributor to the overall rate of the enzymatic reaction.  Although a single covalent bond-
breaking/forming event is unlikely to be the sole rate-determining step, isotope effects are useful tools 
in formulating plausible mechanisms for enzymatic reactions particularly for fundamental processes 
such as proton transfer.  To this end, the kinetic isotope effect experiment can at the very least 
indicate whether a chemical step is partially rate limiting.  The interpretation of isotope effects on 
reactions (both enzymatic and non-enzymatic) has been discussed at length in the chemical and 
biochemical literature (5, 142, 143, 144).  The theory behind occurrence of an isotope effect, aspects 
of experimental set up and interpretation of results will be briefly reviewed in the following section. 
4.1 Theory of Kinetic Isotope Effects 
The physical basis for an observed isotope effect on a chemical reaction lies in the difference in zero-
point vibrational energy for the chemical bond at which the isotopic substitution is occurring (143).  
The simple harmonic oscillator comprises the model on which comparisons of C-H versus C-D bond 
energies can be based.  If the harmonic oscillator is defined by Hooke’s law, the reduced mass of the 
system will proportionally affect the vibrational energy of the system (143).  In the case of the 
deuterium experiment the zero-point vibrational energy for a C-1H bond is 4.15 kcal/mol (17.4 
kJ/mole) and for C-2H is 3.0 kcal/mol (12.6 kJ/mole) (Figure 4.7) (143). For an enzymatic reaction 
where the C-1H or C-2H bond is broken, the same transition state is formed.  However, the activation 
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energy for breaking the C-2H bond will be higher because it is deeper in the potential energy well 
compared to the C-1H bond (143).     
C    H











C – H or C – D interatomic distance  
Figure 4.7: Difference in zero-point vibrational energies for C-H versus C-D bonds (adapted 
from (5)) 
 
The kinetic isotope effect experiment requires availability of a selectively deuterated 
substrate that can be used to characterize reaction rates for an isolated enzyme, in anticipation of 
comparing these data to that acquired with the protio-substrate (143).  The acidity of the deuteron of 
interest must be taken into consideration as it may be subject to exchange with solvent protons (143).  
In the case of isotope effect studies on GlxI, the substrates utilized have been α-
deuteriophenylglyoxal and perdeuteriomethylglyoxal.   
The simplest analysis of a kinetic isotope effect (KIE) is the ratio of reaction rate with the 
deuterated substrate to that with the non-deuterated substrate, to obtain k(H)/k(D) (143).  A ratio with a 
value between 2-15 indicates that the isotope effect for proton transfer occurs in the transition state 
for the enzymatic reaction (143). Low, but real isotope effects are assigned when the ratio has a value 
of less than two (143).  These values are interpreted such that the proton transfer step is considered 
partially rate limiting for the mechanism under consideration.  Typically observed KIE values are 1.5 
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to 2 (143).  Pronounced KIE where values ≈ 8 have been observed in a few enzymatic reactions 
(143).  An important warning before proceeding to determine isotope effect data, particularly 
concerning the absence of a detectable rate difference, is that another step in the mechanism may have 
a rate comparable to that of the step being investigated (143).  This other process may mask an 
apparent isotope effect, particularly if it is more rate limiting than the proton transfers that might 
occur during the reaction.  The simplest interpretation of the absence of a kinetic isotope effect is that 
the step involving hydrogen transfer is not the slowest of mechanistic events (143).  Generally the 
first empirical indicator of a kinetic isotope effect on an enzymatic reaction is the reduction of the 
apparent Vmax value (143).  The Vmax term is a composite that includes rate constants for bond 
breaking/reformation steps.  In the context of hydrogen atom transfer, the presence of a substituted 
deuterium generally does not affect substrate binding to the enzyme, so kinetic isotope effects on Km 
where Km = KS are typically not observed (143).   
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The methodology of Northrop is widely employed for the interpretation of kinetic isotope effects in 
the context of rate limiting steps (142). Northrop’s methodology of kinetic isotope effect analysis 
involves assessing whether the rate perturbation affects Vmax or Vmax/Km (142). Recall under the 
assumption of Michaelis-Menten kinetics that: 
 
V = (Vmax/Km)[S] at low concentrations of S 
 
V = Vmax at high concentrations of S 
  
Both Vmax and Vmax/Km are composites of various rate constants pertinent to the catalytic cycle of the 
enzyme under consideration.  Therefore the magnitude of effect on each of these composites will vary 
for a given isotope effect. Northrop’s scheme for interpretation was based on the following model of 
an enzyme-catalyzed reaction: 
 
 
The catalytic step rate constant would be k2 and would be subject to the isotope effect.  Using this 
scheme several equations can be constructed to describe the enzymatic reaction velocity under 
different conditions.  
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For instance, the initial velocity conditions where k-2 and k-3[P] are insignificant would have a v term 
where: 
 
V =                   k1k2k3 
                        
                           k3(k-1+k2) + k1(k2 + k3)[S] 
 
So the expressions for kinetic parameters will be: 
 
Vmax = {k2k3/(k2+k3)}[ET] 
 
Km = {k3(k-1 + k2)} 
         {k1(k2 + k3)} 
 
Vmax/Km = {k1k2/(k-1 + k2)}[ET] 
 [ET] is the concentration of all enzyme, that is, the sum of free enzyme and of enzyme in a Michaelis 
complex. 
  
The intrinsic isotope effect can be defined as that principally affecting k2, the constant 
associated with substrate conversion (142).  The amount to which the intrinsic isotope effect modifies 
Vmax is governed by the ratio of k2 to k3 (142).  So the relative magnitudes of the chemical step rate 
versus the rate of product release are being compared in this analysis. If k2/k3 << 1, then the intrinsic 
isotope effect will markedly diminish the apparent Vmax (142).  If k2/k3 >> 1 then the rate of product 






















when k3 >> k2
 
Whether the intrinsic isotope effect is influential on Vmax/Km depends on the ratio of k2 to k-1; 
essentially a comparison of the off rates from the ES complex (142).  The isotope effect on Vmax/Km is 
inversely proportional to the ratio of k2/k-1, such that the effect is attenuated when k2 >> k-1 but is fully 
apparent when k-1 >> k2. 
 














The “commitment to catalysis” of the enzymatic reaction refers to how frequently ES decomposition 
to EP occurs relative to ES dissociating into E and S (142).  Therefore if ES is converted to EP many 
more times than the breakdown of ES to enzyme and substrate the commitment to catalysis is high 
(142).  Logically, it follows that a low commitment to catalysis will be reflected by a relatively higher 
rate of non-productive decomposition of the Michaelis complex (142). 
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The yeast GlxI enzyme has been used to obtain deuterium isotope effect values for MG-GSH 
and PG-GSH isomerization using perdeuteriomethylglyoxal and α-deuteriophenylglyoxal 
respectively (86).  Base catalyzed isomerization of methylglyoxal-GSH versus 
perdeuteriomethylglyoxal-GSH results in a measured k(H)/k(D) value of 3.8 (86).  The k(H)/k(D) value for 
base catalyzed isomerization of phenylglyoxal-GSH versus α-deuteriophenylglyoxal is approximately 
5.0 (86).  These values are considered indicative of the deprotonation of PG-GSH as rate-determining 
for this reaction (86).   
For the GlxI-catalyzed reaction the k(H)/k(D) with methylglyoxal and perdeuteriomethylglyoxal 
was approximately 2.9 (86).  The Vmax(H)/Vmax(D) with phenylglyoxal and α-deuteriophenylglyoxal for 
yeast GlxI is 3.2 (86).  The value obtained for both sets of substrates is indicative of the proposed 
proton transfer in the reaction being a rate-determing step (86).  This is interesting also since yeast 
GlxI also exhibits little variation in Vmax when it acts upon α-ketoaldehydes with different side chains 
(86).   
The KIE on the Km values for yeast GlxI require a more discerning approach to interpretation.  
Recorded Km(H)/Km(D) values for methylglyoxal/perdeuteriomethylglyoxal and phenylglyoxal/α-
deuteriophenylglyoxal are 1.7 and 3.3, respectively (86).  The difference in the magnitude of these 
KIE raises the question as to whether secondary isotope effects have arisen in the former situation on 
account of perdeuteriomethylglyoxal having multiple sites of deuteration (86).  In contrast, 
interpretation of the Km KIE on phenylglyoxal is less ambiguous because the deuterated substrate is 
only substituted at the alpha position.  So considering this case in isolation it is apparent that the 
isotope effects on Km and Vmax are approximately the same in the case of yeast GlxI turnover of 
phenylglyoxal versus α-deuteriophenylglyoxal.  These results can be interpreted such that the isotope 
effect is predominantly manifested as an effect on the rate constant governing conversion of substrate 
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to product (86). This means that the Michaelis constant significantly exceeds the value of the 
dissociation constant for the ES complex (86).   
 Recently Feierberg et al. investigated the primary kinetic isotope effects of the GlxI-catalyzed 
reaction and the potential effects of quantum dynamics on the reaction (145).   In particular the effects 
of zero-point energies and tunneling on GlxI-catalysis were analyzed using computational 
simulations.  Their calculated deuterium isotope effect for the GlxI-catalyzed reaction was 5.0 ± 1.3 
which is comparable to the above values determined experimentally with yeast GlxI (145).   The free 
energy profiles from using classical trajectories as well as including quantum mechanical nuclear 
motion converged to the extent that quantum mechanical attributes of the hydrogen translocation 
contributed little to the observed isotope effect (145).    Kinetic isotope effects from this study also 
included a value of 3.6 ± 0.7 for the uncatalyzed proton transfer in solution and a value of 4.9 for the 
gas phase reaction (145).  The comparable magnitude of all three results indicates that the kinetic 
isotope effect for the GlxI-catalyzed reaction is an inherent feature of this proton transfer via enediol 
formation (145).  The kinetic isotope effects observed from yeast GlxI studies and the computational 
study are consistent with isotope effects indexed for mechanistically similar enzymes including 
triosephosphate isomerase, mandelate racemase and enolase (145).   
4.2 Rationale for Investigating Deuterium Isotope Effects in E. coli GlxI 
The mechanistic attributes of enzyme-catalyzed isomerization are repeatedly observed in different 
protein systems involved with similar chemical reactions.  Although isotope effects in GlxI do not 
directly indicate the role of the metal ion in catalysis, it is important to ascertain whether the 
divergence in metal activation has affected mechanistic attributes identified in yeast GlxI. The yeast 
GlxI enzyme is a Zn2+-activated system, and as such the characterization of kinetic isotope effects is a 
portion of the comparably larger body of data on the biochemical properties of Zn2+-activated GlxI 
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enzymes.  The quantitation of kinetic isotope effects (if any) for the E. coli GlxI-catalyzed reaction 
constitutes an enhancement of our understanding of Ni2+-catalyzed endiol proton-transfer 
mechanisms.  Additionally the ease of metal substitution in the E. coli GlxI enzyme permits the 
probing of potential metal-dependent effects on the observed isotope effects for the reaction in this 
system. 
The characterization of E. coli GlxI deuterium isotope effects using the substrates 
phenylglyoxal (PG) and α-deuteriophenylglyoxal (α-deuterioPG) is outlined in this chapter.  The 
mono-substituted phenylglyoxal (PG) was selected as the substrate of interest to avoid the potential 
difficulties associated with studying a substrate deuterated at multiple sites, such as 
perdeuteriomethylglyoxal.   
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4.3 Materials and Methods 
 
4.3.1 Reagents 
See Chapter 2, section 2.5 for materials referred to in the described methods. 
4.3.2 Growth and Induction of MG1655/pGL10 for Production of E. coli GlxI 
The cell line MG1655/pGL10 was used for overproduction of E. coli GlxI.  A 20 mL Luria-Bertani 
(LB) static culture with ampicillin or carbenicillin at 30-50 mg/L was grown overnight at 37ºC.  10 
mL of the starter culture was used to inoculate 1L pre-warmed LB media containing carbenicillin at a 
final concentration of 50 mg/L.  The culture was incubated with shaking at 37ºC until the OD600 was 
approximately 0.5.  At this optical density heterologous GlxI production was initiated with IPTG at 
0.5 mM final concentration.  The culture was incubated for an additional 6 hours prior to harvesting 
cells.   
4.3.3 Cell Lysis/Disruption 
The preparation of crude E. coli cell lysates for protein purification was as follows.  Frozen cells were 
resuspended in 20 mM Tris buffer pH 7.5 using 10 mL buffer per gram of frozen cells. Crude cell 
extracts were prepared using a SonicatorTM cell disruptor model W225, converter model #2 and a 
standard tapered microtip, with the output control set at 5, from Heat Systems-Ultrasonics, Inc. 
(Plainview, NY). Cells were lysed using 30 pulses of a 10 second duration with intermittent cooling 
on ice for 30 seconds.  Following disruption, phenylmethylsulfonyl fluoride (PMSF) was added to the 
lysate at a 1 mM final concentration, and glycerol was also added at 30% v/v concentration and 
thoroughly mixed.  The cell debris was pelleted by centrifugation in a JA-25.50 rotor at 20 000 rpm 
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(48 300 g) for fifteen minutes at 4°C.  The supernatant was re-spun several more times under these 
conditions until no visible cell debris was observed in suspension. 
4.3.4 Purification of E. coli GlxI 
The cell lysate was initially purified by application to a Unosphere-Q (Bio-Rad, Mississauga, ON) 
anion exchange column (1 mL bed volume) at 1 mL/min.  The column was equilibrated with 20 mM 
Tris pH 7.5, 10% glycerol and protein was eluted at 1 ml/min using a KCl gradient of 0M-1M over 
100 min.  GlxI-containing fractions were identified by SDS-PAGE, pooled and dialyzed against 2 x 
1L 10% glycerol at 4°C.  The dialysate was contained in SPECTRA/POR dialysis tubing with a 
molecular weight cutoff of 12000-14000.  PMSF was added to the dialysis solution at the start of this 
desalting process to 1.5 mM final concentration, followed by addition at 1.0 mM after three hours.  
Eight hours into dialysis, the dialysate was placed in a fresh 1L quantity of 10% glycerol and PMSF 
was added to 1.5 mM final concentration.  This exchange was allowed to continue overnight.  After 
PMSF additions the glycerol solution was adjusted to a pH of 7-9 using KOH. 
 The dialyzed protein was concentrated by ultrafiltration to less than 15 mL in volume for 
loading into the Rotofor preparative isoelectric focusing apparatus (Bio-Rad, Missisauga, ON).  The 
focusing chamber was purged of contaminating ions before sample injection by running at 2W 
constant power for 20 min.  The GlxI-containing dialysate was injected into the cell with BioLyte 4-6 
ampholyte solution. The final concentration of Biolyte in the cell was 1% v/v. Running conditions for 
the cell were 12W constant power for 6 hours.  Fractions were harvest and GlxI-containing samples 
were identified by SDS-PAGE.  Pooled fractions were concentrated by ultrafiltration and the buffer 
was concurrently exchanged to Chelex-treated 50 mM MOPS pH 7.0.  Purified E. coli Apo-GlxI was 
stored at 4°C for at least 4 months.   
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4.3.5 Preparation of PG-GSH Hemithioacetal Solutions  
PG monohydrate was obtained from Sigma Chemical Company.  Stocks of this reagent were prepared 
at 20 mM concentration in 50 mM potassium phosphate buffer, pH 6.6 for use in enzyme assays.  
Reduced glutathione was used in the GlxI assay also and its concentration quantitated by DTNB 
titration as described in (114).  Varying concentrations of the PG-GSH hemithioacetal were made in 
50 mM potassium phosphate buffer so that the final desired concentration of hemithioacetal was 
based on the dissociation constant: 
 
Kdiss = [total phenylglyoxal] [GSH]
[hemithioacetal]  
 
The dissociation constant for the PG-GSH hemithioacetal was determined previously to be 
0.6 mM and this value was used for the preparation of substrate stocks for kinetic assay (86).  The 
spectrophotometric assay for GlxI-catalyzed isomerization of the PG-GSH hemithioacetal monitors 
the decrease in absorbance at 263 nm, which is the isobestic wavelength for the free PG and the 
hemithioacetal (86).  The slope data obtained therefore represents the rate of disappearance of the 
hemithioacetal.  The molar extinction coefficient used for the calculation of Vmax values is the 
difference between the extinction coefficients for the hemithioacetal and the thioester at the assay 
wavelength (146).  In these experiments Є= 5690 M-1cm-1 for phenylglyoxal and Є = 4740 M
-1cm-1  
for α-deuteriophenylglyoxal (86). The mixtures of PG/ and GSH, or α-deuterioPG and GSH, were 
equilibrated for 10 minutes prior to assay and the reaction was initiated by the addition of metal-
reconstituted E. coli GlxI.  The holoforms of E. coli GlxI used in this investigation were the Ni2+- and 
Cd2+-reconstituted forms.  The concentration range of α-deuterio and non-deuterated PG-GSH 
hemithioacetals used in these experiments was 0.01 – 0.5 mM. The assay volume was 1 mL and the 
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final enzyme concentration during the assay was 16.8 nM.  Prior to assay, E. coli GlxI was 
reconstituted with 2.5 molar equivalents (per dimeric enzyme) of the appropriate metal chloride.  
Assay data was collected in triplicate and the final kinetic parameters were estimated from the 
average of at least two sets of triplicate data for the ten susbstrate concentrations assayed. 
4.3.6 Synthesis of α-deuterioPG 
The procedure for synthesis of α-deuterioPG is described in Vander Jagt and Han’s report of 
deuterium isotope effects for yeast GlxI (86).  Briefly, acetophenone was treated with NaOD in 
dioxane-D2O, which yields acetophenone-d3.   Formation of this product was followed by selenous 
acid oxidation and distillation.  The identity of the final product was verified by chemical ionization 
mass spectrometry and 1H-NMR (Figure 4.8, Figure 4.9).  A wavelength scan of the product was 
performed to confirm that the isobestic wavelength of the synthesized α-deuterioPG was identical to 
that of the non-deuterated PG (data not shown).  The stock solutions of α-deuterio PG were also 
prepared in 50 mM potassium phosphate buffer; pH 6.6 for use in kinetic assays and dissolution of 
the solid was achieved by heating at 60 ºC.  The gentle heating of the α-deuterioPG stock was also 
repeated prior to the preparation of each hemithioacetal stock used in the kinetic assay to ensure 
complete solubility of the α-ketoaldehyde and disrupt any polymer formation in solution that would 
lower the concentration of available, free compound.  The kinetic assay was performed as specified in 





Figure 4.8: Electron ionization mass spectrum of α-deuterioPG. The expected mass of the 
anhydrous compound is 135.1 amu.  The presence of a peak as shown with m/z of 135.08 indicates 








H NMR spectrum for α-deuterioPG in D2O. The predicted chemical shift values for 
all protons are shown and the alphabetically labelled protons in the structure correspond to the peaks 
labelled in the spectrum. A small peak in the region for the α-proton is present (D), indicating that a 
small percentage of the α-deuterioPG preparation consists of the α-protioPG. Data was not collected 
in a ppm range that permitted visualation of the hydroxyl proton resonances. Predicted chemical shift 
values were calculated using ChemNMR (Cambridgesoft®). 
4.4 Results 
From the aforementioned experiments, Ni2+-substituted E. coli GlxI accepts PG-GSH hemithioacetal 
as a substrate (Figure 4.10). The kinetic parameters for this holoform are as follows: Vmax = 648 ± 54 
µmol/min/mg; Km = 127 ± 23 µmol; kcat = 322 s-1; kcat/Km = 2.5 x 106 M-1s-1 (Table 4.1, Table 4.2).  
The rate of substrate conversion is similar to that for turnover of MG-GSH by the same holoenzyme, 
although the catalytic efficiency for PG-GSH is 4.8 times lower than when MG is the α-ketoaldehyde 
(kcat/Km = 1.7 x 10
7) (51). The recombinant human enzyme also processes PG-GSH at close to a 
diffusion-controlled rate of 2.7 x 107 M-1s-1 (Table 4.1) (147).  Therefore it appears that the the E. coli 
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and human GlxI enzymes are comparable in efficiency of processing this bulkier substrate in spite of 
the differences in volume of the substrate-binding site between these proteins. 
 
Figure 4.10: Representative plot of PG-GSH concentration versus specific activity for Ni
2+-
GlxI. 




This observation is in accordance with the comparable turnover rates for MG-GSH and PG-
GSH that have been reported previously for yeast GlxI (Table 4.1) (86).  PG has been used to 
characterize the substrate specificity of several GlxI enzymes from other organisms (Table 4.1)(86).  
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Table 4.1: Kinetic Parameters for GlxI with PG as the α-ketoaldehyde substrate* 
 
GlxI Source kcat (s
-1










127 ± 23 
 
2.5 x 106 
Yeast 7200 200 3.6 x 107 
Human  883 34 2.7 x 107 
Onchocerca volvulus 82 311 2.6 x 105 
Trypanosoma cruzi (Ni2+) 
(PG-TSH hemithioacetal) 
265 207 1.3 x 106 
 
*References for the non-E. coli GlxI parameters in the table are (86), (147), (146) and (69), 
respectively. 
 
 The human enzyme also processes PG-GSH at close to a diffusion-controlled rate (147).  It 
would appear that the E. coli and human GlxI enzymes are comparable for turnover of this bulkier 
substrate in spite of the notable differences in volume and contours of the substrate-binding site 
within each protein. 
 The kinetic parameters for E. coli GlxI with α-deuterio-PG-GSH are listed in Table 4.2. The 
Ni2+-substituted E. coli GlxI turns over α-deuterioPG-GSH with a comparable rate and efficiency to 
that observed when the non-deuterated substrate is used for initial rate determination (Table 4.2).  The 
Km and Vmax values for the deuterated substrate are also comparable to that observed with non-
deuterated PG. The values for kcat are similar enough to consider the initial velocities of the enzyme 
almost identical for both substrates.  The values for Vmax(H)/Vmax(D) (0.85) and Km(H)/Km(D) (0.76) are 
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indicative of the absence of an observable deuterium isotope effect for proton transfer (Table 4.2).  
Recall that the ratios of Vmax and Km are equivalent to 1 theoretically if the chemical step under 
investigation is not rate limiting.  This data is a marked contrast to the effect of α-hydrogen 
substitution for the same substrates on yeast GlxI.  Yeast GlxI exhibits deuterium isotope effects of 
3.3 and 3.2 on Km and Vmax respectively, values which suggest that proton-transfer is the rate limiting 
step (86).  Because yeast GlxI isotope effects are the same magnitude for Km and Vmax, the rate of 
substrate turnover/conversion seems to be the only mechanistic step affected by the substitution. 
Assuming the mechanism Ni2+-substituted E. coli GlxI is the same, then the isotope effect could be 
obscured by another step in the catalytic mechanism.  This step would not be detectable by the 
experiments typically used to evaluate the contribution of the proton transfer to substrate conversion. 
Table 4.2 Kinetic Parameters and KIE Values for Ni
2+
-Substituted E. coli GlxI 
















648 ± 54 
 
 

















766 ± 69 
 








Data obtained for comparing PG-GSH turnover to α-deuterioPG-GSH turnover with Cd2+-
substituted E. coli GlxI contrasts markedly with the parameters observed for the Ni2+-holoenzyme.  
The rationale behind probing for the deuterium isotope effect with Cd2+-substituted enzyme is based 
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upon the significant reduction in substrate conversion rate when compared to the value with Ni2+-
substitution (Table 4.3)  (51, 60).  If the proton-transfer step in the Cd2+-holoenzyme is slower than a 
mechanistic step masking isotope effects in Ni2+-substituted GlxI, then observable deuterium isotope 
effects might become apparent using Cd2+-substituted GlxI.  The results described in the following 
section support this hypothesis. 
 




-Substituted E. coli GlxI 









648 ± 54 
676 ± 17 
127 ± 23 
27 ± 0.4 
322 
338 
2.5 x 106 





366 ± 59 
43 ± 5 
 
100 ± 25 





1.8 x 106 
2.4 x 106 
 
*parameters originally published in (51) 
†parameters originally published in (60) 
  
The kinetic parameters obtained for Cd2+-substituted E. coli GlxI are summarized in Table 
4.3). The Cd2+-substituted E. coli GlxI isomerizes PG-GSH hemithioactetal with a comparable 
efficiency to that reported for the MG-GSH hemithioacetal (Table 4.3, Figure 4.11). In contrast the 
Ni2+-holoenzyme processes PG-GSH less efficiently by one-order of magnitude relative to the 
turnover of MG-GSH (Table 4.3).  The Vmax of Cd
2+-GlxI is lower with MG than with PG, so the 
substrate specificity of E. coli GlxI may be dependent upon the specific holoform (Table 4.3).  Metal 
activation differences for PG-GSH conversion rates have not been reported for any other Ni2+/Co2+-




Figure 4.11: Representative plot of PG-GSH concentration versus specific activity for Cd
2+
-
GlxI. The curve shown is the result of data fitting to the standard Michaelis-Menten equation using 
Grafit 3.1. 
 The preliminary assessment of Cd2+-GlxI with α-deuterioPG as the α-ketoaldehyde indicates 
that an isotope effect is observable in this experimental system.  The kinetic parameters for this 
holoform with the deuterated substrate are listed in Table 4.4. The Km is affected modestly by isotopic 
replacement in the substrate while the Vmax(H)/Vmax(D) value of 2.3 indicates that the α-proton transfer is 
partially rate-limiting in the reaction (Table 4.4).  The effect of deuterium substitution on the ratio 
Vmax/Km is low with a value of 1.7 (Table 4.4).  This value does not adequately support the hypothesis 
that the ES complex off-rate is influencing the value of the intrinsic isotope effect.  The KIE on 
Vmax/Km value is small, which reflects a high commitment to catalysis for the GlxI isomerization, 
which is also apparent from the values observed for kcat (Table 4.4).
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 Table 4.4 Kinetic Parameters and DIE Values for Cd
2+
-Substituted E. coli GlxI 
















366 ± 59 
 
 
















161 ± 5 
 
73 ± 9 
 
     1.1 x 106    
 
 4.5 Discussion 
That metals can be removed from the E. coli GlxI active site and re-constituted with different divalent 
cations is advantageous relative to yeast GlxI in the context of kinetic characterization.  Yeast GlxI, 
although well characterized in the biochemical literature, cannot be de-metallated to yield a 
potentially functional apoenzyme that can easily be reconstituted to an active holoform.  Removal of 
the metal ion from yeast GlxI enzyme actually renders the protein permanently inactive.  The E. coli 
GlxI enzyme represents an ideal model system for probing potential metal-ion dependent 
idiosyncrasies in this lyase/isomerase such as related changes in substrate specificity or substrate 
binding capacity.  The ability to easily use E. coli GlxI to detect a potential metal ion-dependent 
effect is in and of itself novel, since metal replacement as a correlate to isotope effects has not been 
described previously in the biochemical literature.  Comparing the kinetic parameters of Ni2+-
substituted and Cd2+-substituted E. coli GlxI, it can be seen that the kcat value is reduced 15.8-fold as a 
consequence of reconstitution with the latter ion (Table 4.3).  So it is apparent that the Cd2+ metal 
centre in E. coli has the effect of attenuating the rate of catalysis significantly.   
The ligand exchange rates for different metal ions may provide a basis for metal-dependent 





(i.e. kH2O in s
-1) from a Cd2+ centre is approximately four orders of magnitude faster (kH2O ≈ 10
8.5 s-1) 
than the exchange rate for waters associated with a Ni2+ center (kH2O ≈ 10
4.4 s-1) ((148). Note that these 
exchange rates are for the first coordination sphere for the metal ion [M(H2O)n
m+].  The impact of 
water ligand exchange on the rate of the GlxI-catalyzed reaction can be considered under the 
assumption that substrate binding occurs at the active site metal via vicinal oxygen chelation with 
concomitant displacement of the resting-state water ligands.  If the rate constant for association of the 
substrate with the active site metal is small relative to the rate constant for the chemical step, the 
kinetic isotope effect will be suppressed.  This is because the chemical step will have occurred 
regardless of isotopic substitution on the substrate, at a rate exceeding the rate of product release from 
the enzyme.  Conversely if the chemical step occurs at a slower rate relative to the off-rate of the 
substrate from the active site metal, the isotope effect for the reaction will be manifest in Vmax.  The 
difference in H2O exchange rates off Ni
2+ versus Cd2+ centres may imply that substrate binding or 
release with Ni2+ is rate-limiting relative to the catalyzed reaction.  In turn, the isomerization itself 
still proceeds at a faster rate than product release from the Ni2+ centre, so the data indicates 
suppression of the kinetic isotope effect due to the limiting product release.  For the Cd2+-substituted 
GlxI, the isotope effect is therefore apparent because the isomerization occurs at a slower rate 
compared to the rate of for substrate association/dissociation with the metal ion. 
Another possible consequence of the metal-dependent ligand exchange rate is that the 
catalytic base may be affected in its ability to disengage from metal coordination to facilitate proton 
abstraction.  In this case the deuterium isotope effect for proton transfer is masked because of the 
decreased propensity for that catalytic residue (or water molecule) to abstract itself from the metal 
coordination sphere.  This “base off-rate” should be distinct from the rate of the substrate to product 
conversion.  Glutamate ligands have been implicated as potential catalytic bases in the enzymatic 
reaction (63, 65). Consequently it would be useful to determine whether such a ligand has a different 
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rate of dissociation from a Cd2+-centre versus a Ni2+-centre in E. coli GlxI in the presence of 
substrates or substrate analogs. 
The most notable observation from these kinetic experiments is that different metal ions in E. 
coli holoGlxI affect the ability to detect a kinetic isotope effect using α-deutero-substituted substrates.  
This observation of a kinetic isotope effect was made using Cd2+- substituted E. coli GlxI, and was 
non-detectable with the Ni2+-substituted GlxI enzyme.   
Slowing the GlxI kcat by metal ion substitution at the active site may be a potentially useful 
tool for identifying intermediates from the catalytic cycle.  This experimental approach would 
complement Laue crystallography or other time resolved techniques for resolving short-lived 
compounds relevant to the enzyme mechanism. 
Subtle reconfigurations of E. coli GlxI during substrate binding might be different depending 
on the holoenzyme type.  The isotope effects previously described may be indicative of this 
phenomenon. Slight differences in the outer sphere of E. coli GlxI that correlate to the species of 
bound metal can be determined through highly sensitive methods such as 2-dimensional 1H-15N-
HSQC NMR. Metal dependent changes in the nature of substrate or inhibitor binding can also be 
observed by this NMR technique. 
The E. coli GlxI enzyme can efficiently turn over PG-GSH hemithioacetals in the Ni2+- and 
Cd2+-substituted holoforms.  A kinetic isotope effect is not apparent for Ni2+-substituted GlxI when an 
α-deuterio-substituted PG is supplied as substrate.  In contrast deuterium isotope effects on Km and 
Vmax with values of 1.6 and 2.3 respectively are observable with the Cd
2+-substituted enzyme. In this 
case the proton transfer step for hemithioacetal isomerization is at least partially rate limiting. Further 
replicates of data will be collected to verify the reproducibility of this effect with Cd2+-substituted 
GlxI.   The basis for metal ion-dependent presence of a deuterium isotope effect with this enzyme is 
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not apparent but it is novel since E. coli GlxI is the first non-Zn2+-dependent GlxI enzyme 
characterized by such experimental approaches. The Lewis acidity of Ni2+ (pKa ≈ 9.9) versus Cd2+ 
(pKa ≈ 10.1) indicates that α-proton abstraction could be more rate limiting when the latter metal 
center is present at the GlxI active site, while the hemithioacetal is coordinated to the metal centre via 
the vicinal oxygen atoms (149). This could account for the apparent KIE with the Cd2+-substituted 




Investigation of SlyD Involvement in E. coli Glyoxalase I 
Metallocentre Assembly 
The earliest reports of transition metals (iron, cobalt, molybdenum) as bacterial growth requirements 
were published between 1959 and 1965 (150, 151, 152).  Hydrogenomonas strains were the first 
bacteria documented to require nickel for growth, this information being reported in 1965 (153).  
Dixon and co-workers described urease from jack bean in 1975 as the first enzyme requiring Ni2+ for 
catalytic activity (154).  Since this time, a number of nickel-dependent enzymes and/or biochemical 
systems have been characterized in significant detail, greatly enhancing our understanding of 
biological inorganic chemistry for this particular element.  The bacterial Ni2+/Co2+-activated GlxI 
enzymes are among the relatively small numbers of Ni2+-activated enzymes that have been identified 
over the last 40 years.  These enzymes include urease, NiFe hydrogenase, carbon monoxide 
dehydrogenase, acetyl-coenzyme A decarbonylase/synthase, methyl-coenzyme M reductase, 
superoxide dismutase and aci-reductone dioxygenase (155).  Two of these well-studied 
metalloenzymes, urease and the NiFe hydrogenase, require specific metallochaperone systems for 
nickel atom insertion (155).  Proposed schemes for nickel metallocenter assembly have been 
described in the literature for both urease from Klebsiella aerogenes and NiFe hydrogenase-3 from E. 
coli (90, 156, 157, 158, 159, 160).  The hydrogenase metallochaperone system is an example of a 
well-characterized nickel insertion mechanism in E. coli. 
 
5.1 The E. coli NiFe Hydrogenase Active Site 
The NiFe hydrogenase in E. coli catalyzes reversible formation of diatomic hydrogen with two 
electrons and two protons as substrates (161).  The protein is heterodimeric with the NiFe metal 
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centre located on the larger subunit (Figure 5.1) (162).  Four cysteine residues coordinate the Ni2+ ion 
and two of these cysteines (Figure 5.2), one CO ligand and two CN ligands coordinate to the iron 
atom (89). There are three types of NiFe hydrogenase enzymes in E. coli, all consisting of a large and 
small subunit (Figure 5.1) (89).  Hyd-3 is the most extensively characterized NiFe hydrogenase from 
a biochemical perspective (89).    
 
Figure 5.1: Structure of NiFe hydrogenase from Desulfovibrio vulgaris (PDB ID:1HR2). The 
NiFe center is located on the large subunit and indicated in black.  The FeS clusters on the small 





Figure 5.2: The NiFe center of D. vulgaris hydrogenase.  The coordinating cysteine residues are 
shown in stick form. 
5.2 Nickel Insertion into the Hyd-3 Large Subunit 
Two groups of proteins designated Hyp and Hyc are responsible for adding nickel to the Hyd-3 
apoenzyme (89).  The hyp operon encodes five proteins (A-E), and two of them (HypA and HypC) 
are specific for Hyd-3 maturation (89).  
The complex HypCDEF delivers iron and the three diatomic ligands (Fe(CN)2CO) to the 
Hyd-3 large subunit (LS) (Figure 5.3)(89, 90). The accessory proteins HypB and HypA mediate 
nickel loading of the LS (Figure 6.3) (89, 90).  The peptidyl-prolyl cis/trans-isomerase (PPIase) SlyD 
has been recently identified as a participant in Ni2+ insertion into Ni-Fe hydrogenase; specifically 
SlyD has been shown to interact with the protein HypB in E. coli (Figure 5.3) (7, 163).  Intriguingly, 
SlyD is the only PPIase superfamily member possessing a defined metal-binding region (7).  In spite 




Figure 5.3: Scheme for NiFe insertion into the Hyd-3 large subunit. The abbreviations LS, CN 
and CO represent the large hydrogenase subunit, the cyanide ligands and the carbon monoxide 
ligands respectively. HycI cleaves part of the C-terminus of the Hyd-3 large subunit, and Ni2+ must 




5.3 SlyD Facilitates Ni Release from HypB into Hyd-3  
SlyD was initially assigned a putative nickel loading function in a screen for multiprotein complexes 
within the E. coli proteome (6). The presence of a C-terminal metal-binding domain is relevant to the 
recently discovered metallochaperone function of SlyD (91).  This C-terminal region contains many 
amino acids that typically function as metal ligands. The SlyD C-terminus contains 15 histidines, 6 
cysteines and 7 glutamate/aspartate residues (Figure 5.4) (6).    
In the survey of the E. coli proteome for SlyD binding partners, no accessory proteins other 
than HypB were found (6).  In E. coli strains lacking the SlyD-encoding gene, hydrogenase activity 
was lower compared to the activity in cells possessing the gene (6).  Partial restoration of 
hydrogenase activity in the deletion mutant could be achieved by the addition of NiCl2 to the growth 
medium (6).  The results of this study indicated that SlyD is involved in Hyd-3 Ni2+ insertion and 
final C-terminal processing of the mature hydrogenase. Hydrogenase activity in slyD- cells could be 
partially complemented by NiSO4 loading in the growth medium (6). 
5.4 Interaction between SlyD and HypB 
Two metal binding sites of differing affinities have been identified on the HypB protein (164).  The 
high affinity site binds a single nickel ion at an N-terminal CXXCGC motif with picomolar affinity 
(Figure 5.4) (164).  The low-affinity site binds a single nickel ion with an affinity in the micromolar 
range using several amino acids in the C-terminal GTPase domain of HypB (Figure 5.4) (164).  
Whether one or both nickel sites are involved in metallocenter assembly of NiFe hydrogenase 
remains as yet undetermined.   
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Figure 5.4: Functional domains of hydrogenase accessory proteins HypB and SlyD. This diagram 
was re-drawn from (7) 
 
The region of HypB that interacts with SlyD is located between the high affinity Ni2+ binding site 
and the GTPase domain (7).    A large insert of 41-49 residues in length has recently been 
identified in FKBP proteins as pertinent to the chaperone activities within this class (165).  This 
region has been designated the “insert in the flap” or IF domain, which has also been identified in 
SlyD through sequence comparison to related proteins (Figure 5.4) (165). Deletion of amino acids 
107-111 in the IF domain impair the chaperone activities of SlyD and the protein is not able to 
form a non-covalent complex with HypB in vitro (7).   
 The N-terminal region of HypB interacts with SlyD, and the isolated HypB GTPase domains 
(C-terminal) do not interact with SlyD (7).  Both the PPIase and metallochaperone activities of SlyD 
appear relevant to NiFe Ni2+ insertion.    
The probable function for these other proteins is to induce metal release from another 





role with regards to metal sensing, delivery and transfer for creation of functional NiFe hydrogenase 
in vivo. 
5.5 SlyD and Ni Insertion into E. coli GlxI 
This chapter summarizes experimental attempts at determining whether SlyD is a general accessory 
protein for nickel insertion into multiple metalloproteins including GlxI.  These experiments represent 
a collaborative effort with Dr. Deborah Zamble’s research group at the University of Toronto where 
SlyD was identified as a hydrogenase metallochaperone.  This investigation aimed to determine 
whether SlyD and GlxI can form a stable protein complex, and whether the presence of SlyD in E. 
coli correlated to the level of measureable GlxI activity at basal expression levels. 
5.6 Materials and Methods 
 
5.6.1 Reagents 
See Chapter 2, section 2.5 for materials referred to in the described methods. 
5.6.2 Strains 
The E. coli strains supplied for the basal level expression tests were a generous gift from the 
laboratory of Dr. Deborah Zamble at the University of Toronto, Department of Chemistry.  The 
control strain used was E. coli DY330 (W3110 lacU169 gal490 lambda cI857 (cro-bioA)), and the 
isogenic slyD deletion mutant was designated ∆slyD (6).  The strain used for obtaining purified 
apoGlxI for the protein partner experiment was MG1655/pGL10.  Note that this strain was employed 
previously for the initial characterization of E. coli GlxI (51). 
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5.6.3 Overproduction and Isolation of E. coli GlxI for Crosslinking Experiment 
Expression and purification of apoGlxI from E. coli strain MG1655/pGL10 was performed as 
described by Clugston et al. (51).  Apo-GlxI was obtained in sufficient quantities and in appropriate 
purity for use in the protein partner experiment.  The enzyme was supplied in the apo-form based on 
the assumption that a stable interaction between SlyD and GlxI may not be detectable if the recipient 
metalloprotein is already metallated.  The purified GlxI was supplied as a stock at 0.4 mg/mL in 50 
mM MOPS (Chelex-treated, pH adjusted with KOH) pH 7.0.   
5.6.4 Conditions for Crosslinking Experiment 
Kathleen Zhang, a technician in the laboratory of Dr. D. Zamble (Department of Chemistry, 
University of Toronto) performed the crosslinking experiment using a purified apo-GlxI preparation 
from the laboratory of Dr. J. F. Honek. The experimental setup for identifying the aforementioned 
heterodimeric complexes involves incubation of the two partner proteins followed by the addition of a 
chemical cross-linking agent to covalently stabilize the dimer.  For the incubations, SlyD and HypB 
were supplied at a final concentration of 16 mM and apo-GlxI was supplied at a final concentration of 
12 mM.  The proteins were incubated overnight at 4 degrees Celsius followed by treatment with 5mM 
1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride) (EDC) for one hour at room 
temperature. This reagent is used to couple primary amines to carboxyl groups, and is commonly 
employed. The buffer employed for the cross-linking reaction was 25 mM HEPES, 200 mM NaCl, 
pH 7.5.  Samples were analyzed on 12.5% SDS-polyacrylamide gels stained with Coomassie 
Brilliant Blue. To investigate complex formation in the presence of nickel 100 µM (final 
concentration) NiCl2 was added to the incubation mixtures. 2.5mM EDTA was used in conditions for 
identifying complex formation in the presence of a chelating agent. 
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5.6.5 Conditions for Lysate Preparation: Basal Level GlxI Expression Growth  
Broth cultures (20 mL culture volume) of E. coli DY330 and DY330∆slyD were grown to stationary 
phase in LB medium using a 250 mL shake flask at 37 degrees Celsius at 200 rpm. Conditions for 
growth of DY330 and DY330∆slyD cultures with metal supplementation involved growth under the 
aforementioned conditions with 0.1 mM NiCl2 present in the media. 10 mL of the cultures was 
harvested by centrifugation at 3000 g for 15 min and frozen at – 80 °C until required.  
Microaerophilic cultures of E. coli DY330 and DY330∆slyD were propagated in 200 mL 
volumetric flasks that were stationary at 37 degrees Celsius to minimize aeration of the culture.  The 
Microaerophilic cultures were grown for 24 hours and harvested as indicated for the aerobic cultures. 
Cultures were grown with and without NiCl2 supplementation at 0.1 mM final concentration of the 
metal chloride. 
Cultures grown in minimal media were propagated at a 250 mL scale using M9 minimal salts 
medium with 0.2% glucose and 8µM NiCl2 when metal supplementation was desired.  The M9 
cultures were grown to stationary phase aerobically using a 1L shake flask incubated at 37 degrees 
Celsius using 200 rpm agitation.  Cultures were harvested as indicated above.   
The cell pellets from the growth conditions described above were resuspended in 
approximately 1 mL/0.5 g cells (wet weight) with 50 mM potassium phosphate buffer, pH 6.6 
containing 0.5% v/v Triton-X 100 and 0.15 mg/mL lysozyme.  The cells were sonicated on ice for 10 
cycles of 10 one-second pulses with intermittent pauses for cooling.  The lysates were clarified by 
centrifugation and the supernatants were used as the source of enzyme for the GlxI assays.  The 
assays were performed as described previously in Clugston et al. 1998 in 0.5 mM MG-GSH using 50 
mM potassium phosphate pH 6.6 as the assay buffer.  Assays were performed in duplicate on a one 
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mL scale with the addition of 0.1 mM NiCl2 where indicated. Approximately 0.1 mg of total lysate 
protein was assayed for each growth condition for both the slyD+ and slyD- strains. 
 
5.7 Results 
5.7.1 SlyD-Apo-GlxI and HypB-Apo-GlxI Cross-linking Experiments 
 
The cross-linking experiments permit the isolation of covalent complexes between partner proteins 
based on the ability to reactively couple protein partners following formation of a stable non covalent 
heterodimer.  The dimerization should occur with the incubation of the two proteins of interest 
together for an extended period of time.  The SDS-PAGE analysis of any potential complexes will 
result in loss of the GlxI homodimeric structure. If a complex was formed with either HypB or SlyD 
however, it should be detectable due to the chemical coupling of the two partner proteins by EDC 
crosslinking.  The SDS-PAGE gel showing the results of the incubation is presented below (Figure 
5.5).   SlyD from E. coli is present in solution with as a dimer of 42 kDa, the monomer being 21 kDa 
in molecular mass (Figure 5.5).  This monomeric weight corresponds well with the observed 
migration relative to the 25 kDa marker on the gel (Figure 5.5).  E. coli GlxI is a 30 kDa dimer in 
solution with the monomer having a predicted mass of approximately 15 kDa.  Again the observed 
migration of E. coli GlxI on the SDS-PAGE electrophoretogram is in good agreement with the 
expected molecular mass.  Following incubation of SlyD with the apo-GlxI one would expect a 
heterodimeric complex of both proteins exceeding the molecular mass of each component 
independently, if they engage in a physical interaction.  Clearly from the results shown below, there is 
no apparent interaction between SlyD and the GlxI enzyme as both proteins migrate independently 
following incubation and EDC treatment (Figure 5.5).   
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 Similarly there was no detectable interaction between HypB and GlxI based on the SDS-
PAGE results.  Both proteins migrate independently and no band with a molecular mass indicative 
of heterodimer formation is observed.  The HypB monomer has a predicted molecular mass of 
31.6 kDa in agreement with the position of the corresponding protein band on the gel (Figure 5.5). 
The significance of assaying for an interaction between HypB and GlxI is that the HypB accessory 
protein may be promiscuous in its function of facilitating nickel metallocenter assembly.  HypB 
may not be exclusively a nickel ion donor for the NiFe hydrogenase.  The results of this 
experiment suggest however that an interaction between this metallochaperone and GlxI does not 
exist (Figure 5.5). 
 
Figure 5.5: SDS-PAGE gel showing results of cross-linking experiment with E. coli proteins 
SlyD, HypB and GlxI. 
  
 In vitro cross-linking may not reliably indicate a potential for in vivo protein complex.  One 
reason is that the nature of the interaction between the two proteins of interest may be so transient that 
the complex does not last for the duration of the incubation preceding EDC treatment.  Also there 
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may be an interaction of multiple proteins in addition to the proteins of interest that is necessary for 
the productive metallochaperone complex to form.  
 
5.7.2 Basal Level GlxI Activity in E. coli Strains with and without the slyD Gene 
Previously, assaying of lysates has been employed to assess the expression level of recombinant E. 
coli GlxI in MG1655/pGL10 (51).  The levels of GlxI activity detected in the lysates of this strain are 
very high because of the copious amounts of recombinant GlxI produced following IPTG induction of 
the culture (51).  The culture experiments with the slyD+ and slyD- strains involved attempts at 
detecting basal levels of the enzyme activity at typical expression levels for the chromosomal gene.  
Glx system components are probably constitutively expressed in E. coli yet the level of enzyme 
present in the lysates was low enough to be undetectable in the presence of MG-GSH with no added 
NiCl2.  Addition of Ni
2+ ions to the assay buffer permitted measurement of a low level of GlxI activity 
from the lysates of the strains. The results of the assays in the presence of Ni2+ are summarized as 
follows: 




+ 0.1 mM NiCl2        0.73 µmol/min/mg 
w/o 0.1 mM NiCl2   0.81 ± 0.02 µmol/min/mg 
∆SlyD strain 
+ 0.1 mM NiCl2         0.85 ± 0.02  µmol/min/mg 








w/ 0.1 mM NiCl2        0.17 ± 0.01 µmol/min/mg 
w/o 0.1 mM NiCl2    0.57 µmol/min/mg 
∆SlyD strain 
w/ 0.1 mM NiCl2        0.12 µmol/min/mg 
w/o 0.1 mM NiCl2    0.67 ± 0.04 µmol/min/mg 
 




w/ 8 µM NiCl2         0.12 µmol/min/mg 
w/o 8 µM NiCl2    0.06  µmol/min/mg 
∆SlyD strain 
w/ 8 µM NiCl2        0.10 µmol/min/mg 
w/o 8 µM NiCl2    0.12 ± 0.01 µmol/min/mg 
 
The range of observed GlxI activity in the lysates was from 0.1 µmol/min/mg to 1 
µmol/min/mg. The levels of activity measured between the aerobic and microaerophilic cultures with 
or without NiCl2 supplementation were quite similar when measured with Ni
2+ added to the assay 
buffer. Furthermore the absence of the slyD gene did not appear to uniformly decrease the amount of 
measured GlxI activity in the lysates across the various growth conditions. In some cases, the 
apparent activity of the slyD deletion mutant lysates appeared higher than for the strain with the 
metallochaperone-encoding gene for a similar condition. This is apparent for the results with the 
microaerophilically grown cells. A possible explanation for this result is that the growth condition 
may make both strains susceptible to growth inhibition by Ni2+ and so a lower level of GlxI activity is 
observed.   These results do indicate that the presence of the SlyD metallochaperone-encoding gene in 





5.8.1 Alternative Methods for Detecting a SlyD-GlxI Interaction 
This investigation failed to detect interactions of the NiFe hydrogenase accessory proteins SlyD and 
HypB with the Ni2+-dependent isomerase/lyase GlxI in E. coli.  This conclusion is based upon the 
failure to observe EDC-stabilized dimerization of either metallochaperone with GlxI following 
protracted incubation.  Additionally the basal GlxI activity in wild type and slyD- strains are 
comparably low with no siginificant differences.  Alternative methods of assessing the formation of 
SlyD-GlxI or HypB-GlxI complexes might include a Western blotting approach. The absence of 
detectable post-incubation complexes in the aforementioned experiments indicates that such an 
interaction may not be observable by Western blot analysis.    
 The two-hybrid method is a widely used in vivo technique that was initially pioneered in 
yeast cell hosts (166).  Detection of the protein complex in vivo relies on transcriptional activation of 
a measurable reporter gene that is expressed when the interaction of interest occurs (166).  The 
components of the two-hybrid system are two fusion proteins.  The gene encoding the bait protein is 
fused to the gene encoding the reporter’s promoter binding domain of the transcription factor on one 
plasmid (166). A second plasmid contains a fusion of the gene for the partner protein of interest and 
the gene for the transcriptional activation domain of the transcription factor (166).  Both plasmids are 
expressed in the host cell and the presence of a protein-protein interaction is inferred from increased 
expression levels for the reporter gene.  This reporter gene allows amplification of the signal 
indicating a protein interaction so that this method may be more useful for detecting transient protein-
protein interactions in the host cell (167).  However the false positive rate using the two-hybrid 





5.8.2 E. coli GlxI and Possible Metallochaperone Interactions in vivo 
A notable aspect of the Ni2+/Co2+-activated GlxI enzymes is the ease of metal removal and 
reconstitution under experimental conditions.  The holoforms from this metal activation class can 
easily be converted to the apoform by EDTA treatment or preparative isoelectric focusing (51).  
Reactivation of the purified enzyme requires only short-term incubation in a stoichiometric excess of 
activating metal ion (51).  The metallation of nascent E. coli GlxI may not require an additional 
repertoire of accessory proteins for insertion of the ion into the active site.  Given the potential for 
GlxI activation by different cations (Ni2+, Co2+, Cd2+, Mn2+), there may be a sampling of holoenzymes 
in the E. coli cell that are differently metallated depending on the ions available to the apoprotein 
(51).  It is also possible given the nanmolar affinity of E. coli GlxI for Ni2+ that it may be able to 
efficiently take up ions from NiFe hydrogenase or SlyD when these proteins are being degraded in the 
cell (60). 
 Nickel is a relatively low abundance metal in bacterial cells.  Magnesium is the most 
abundant metal ion with approximately 0.1 M cellular concentration (169).  Fe, Zn, and Ca follow Mg 
for cellular abundance with concentrations of about 10-4 M (169). The divalent ions Cu and Mn are 
present in E. coli at concentrations around   10-10 µM (169).  Nickel and cobalt are at the low and sub-
micromolar range in cells respectively (169).  Therefore the availability of Ni2+ relative to the cellular 
concentration of GlxI in E. coli may provide an indication as to whether it is predominantly Ni2+-
activated or otherwise in vivo. 
 Glx system enzymes are likely constitutive elements of the E. coli proteome given the 
potential to form toxic MG from glycolytic triose phosphates. In conjunction with evidence for highly 
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active GlxI with only half-of-the-sites metallation, the stoichiometric demand for Ni2+ by this enzyme 
is not nearly as great as for the NiFe hydrogenase-3 of E. coli (51, 60).   
5.8.3 Ni2+ Transport in E. coli and its Relevance to GlxI 
Metal ion transport in E. coli is mediated in part by influx systems with broad selectivity for different 
ions of the same valency.  Promiscuity of metal transporters is a beneficial strategy to maintain the 
ionic requirements of E. coli without the metabolic expense of having to synthesize a specific 
transporter for each required metal ion.  In the case of the NiFe hydrogenases the Ni2+ requirement is 
sufficiently great that it is beneficial to have the Nik transporter that is dedicated to Ni2+ influx to 
assemble the protein under microaerophilic conditions.  The Nik system employs an ATP-dependent 
ABC-type transporter called NikABCDE for import of Ni2+ ions (160).  The repressor protein NikR, 
which prevents expression of NikABCDE in the presence of nickel, regulates the expression of this 
transporter (170).  The FNR regulator controls expression of the nik operon, which codes for the 
NikABCDE and NikR, so that increased Ni2+ transport into E. coli occurs as the organism transition 
from aerobic to anaerobic respiration (171). 
 Ni2+ and Co2+ mobilization into E. coli is also possible through the magnesium transporter 
CorA and the Zn recruitment system ZupT (172, 173, 174).    
 
5.8.4 RcnA is a Ni2+/Co2+ Efflux Protein in E. coli  
The identification of the RcnA/RcnR Ni2+/Co2+ efflux system suggests that there is a second pool of 
nickel available to E. coli that may be relevant to Ni2+ availability for GlxI in vivo.  Rodrigues et al. 
identified the RcnA and RcnR gene products (initially denoted YohM and YohL respectively) in 2005 
(175).  RcnA appears to be a Ni2+ and Co2+ efflux protein and rcnR encodes a divergently transcribed 
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repressor of rcnA expression (175, 176, 177).  RcnA is a membrane-associated protein with a 
histidine rich region located that likely plays a role in metal binding (175).   
 The rcnA gene appears to be strictly induced in the presence of Ni2+ and Co2+.  The rcnA gene 
is not fully expressed until complete repression of the Nik transporter genes has occurred under 
anaerobic conditions.  rcnA expression is unaffected in a ∆nikR background, so a different Ni2+/Co2+ 
transport system likely controls regulation of this efflux protein (176). Ni2+-induced rcnA expression 
is similar under anaerobic and aerobic growth conditions (176). This implies a general function for 
the Ni2+/Co2+ efflux even when the cell does not require large quantities of nickel for hydrogenase 
assembly (176). 
 Deletion of the rcnA gene generates an E. coli phenotype of reduced Hyd-3 activity on 
formate (which induces Hyd-3 activity via the transcription factor FhlA) which is evidence for an 
RcnA-NikR interaction (176).  The deletion of nikR restores Hyd-3 activity in the ∆rcnA strain.  
Based upon these results Iwig et al. suggest that RcnA might function to maintain the expression of 
the Nik transporter at lower Ni2+ concentrations by exporting excess Ni2+ that may inappropriately 
activate NikR.  This ensures that Hyd-3 can be fully activated at lower Ni2+ concentrations during 
anaerobic growth.  Iwig et al. also proposed that RcnA might be necessary for export of Ni2+ 
following degradation of Hyd-3 when the cell no longer requires this enzyme.  
5.8.5 E. coli may have Protein-Specific Ni Reserves  
Iwig et al. have hypothesized that E. coli has access to two pools of Ni2+ ions based on their studies of 
the RcnA/RcnR system (Figure 5.6). The first pool is imported by the Nik transporter and provides 
the main source of Ni2+ for assembly of the NiFe hydrogenases (Figure 5.6).  The second pool of Ni2+ 
ions has a currently undefined import system but is regulated at least in part by the RcnA and RcnR 
proteins (Figure 5.5).  The proposed function of the second pool is to supply Ni2+ to other constituents 
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of the E. coli metalloproteome, which would include GlxI (Figure 5.6) (176). The “Nik” pool is a 
larger reserve of Ni2+ but when E. coli does not require hydrogenase enzymes, then the concentration 
of Ni2+ from both pools will be low (176).  If the Nik pool is saturated, Ni2+ ions can enter the second 
pool according to the model proposed by Iwig et al. (Figure 5.6).  The RcnA associated pool of Ni2+ 
exerts some control over the activity of RcnR and NikR for binding their cognate DNA regions (176). 
 The two Ni2+ pools in E. coli are “linked” through NikR, because the levels of its activity can 
be influenced by the ion concentration from both reserves (Figure 5.6) (176).  Ni2+ from the 
hydrogenase assembly pool may enter the RcnA-associated pool through degradation of Hyd-3 large 
subunits so that the excess Ni2+ has a route for cellular efflux (Figure 5.6).  Also excess nickel from 
the hydrogenase assembly pool may be re-routed to the second pool for export by RcnA to maintain 
cellular homeostasis (176). 
 In the context of E. coli GlxI assembly in vivo, the RcnA associated Ni2+ pool may constitute 
the source of activating ions for the enzyme as opposed to Ni2+ imported by NikABCDE and supplied 
to Hyd-3 via SlyD.  The presence of a histidine rich region on RcnA may function as a site for 
transient metal binding for transfer to apoenzymes such as nascent GlxI (176).  This would imply a 
dual function for RcnA as metal delivery protein as well as an efflux pump.   





Figure 5.6: Scheme for nickel transport in E. coli. Diagram adapted from (176) 
 
6.8.6 Cobalt is not a Likely Contributor to E. coli GlxI Activation in vivo  
Cobalt impairs the growth of E. coli significantly at concentrations of 100 µM in minimal medium 
(178).  The CorA transporter does seem to play a major role in Co2+ accumulation as mentioned 
previously, and deletion of the encoding gene decreases uptake markedly in medium spiked with 
CoCl2 (178).  Expression of the Fur (ferric uptake regulator) gene fhuF (encodes ferrichrome 
reductase) is increased in E. coli with exposure to exogenous CoCl2, implying that observed decreases 
in iron uptake may be due to cobalt accumulation via iron transport systems (178).  This impairs the 
activities of several important [Fe-S] enzymes in E. coli cells (178).  Experimental findings by 
Ranquet et al. indicate a disruption of iron homeostasis and [Fe-S] cluster synthesis in E. coli 
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resulting from the insertion of Co2+ into [Fe-S] clusters, leading to protein inactivation.  The potential 
for cellular impairment with Co2+ concentrations exceeding 5-10 µM in E. coli implies that wild type 
cells limit Co2+ uptake, except for the ions present in vitamin B12.  Therefore Co2+ may not be a 
plausible reservoir for activation of E. coli GlxI in vivo.  Assuming that Ni2+ is the preferred activating 






Metal Binding and Inhibitor Binding Studies of E. coli Glyoxalase I  
6.1 Monomeric GlxI Enzymes Exhibit Differential Catalytic Site Activities 
Glyoxalase I enzymes can occur as homodimeric or fused dimer structures (Figure 6.1).  Examples of 
homodimeric GlxI enzymes include those from E. coli, H. sapiens, L. major and P. putida (51, 59, 67, 
147).  Fused dimer GlxI enzymes have been isolated primarily from S. cerevisiae, Plasmodium 
falciparum and plant sources such as wheat bran (57, 58, 179).  The proteins in the βαβββ 
superfamily (including GlxI) are assembled so that the constituent monomers form two identical 




Figure 6.1: Schemes for assembly of homodimeric versus monomeric GlxI enzymes. In the 
homodimeric model, similarly coloured octagons represent identical domains in the protein. In the 
monomeric model all βαβββ domains are connected sequentially in a contiguous polypeptide 




P. falcip -------MAQEISNLVKKYNVTWQQTMLRIYDPKETVEFYEKNFGMINIHTYHFNEYNFS 
S. cerev MSTDSTRYPIQIEKASNDPTLLLNHTCLRVKDPARTVKFYTEHFGMKLLSRKDFEEAKFS 
E. coli ------------------------------------------------------------ 
H. sapiens ------------------------------------------------------------ 
 
P. falci LYFLITPPYDEEERKKLPEPNTKESEKYLWNLNTVCLELTYNHNSQEKL----SNGNNEN 
S. cerev LYFLSFPKDD--------IPKNKNGEPDVFSAHGV-LELTHNWGTEKNPDYKINNGNEEP 
E. coli ------------------------------------------------------------ 
H. sapiens -------------------------------------------MAEPQP----PSGGLTD 
 
 
P. falci DRGFGHIAFNCNDVIEQCDNLFKKNVKFHKLPHETKMKTIGFALDPNNYWIEIVKRSNQV 
S. cerev HRGFGHICFSVSDINKTCEELESQGVKFKKRLSEGRQKDIAFALGPDGYWIELITYSREG 
E. coli ------------------------------------------------------------ 
H. sapiens EA-----ALSC------CSD-----------------------ADPST------------ 
 
 
P. falci KWKNYKNIT---NFS QTMIRVKNPEKSLYFYIHILGMKLIHVKHCS----DFSLYFLKSN 
S. cerev --QEYPKGSVGNKFNHTMIRIKNPTRSLEFYQNVLGMKLL--RTSEHESAKFTLYFL--- 
E. coli -----------MRLL HTMLRVGDLQRSIDFYTKVLGMKLL--RTSENPEYKYSLAFV--- 
H. sapiens --KDFL-------LQ QTMLRVKDPKKSLDFYTRVLGMTLI--QKCDFPIMKFSLYFL--- 
 
 
P. falci YACAENNKEMIEDQSNKNTNEIYDFNSLKNSYQTDEDYENFKQSWEPVLELTHNHGTEDD 
S. cerev ------GYGVPKTDS--------------------------VFSCESVL ELTHNWGTEND 
E. coli ------GYG-PETE-------------------------------EAVI ELTYNWGVDK- 
H. sapiens --AYEDKNDIPKEKDEKIA---------------------WALSRKATL ELTHNWGTEDD 
 
 
P. falci DNFSYHNGNTEPRGFGHIGFLVNDLENYCKELETL---NVTFKKKVTEGLMKNIAFIYDP 
S. cerev PNFHYHNGNSEPQGYGHICISCDDAGALCKEIEVKYGDKIQWSPKFNQGRMKNIAFLKDP 
E. coli ----YELGTA----YG HIALSVDNAAEACEKIRQN-GGNVTREAGPVKGGTTVIAFVEDP 
H. sapiens ETQSYHNGNSDPRGFGHIGIAVPDVYSACKRFEEL---GVKFVKKPDDGKMKGLAFIQDP 
 
 
P. falci DNYVI ELIQRDTSFIAK-- 
S. cerev DGYSI EVVPHGLIA----- 
E. coli DGYKI ELIEEKDAGRGLGN 
H. sapiens DGYWIEILNPNKMATLM-- 
 
Figure 6.2: Alignment of sequences of monomeric GlxI enzymes from P. falciparum and S. 
cerevisiae (Accession nos. AAQ05975 and CAA67622 respectively) with homodimeric GlxI 
sequences from E. coli and H. sapiens (Accession nos. U57363 and NP_006699 respectively). Metal 





Several studies of monomeric GlxI enzymes have allowed some exploration of differential 
kinetics of the two active sites in the native protein.  The monomeric GlxI enzymes are structurally 
“fused dimers” where all βαβββ modules are joined via protein linkers to form both active sites 
within a contiguous stretch of polypeptide sequence (Figure 6.2) (9, 57, 58, 179).  Analysis of 
monomeric GlxI sequences indicates that they were likely formed as a result of two gene duplications 
(of a unit of a gene encoding a single βαβββ module) and subsequent fusion events resulting in 
assembly of consecutive βαβββ modules (1/2 active site) at the genetic level (Figure 6.3)(9, 54).  
Each gene duplication event would have resulted in the formation of an additional βαβββ module 
(1/2 active site) or tandem βαβββ module.   
 
Figure 6.3: Scheme for evolution of homodimeric and fused monomeric GlxI enzymes. Adapted 
from (9). 
6.2 Yeast GlxI has Different Kinetic Parameters for Each Active Site 
The yeast (Saccharomyces cerevisiae) GlxI displays significantly different kinetic parameters for 
turnover of MG-GSH depending on which active site is inactivated (57).  Frickel et al. created two 
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yeast GlxI variants with E163Q and E318Q substitutions respectively, selectively disabling the active 
sites.  Glutamate substitutions in both active sites resulted in a variant with a severely compromised 
capacity to isomerize MG-GSH (kcat ≈ 0.31 s-1) (57). Interestingly, inhibition constants for both of the 
single active site variants were found to be comparable in the presence of S-hexylglutathione (57).  
Frickel et al. estimated from their kinetic analysis that the active site containing His25, Glu89, His269 
and Glu318 supplies approximately 75% of the total enzyme activity with the remaining 25% 
contributed by the site with His185, Glu242, His117 and Glu163.  This estimate is conservative, as 
the residual enzymatic activities of each single active site variant together do not account for the total 
enzyme activity observed for wild type yeast GlxI (57).  Furthermore they did not explore any aspect 
of potential allosterism between active sites but acknowledged that this phenomenon may apply to the 
enzyme under study.     
 6.3 P. falciparum GlxI Active Sites Exhibit Allostery 
P. falciparum GlxI is another Zn2+-activated monomeric GlxI enzyme whose characterization was 
first reported in 2003 (128, 180).  Similar to the yeast GlxI study, Deponte et al. created variants with 
a glutamate substitution specific to each active site and characterized the proteins by performing 
steady state kinetic measurements (8).  Their approach to active site inactivation was to create single 
and double E→Q substitutions corresponding to each active site (E91 and E345 are from one active 
site, E161 and E272 are in the other) (8).  The muteins created were E91Q, E345Q, E91Q/E345Q, 
E191Q, E272Q, E161Q/E272Q and E161Q/E345Q (latter variant had both active sites modified) (8).  
Biphasic kinetics are observed for the wild type and mutagenized enzymes, so that two apparent Km 
and kcat values can be calculated for each active site (8). The catalytic efficiencies of the E91 and 
E345 variants (including the double residue substitution), are equivalent to approximately 7% of that 
for the wild type P. falciparum GlxI (8).  Conversely, the catalytic efficiencies of the E161 and E272 
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variants (including the double residue substitution), were equivalent to approximately 60% of wild 
type P. falciparum GlxI (8).  Furthermore the “relative to wild type” magnitudes of Kmapp and kcat app 
appear to correlate to the active site which was modified (8).  The residual enzyme activities in each 
of the single active site glutamate to glutamine variants did not indicate additive activities 
contributing to the catalytic proficiency of the P. falciparum GlxI as a whole (8).   
Additionally Deponte and co-workers observed differential protease susceptibility of P. 
falciparum GlxI (wild type and variant enzyme) in the presence and absence of added substrate (8).  
These data are complementary in supporting the hypothesis that the active sites of monomeric P. 
falciparum GlxI are allosterically coupled even though the binding affinity of each active site is 
markedly distinct (8).  Whether coupling of active sites in homodimeric GlxI enzymes occurs remains 
to be determined, but asymmetry of active sites has been documented in E. coli GlxI, specifically the 
different metal stoichiometry between two supposedly identical active sites.  
 
6.4 Evidence for Non-Symmetric Active Sites in E. coli GlxI 
The metal binding site stoichiometry in E. coli GlxI is a property of the enzyme for which there is 
conflicting data.  Titration of the apoenzyme with Ni2+, Co2+, Mn2+ and Cd2+ results in maximal 
activation levels achieved at a ratio of approximately one metal per dimer (56).  Inductively coupled 
plasma atomic emission spectroscopy of Ni2+-, Co2+, Mn2+, Cd2+ and Zn2+ holoGlxI indicates a 
binding ratio of one metal ion per dimer as well (51, 60). Furthermore these estimates are in 
agreement with the number of metallation sites determined by isothermal titration calorimetry (ITC) 
of E. coli GlxI with all metals used for ICP-AES analysis (51, 60).  However the published crystal 
structures for Ni2+-, Co2+, Zn2+ and Cd2+-bound E. coli GlxI indicate that both active sites of the 
homodimer are occupied by metal ions (52).   
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Further characterization of metal binding in E. coli GlxI is required to resolve whether the 
enzyme is fully active with metal occupancy at one or both of the active sites.  From a structural 
perspective, metallation of E. coli GlxI must be a subtle process. This is apparent from the absence of 
secondary structure changes between the apo-dimer versus the holo-dimer as shown by circular 
dichroism spectroscopy (56).  Furthermore the root mean-squared deviation when comparing the C-α 
atoms of the apo-GlxI crystal structure to that of the Ni2+-substituted enzyme is only 0.32 Angstoms 
(60).   
This chapter describes the examination of microscopic structural changes in E. coli GlxI 
accompanying metal binding, using 1H-15N heteronuclear single quantum coherence (HSQC) NMR. 
This study is pertinent to addressing whether GlxI actually uses both active sites for enzymatic 
catalysis.  
6.5 Materials and Methods 
6.5.1 Reagents 
See Chapter 2, section 2.5 for materials referred to in the described methods. 
6.5.2 Expression and Purification of 15N-labelled E. coli GlxI – Wild Type and H74Q  
All cultures for overproduction of 15N-labelled protein were grown on a 0.5 L or 1 L scale.  Wild type 
E. coli GlxI was overproduced in an E. coli BL21(λDE3) host using the plasmid pGL10, which is 
normally expressed in the MG1655 background for recombinant protein production.  The BL21 strain 
was used in this study as less co-contaminating proteins persisted across purification steps for the 
protein.  Large scale (1L volume) cultures of BL21(λDE3)/pGL10 grown in M9 minimal salts 
medium containing 18.8 mM 15N-labelled (NH4)2SO4 (Cambridge Isotope Laboratories, Andover, 
MA, USA)  50 mg/L carbenicillin were inoculated with growth from a 20 mL culture of the 
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bacterium cultivated in M9 minimal salts medium (containing unlabelled (NH4)2SO4 as a nitrogen 
source) with  50 µg/mL carbenicillin. The aforementioned 20 mL culture was initially inoculated with 
growth from a 10 mL starter culture of BL21(λDE3)/pGL10 grown in LB broth containing 50 µg/mL 
carbenicillin.  Prior to inoculating the intermediate and large-scale cultures, the innoculum was 
centrifuged at 3000 g and resuspended in sterile M9 salts solution to minimize the carry-over of any 
secreted β-lactamase.  The large-scale culture was grown to an OD600 of 1 and then induced with 0.5 
mM IPTG for 12 hours.  Cells were harvested by centrifugation at 6000 g and frozen in liquid 
nitrogen until the time of purification. 
 For overproduction of the H74Q active site variant of E. coli GlxI, the MG1655 host strain 
containing the plasmid pGL13 was used.  The protocol described above for overproduction of wild 
type 15N-labelled E. coli GlxI was similarly employed for labelling of H74Q GlxI. 
Purification of the cell lysates for wt and H74Q GlxI initially consisted of precipitating 
contaminating proteins by the addition of (NH4)2SO4 to 60% saturation. The majority of recombinant 
GlxI remains in the supernatant at this salt concentration and this remaining soluble portion of lysates 
was dialysed into 20 mM Tris pH 8.0 containing 1 mM PMSF for application to the UnosphereQ 
anion exchange column.  The dialysed protein was applied to the column (loaded at 0.8 mL/min) and 
eluted using a linear gradient of KCl from 0 to 1M over 100 minutes at 0.8 mL/min.  The labelled 
GlxI fractions were eluted between 20 and 40% KCl and pooled for dialysis into 20 mM Tris pH 8.5 
and loaded onto a MonoQ 5/5 column at 0.5 mL/min.  The enzyme was eluted from the column with 
a linear gradient of KCl from 0 to 1M over 100 minutes at 0.5 mL/min.  GlxI containing fractions 
were pooled and concentrated.  The buffer change and concentration of the purified 15N-labelled GlxI 
was carried out by ultrafiltration using a Vivaspin 2mL centrifugal concentrator (10000 MWCO) spun 
at 3000 g in a clinical centrifuge.  During the buffer change the protein was exchanged into 50 mM 
MOPS containing 100 mM DPA pH 7.0 to ensure removal of any bound metal.  The protein was then 
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exchanged (centrifugal ultrafiltration) into 20 mM MOPS pH 6.59 for storage and NMR analysis 
using enough buffer solution to ensure that prior buffer components were diluted more than 1000-fold 
before storage of the protein at 4 °C.  The protein concentration was determined by the method of 
Bradford and the absence of any contaminating metal was confirmed by the PAR assay using protein 
denatured in 4M Gdn-HCl (118, 181). 
 For the purification of 15N-labelled H74Q GlxI the lysate was subjected to ammonium sulfate 
as described for the wild type enzyme. A significant quantity of H74Q GlxI precipitated following 
addition of (NH4)2SO4 to 60 % saturation in the lysate.  This protein was solubilized and desalted by 
dialysis into 20 mM Tris pH 8.5 for application to a UnosphereQ column where the protein was 
eluted off using a linear gradient of 1 mL UnosphereQ (flow rate for application was 0.8 mL/min) 
column where the protein was eluted with a linear gradient of KCl from 0 to 1M over 100 minutes 
(flow rate was 0.8 mL/min).  The GlxI containing fractions from this step were dialyzed into 20 mM 
Tris pH 7.5 and solid (NH4)2SO4 was added to the sample for a final concentration of 1M.  The 
sample was applied to a Phenyl HP Hi Sub (Amersham Biosciences) column with 20 mM Tris pH 7.5 
containing 1 M (NH4)2SO4 at 1 mL/ per minute and eluted off the column with a  linear decreasing 
gradient of (NH4)2SO4 (1M to 0M over 15 minutes).  A polishing size exclusion step was included 
when necessary during purification.  Specifically the concentrated H74Q GlxI sample was applied to 
and eluted from a Superdex75 column (10/30) at 0.5 mL/min using 20 mM Tris pH 7.5, containing 
150 mM (NH4)2SO4.   Subsequently these fractions were pooled, the buffer exchanged and 
concentrated as described above for wild type E. coli GlxI. 
6.5.3 1H-15N NMR Conditions 
All NMR spectra were collected at 25°C on a Bruker Avance 600 or 700 MHz spectrometer equipped 
with a triple-resonance pulse-field gradient probe. 1H-15N HSQC NMR spectra were recorded in the 
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States-TPPI mode for quadrature detection (182, 183). All the NMR samples were prepared in the 
same buffer, (20 mM MOPS pH 6.59 plus 5% D2O (final concentration)) 
1H-15N HSQC titrations of 
the Apo-wild type and H74Q E. coli GlxI enzymes were performed by stepwise addition of Ni2+ or 
inhibitor (at a high concentration) into the 15N-labeled component (typically at a concentration of 0.1-
0.3 mM) to a final 1 to 2-fold excess. 
7.5.3 NiCl2 Titration of Wild Type and H74Q Variant E. coli GlxI 
The step-wise titrations of Ni2+ ions into the apo-wild type and H74Q E. coli GlxI enzymes were 
performed on a 600 MHz and 700 MHz NMR machine respectively.  NiCl2 stocks were prepared at 
concentrations so that the wild type dimeric enzyme was exposed to 0.25 equivalents of Ni2+ with the 
addition of 5 mL of metal chloride solution.  
6.6 Results 
6.6.1 Ni2+ Titration of Wild Type and H74Q GlxI 
ESMS analysis confirms that 15N-labelling of the amide backbone of wild type (Figure 6.4) and H74Q 
GlxI is complete when the aforementioned expression systems are used.  Thus 15N-labelled wild type 
and H74Q GlxI was obtained with molecular masses at the expected values for protein produced by 
BL21(λDE3)/pGL10 and MG1655/pGL13 with 15N-labelled (NH4)2SO4 as the sole nitrogen source.  
Gel filtration chromatography on a Superdex 75 column during purification indicates that the 15N-
labelled GlxI is homodimeric. An apparent molecular weight of 24 kDa and a similar elution volume 
to carbonic anhydrase (30 kDa) were observed during this procedure. No protein-containing fractions 
indicative of GlxI monomers (14.9 kDa) were observed during separation. Preparations of 15N-
labelled GlxI for this investigation approach 85-90% purity as assessed by SDS-PAGE with 
Coomassie Brilliant Blue Staining.  However the yields are quite modest averaging about 1-2 mg of 
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protein from 4L of culture for wild type and H74Q E. coli GlxI under the described growth 









Figure 6.4: Representative electrospray ionization mass spectrum for 
15
N-labelled wild type E. 
coli GlxI. The peak corresponding to the protein of interest is indicated with an arrow. The calculated 
molecular mass of the GlxI monomer is 15097 Da and the observed molecular mass is 15093 Da. 
 
During the execution of this project, Dr. Zhengding Su attempted to create a plasmid 
construct in which the E. coli gloA gene was flanked at the 3’-end by a sequence encoding a 
hexahistidine tag preceded by a thrombin cleavage site.  In practice this may have improved recovery 
of 15N-labelled E. coli GlxI, as the enhancement of purity by nickel-nitriloacetic acid affinity 
chromatography is generally superior and more efficient than the chromatographic methods 
documented in this section.  However the recombinant expression system obtained from this re-
cloning exercise generated detectable but insoluble GlxI based on SDS-PAGE analysis of lysates 
from test inductions. 
glxI N15 labelled +ESI in 1:1 MeCN/H2O+0.2%FA
mass








E. coli GlxI 
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The initial 1H-15N HSQC NMR experiment conducted was a Ni2+-titration of wild type E. coli 
with NiCl2.  The colorimetric PAR assay was used to confirm that the protein being titrated was in the 
apo-form following ultrafiltration in the presence of DPA before the NMR experiment was 
performed. An initial 1D 1H-NMR spectrum (data not shown) of the apoGlxI revealed a well-defined 
amide region indicating that the protein was well folded under the solution titration conditions (20 
mM MOPS pH 6.59 + 10% D2O v/v).  Theoretically, there would be 132 resonance peaks (135 amino 
acids in E. coli GlxI minus the non-detectable proline residues) corresponding to each residue in the 
monomer if the homodimer is symmetric or if the protein was monomeric in solution. Alternatively, 
dimer asymmetry where the residues in each monomer were not chemical shift equivalent would 
yield a 2D spectrum with 270 peaks.  There are approximately 128 detectable resonance peaks in the 
wild type GlxI spectrum (Figure 6.5). In conjunction with the gel filtration analysis, this shows that 
the apoGlxI enzyme in solution is dimeric. 
Interestingly, the 1H-15N HSQC spectrum of the apoGlxI reveals an initial asymmetry of the 
monomeric modules comprising the native protein.  Specifically, two peaks were observed in the 
region of the spectra that correspond to ring 15N resonances of tryptophan residues (Figure 6.5).  
Examination of the amino acid sequence reveals that the E. coli GlxI monomer possesses only one 
tryptophan residue (Figure 6.5). The presence of two peaks indicates conformational asymmetry of 
Trp61 in the native GlxI apoenzyme. 
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spectrum of wild type GlxI apoenzyme with labelled resonance peaks for Trp61. 
 
Although assignment of all peaks in the E. coli GlxI 1H-15N HSQC spectrum has not yet been 
performed, the systematic NiCl2 titration of wild type GlxI permits the observation of subtle protein 
backbone reorganization.  These conformational differences were not previously revealed in 
crystallographic or circular dichroism analysis.  Following titration of one equivalent of Ni2+ ions into 
the GlxI sample, the spectrum reveals splitting for several peaks, indicative of asymmetries in the 
dimer environment that accompany metal binding.  The chemical shifts for the Trp61 residues remain 
constant during Ni2+ titration of the enzyme (Figures 6.6 and 6.8).  Additionally, spatially distinct 




specific locations in both monomers of the native enzyme (Figure 6.7).  A key implication of these 
spectral features of the titrated enzyme is that wild type E. coli GlxI does not possess a uniform dimer 
environment and that the holoprotein assumes a conformation distinct relative to the apoenzyme when 
it acquires activating Ni2+ ions.   
The changes in peak distribution/splitting are essentially complete after titration with one 
equivalent of Ni2+ into apoGlxI (Figures 6.6, 6.7 and 6.8).  Superimposition of the spectra following 
one-equivalent and two-equivalent additions of Ni2+ to E. coli GlxI indicate that little change in 
protein conformation occurs when titrated past one-half of the total active sites.  The data implies that 
the active enzyme saturates for metal binding at one equivalent Ni2+ per dimer.  This data is consistent 
with ITC and ICP-AES studies as well as activity versus metal content plots indicating that E. coli 




Figure 6.6: A) Overlay of apoGlxI spectrum (black) with 1:1 Ni2+:GlxI in solution (red) B) 
Overlay of spectra for 1:1 Ni2+:GlxI (green) and 2:1 Ni2+:GlxI (red).  Resonances labelled H74 
and W61sc are associated with His74 backbone resonances and Trp61 side chain resonances 
respectively.  The box in A) denotes the area of the spectra where peak splitting occurs during metal 






Figure 6.7:  Selected resonances (indicated by arrows in wild type GlxI that split in response to 
Ni
2+
 binding. Each panel represents resonances an overlay of the apoenzyme spectrum (black) with 
non-black titration spectra at increasing metal:dimer ratios: A) 0:1 B) 0.25:1 C) 0.5:1 D) 0.75:1 E) 1:1 





Figure 6.8: Chemical shift changes accompanying metal binding in wild type GlxI for A)His74 
and B) Trp61 side-chain N-H resonances. Colours of resonances denote positions metal:dimer 
ratios of 0:1 (black), 0.4:1 (green), 0.6:1 (purple), 0.8:1 (yellow), 1:1 (red), 1.5:1 (brown) and 2:1 
(blue). Display of these resonances is enlarged (inset) for clearer illustration. 
  
 1H-15N HSQC NMR spectra were also obtained for the H74Q variant of E. coli GlxI, which 
has been previously characterized for metal activation.  This metal versus activity titration data is 
described thoroughly in the Master’s dissertation of Nicole Sukdeo.  This active site variant was 
chosen for 1H-15N HSQC NMR analyses to identify the peaks associated with the His74 metal ligand.  
Additionally, the yields of recombinantly expressed H74Q GlxI are superior to those for the H5Q and 
double active site histidine variant H5Q/H74Q GlxI (both have been previously described), so it was 
a suitable candidate for 15N-labelling where yields of protein tend to be more conservative.   The 1D 
proton NMR spectrum for H74Q GlxI was indicative of a well-folded dimeric protein comparable to 
the 1D spectrum for the wild type enzyme.  The overall distribution of 1H-15N HSQC peaks for the 
H74Q dimer is quite similar to those observed for the wild type enzyme.  Particularly the backbone 
resonances in the chemical shift range 15N 103-111 ppm, 1H 7.1-8 ppm are spatially arranged in an 




expected, as His74 is primarily a metal binding residue and likely not a great contributor to the 
structural configuration of the overall dimer.  
There are some notable differences between the 1H-15N HSQC spectra of the wild type E. coli 
GlxI and this active site variant.  The most prominent difference is the absence of two resonances in 
the H74Q GlxI spectrum that are located at 15N 106 ppm, 1H 8.96 ppm and 15N 108.5 ppm, 1H 9.25 
ppm in the wild type E. coli GlxI spectrum (Figure 6.8).  During NiCl2 titration of the wild type 
enzyme it is also observed that the peak with the chemical shifts 15N 108.5 ppm, 1H 9.25 ppm 
translocates in the spectrum in the presence of Ni2+ whereas the peak at 15N 106 ppm, 1H 8.96 ppm 
does not (Figure 6.9).  These peaks in the wild type spectrum are likely representative of the His74 
backbone amide resonances and their difference and their absence in the H74Q spectrum is plausible 
given the glutamine substitution.  Furthermore the presence of two peaks that can be assigned to each 
of the active site His74 residues in the homodimer indicates inherent asymmetry of the active sites in 
the wild type apo- and holo-enzyme (Figure 6.9).  In accordance with half-of-the-sites metallation of 
E. coli GlxI the chemical shift change for only one of the two peaks implies metal ion binding at only 
one active site in the native apoenzyme.  Other notable features of the H74Q variant spectrum are 
several resonances that are translocated relative to the analogous resonance in the wild type GlxI 
spectrum (Figure 6.9).  It is possible that these chemical shift differences indicate a subtle 
reconfiguration of hydrogen-bonding that is strongly influenced by the presence of His74 in the 
polypeptide. Consequently the lower activity (and weaker metal binding) observed for H74Q GlxI 
may be the result of ligand substitution inducing unfavorable changes in the second sphere 




Figure 6.9:  Overlay of wild type apoGlxI spectrum (black) with the apoH74Q-GlxI spectrum 
(red). The resonances associated with His74 residues in the wild type spectrum are indicated with 
arrows (H74). Resonances that are shifted in both monomers of the H74Q variant relative to wild type 
GlxI are indicated with blue boxes. 
The E. coli GlxI H74Q variant has been characterized previously by metal versus activity 
titration.  The relative activation of the enzyme with different divalent metal ions (Ni2+ > Co2+ > Mn2+ 
> Cd2+) is similar to the wild type GlxI although the activity is almost abolished (specific activity of 
H74Q is approximately 1% of the Vmax reported for wild type E. coli GlxI) as a consequence of the 
ligand substitution.  The metal titrations indicate that the metal affinity of the variant GlxI is 
attenuated.  Wild type E. coli GlxI exhibits maximal activation when titrated with reconstituting metal 
ions (Ni2+, Co2+, Mn2+, Cd2+) when titrated from the apo-form to one equivalent of metal per 
homodimer in solution.  The H74Q GlxI variant reaches maximal activation when titrated from the 
apoform closer to two equivalents of metal ion per dimer.  Although calorimetric or equilibrium 
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dialysis data have not been used to characterize metal affinity of this variant, these titrations 
demonstrate the essential role of His74 for binding catalytic metal ions in E. coli GlxI.   
NiCl2 titration of the 
15N-labelled H74Q GlxI enzyme also demonstrates the compromised 
metal-binding capacity of this variant.  1H-15N HSQC spectra of the apo-form H74Q compared to the 
spectra of the enzyme with one equivalent of Ni2+ reveals no significant shift in the backbone 15N and 
1H chemical shift values (data not shown).  This contrasts significantly with Ni2+ titration of wild type 
GlxI where peak splitting and/or re-orientation is observable with the introduction of only 0.25 
equivalents of Ni2+ to the preparation of apoenzyme.  One important attribute of the 1H-15N HSQC 
NMR spectra obtained for the H74Q variant is that the two peaks associated with the indole ring 
nitrogen resonances from Trp61 are still visible as observed in the wild type spectrum.  This implies 
that a degree of dimer asymmetry is present in the variant, which is plausible, as the histidine to 
glutamine substitution is not positioned to significantly alter the native structure of the enzyme.  
However the absence of spectral changes accompanying metal titration indicates an inability of the 
variant to assume the active metal-binding conformation, in spite of the subtle nature of the apo- to 
holoenzyme conversion.   
6.6.2 Titration of Ni2+-Reconstituted E. coli GlxI with S-{2-[3-
(hexyloxy)benzoyl]vinyl}glutathione 
In an effort to characterize subtle structural changes of the wild type E. coli GlxI enzyme that would 
accompany substrate/substrate analogue binding, the Ni2+-reconstituted enzyme (re-metallated during 
NiCl2 titration experiment) was incrementally titrated with a comparably strong inhibitor.  S-{2-[3-
(hexyloxy)benzoyl]vinyl}glutathione (Figure 6.10) and its interaction with E. coli GlxI has previously 
been characterized in an electrospray time-of-flight mass spectrometric examination of GlxI-inhibitor 
complexes (184).  This compound was one of several S-substituted glutathione analogues screened 
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against E. coli GlxI previously.  This inhibitor has a micromolar inhibition constant for E. coli GlxI, 
with a published IC50 value of approximately 57 µM (184).  
 
Figure 6.10: Structure of S-{2-[3-(hexyloxy)benzoyl]vinyl}glutathione 
 
Mass spectrometric and enzyme kinetic studies indicate that the dimeric enzyme can bind S-
{2-[3-(hexyloxy)benzoyl]vinyl}glutathione in the apo- and Ni2+-reconstituted forms (184).  E. coli 
GlxI is also capable of binding two molecules of S-{2-[3-(hexyloxy)benzoyl]vinyl}glutathione based 
on an ESMS-monitored titration of apo-GlxI (184).  For monometallated E. coli GlxI, this finding 
implies that both apo- and holo- active sites of enzyme can bind inhibitors (and possibly substrates).  
Alternatively, this inhibitor stoichiometry might imply that the mode of E. coli GlxI inhibition 
involves indiscriminate interaction with both active sites. 
 The substrate analog S-{2-[3-(hexyloxy)benzoyl]vinyl}glutathione was solubilized in 100% 
dimethyl sulfoxide (DMSO) and titrated into the holoenzyme preparation as a millimolar 
concentration working stock so as to minimize any detrimental effects of this organic solvent on the 
protein structure.  The overall distribution of peaks in the 1H-15N HSQC NMR spectra during titration 
remains the same indicating that the protein structure is stable in low concentrations of DMSO.  
When Ni2+-GlxI is exposed to S-{2-[3-(hexyloxy)benzoyl]vinyl}glutathione at 1:1 inhibitor to dimer 
in solution, the peak at 15N 106 ppm, 1H 8.96 ppm does not change in chemical shift whereas the peak 
at 15N 108.5 ppm, 1H 9.25 ppm remains stationary (Figure 6.11 B).  These two peaks once again are 
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associated with the backbone amide resonances of the His74 active site residues in the homodimer 
(Figure 6.11).  What is interesting to note about these changes accompanying binding of this 
glutathione analog is that the monometallated enzyme would appear to bind the inhibitor initially at 
the active site that is not metallated, whereas titrating the apoenzyme with Ni2+ results in re-
organization of the enzyme for metal binding at the other end of the dimer.  These inferences are 
based on the H74 resonances identified through 1H-15N HSQC analysis of H74Q GlxI and the 
observation of a differential response of the two H74 to metal binding versus inhibitor binding.  
 
Figure 6.11 A) Overlay of NMR spectrum for wild type Ni
2+
-reconstituted GlxI pre-inhibitor 
(black), after titration to 1:1 inhibitor to dimer (red) and following titration to 2:1 inhibitor to dimer 
(blue). The resonances associated with residues His74 and Trp61 are labelled in the spectrum B) 
Chemical shift perturbations of His74 accompanying inhibitor binding in the following 
inhibitor:dimer ratios: 0:1 (black), 0.5:1 (blue), 1:1 (red) and 2:1(green). C) Chemical shift 
perturbations of Trp61 accompanying inhibitor binding in the following inhibitor:dimer ratios: 0:1 






 These results should be interpreted cautiously as the S-{2-[3-
(hexyloxy)benzoyl]vinyl}glutathione is an inhibitor of GlxI and therefore not a true representation of 
the substrate.  The observed chemical shift changes may actually reflect the inhibitor-induced 
assumption of an inactive E. coli GlxI conformation instead of the substrate-binding conformation. 
However these observations again indicate that there is very little structural reorganization of the 
enzyme that accompanies binding of substrate analogues.   
One aspect of catalysis that cannot be resolved by the 1H-15N HSQC NMR analysis described 
in this chapter is the dynamics of the water molecules observed as metal ligands in crystal structures 
of the resting holoenzyme.  XAS studies of E. coli GlxI in complexes with S-D-lactoylglutathione and 
S-octylglutathione indicate that the incoming substrate/analogue molecule displaces neither active site 
histidine residue (65).  However hydroxamate inhibitor binding to E. coli GlxI results in the 
displacement of both water ligands (65).  XAS shows that inhibitor binding to E. coli GlxI results in 
displacement of an active site Glu residue that could function as a catalytic base (65).  Eventual 
assignment of all peaks in the E. coli GlxI 1H-15N HSQC NMR spectrum should prove useful in 
determining whether any metal coordination changes involving glutamate accompanies the binding of 
incoming substrate/inhibitor. 
6.7 Discussion 
E. coli GlxI is by no means the only metalloprotein in the biochemical literature for which half-of-
the-sites metal binding is relevant to the active holoform.  Porphobilinogen synthase serves as a 
paradigm for this phenomenon.  
 Porphobilinogen synthases (PBGS) are a family of enzymes that catalyze the asymmetric 
condensation of two 5-aminolevulinic acid molecules (185).  This reaction constitutes the first 
common step in tetrapyrrole biosynthesis (185).   
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Like GlxI, PBGS enzymes can be divided into two metal activation classes, specifically 
those requiring Zn2+ for activation and those activated by Mg2+ ions (185).  The native PBGS 
enzymes from human and Drosophila melanogaster are homo-octameric tetramers of dimers (186, 
187). The monomer possesses an α8β8 barrel tertiary structure and the catalytic site is situated at the 
C-terminal regions of the β-strands that converge at the top of the barrel cavity (185, 188).  The 
dimers are assembled so that the N-terminal arm of each monomer wraps along the periphery of the 
adjacent subunit (Figure 6.12).  This configuration is very similar to the positioning of the N-terminal 
arm contact with the opposite monomer in the human GlxI homodimer (185, 188).  The β-barrels in 
the dimer are positioned so that the barrel cavities are oriented at right angles to each other (188).  
Yeast and mammalian PBGS enzymes have two binding sites for the zinc ions (Figure 6.12).  The site 
designated ZnA is not the catalytic site, but a region for binding of a non-essential Zn2+ ion (185).  
The active site Zn2+ binds to a location designated ZnB (Figure 6.12)(185). 
PBGS enzymes from different organisms exhibit different stoichiometries of catalytic Zn2+-
binding. For example human PBGS has only four active sites per octamer that are Zn2+-occupied 
whereas the yeast enzyme has full occupancy of all eight catalytic sites per octamer (186).  The D. 
melanogaster PBGS (DmPBGS) has been investigated in depth concerning Zn2+-binding and is the 
only PBGS for which half-of-the-sites metal binding has been described in detail (189).   
Maximal activity of DmPBGS is observed at a pH of 8 when the purified enzyme is assayed 
without addition of exogenous metal ions (189).  This active octamer possesses 0.5 - 0.7 Zn atoms per 
subunit (monomer) (189).  The addition of ZnCl2 at 10 mM concentration significantly decreases 
activity and the metal occupancy in this case is 1.5 Zn atoms per subunit (189).  This implies that 
inhibitory Zn atoms bind to DmPBGS with the stoichiometry of one atom per monomer (189). The 
dissociation constant for Zn2+ at the inhibitory site is ~ 5 mM which is comparable to the Kd for ZnA 
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metal ions in mammalian PBGS (189).  Therefore the inhibitory binding site in DmPBGS might be 
analogous to ZnA sites in PBGS from other sources (189).  The removal of catalytic Zn2+ from 
DmPBGS requires more of the chelator o-phenanthroline in the presence of the substrate 5-
aminolevulinic acid (ALA) than when ALA is absent, indicating that the substrate may engage in 
coordination of the active site metal (189).  
Potential sites for Zn2+ binding on DmPBGS have been identified using a homology model 
for the enzyme based on the structure of yeast PBGS (Figure 6.12) (188, 189).  The active site Zn2+ 
ion is coordinated by three Cys residues, which are 120, 122, and 130 (189).  The residues that 
correspond to the ZnA site of yeast and mammalian PBGS are Cys219 and His10 (Figure 6.12) (189).  
These two residues are situated on different monomers of the dimeric subunit.  Cys219 is located on 
the N-terminal arm that forms the lid over the active site of its parent monomer (189).  Ligation to a 
second Zn atom would depend on whether the lid was open or closed, with the closed configuration 





     
Figure 6.12: A) Structure of human PBGS dimer (PDB ID: 1E51) showing ZnB site and residues 
for non-essential Zn atom binding (ZnA site) B) Structure of yeast PBGS monomer (PDB ID: 1H7P) 
showing the mobile lid region (black) and the ligands associated with non-essential Zn atom binding 
(ZnA site) 
 
If the second site contains Zn, then the enzyme inhibition will occur because the active site is 
closed off to incoming substrate (189).  Mutation of His10 to Phe generates a DmPBGS variant that is 
not inhibited by exposure to Zn2+ ions, indicating that the non-catalytic metal site reduces enzyme 
activity (189).  The variant binds the inhibitory Zn2+ ion with the stoichiometry of 0.5 atoms per 
monomer.  Because Cys219 is part of the ZnA site (non-essential but non-inhibitory) there cannot be 
simultaneous Zn occupancy of this site as well as the inhibitory metal site (189).  The data indicates 
that there are three sites for Zn binding on DmPBGS; the catalytic site, the ZnA site and an inhibitory 
site.  Kundrat et al. have postulated that each of the Zn binding sites on DmPBGS exhibit half-of-the-




Zn2+-bound.  Different crystal structures of yeast PBGS reveal that the N-terminal arm which forms 
the active site lid can be found in dissimilar positions that influence whether the ZnA or inhibitory 
metal sites are available for binding (189). 
 One model that Kundrat et al. proposed is that Cys 219 coordinates the Zn atom in the 
inhibitory site as well as the ZnA site, but the site containing the metal is dependent upon the lid 
position (open versus closed).  A closed lid would facilitate Zn2+ binding at the inhibitory site with 
His10 and Cys219 as ligands.  The open lid conformation allows metal occupancy at ZnA where the 
ligands would be Cys219 and His129.  The experimental data implies that the DmPBGS octamer can 
have Zn simultaneously bound to ZnA and the inhibitory site, so half of the lids must be open while 
the other half are closed (189).   
A “reciprocating motion model” for conformational change during DmPBGS’s catalytic cycle 
can account for the alternating occupancy of ZnA and inhibitory sites in each monomer (189). This 
model provides an explanation for half-of-the-sites metal binding and half-of-the-sites reactivity that 
has been observed in PBGS enzymes.  Crystallography on PBGS has shown product molecules bound 
to only half of the active sites (189). Other studies have shown that product release from PBGS 
requires the binding of substrate in an adjacent monomer, so that the lid closure over incoming 
product is a reciprocal motion in the protein that facilitates lid opening in the porphobilinogen-
containing active site (189).  This mechanistic evidence for a reciprocal catalytic cycle in the enzyme 
may correlate to a model of reciprocating subunit metallation in PBGS enzymes. 
The GlxI dimer does not undergo significant conformational changes when the substrate 
analogue binds to the enzyme.  The lack of evidence for large domain motions provides little support 
for the possibility that GlxI has a reciprocal motion component in its catalytic cycle.  The half-of-the-
sites metal occupancy is not uniform amongst GlxI enzymes, since human and yeast GlxI have two 
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Zn atoms per dimer, whereas the E. coli GlxI has only one (51, 147, 190).  Active site mutagenesis 
studies on P. falciparum GlxI indicate that this di-metallated enzyme has two functioning catalytic 
sites that may exhibit cooperativity for substrate binding and turnover (8).   
Whether E. coli GlxI has half-of-the-sites reactivity in parallel with its metal content still 
needs to be determined.  One possible approach is to perform ITC analysis on Ni2+-substituted E. coli 
GlxI with a micromolar potency inhibitor such as S-{2-[3-(hexyloxy)benzoyl]vinyl}glutathione.  The 
isotherm can be used to enumerate the number of inhibitor molecules bound, which in turn can 
indicate the number of substrate-receptive active sites.  A serious limitation to this approach is that 
this inhibitor may bind to both active sites as a means of inhibiting catalysis.  Also the data would 
have to be interpreted with caution, as inhibitors are not truly representative of the normal substrate.  
Another experimental approach to investigate half-of-the-sites reactivity in E. coli GlxI would be to 
create an active fused dimer by site-directed mutagenesis.  The active sites in a monomeric E. coli 
GlxI can be probed for metal occupancy and activity by selectively mutagenizing one active site or 
the other.  This approach would be similar to that used by Deponte et al. in their investigation of P. 
falciparum GlxI (8).  The availability of a fused-dimer variant would also allow the kinetics of each 
active site to be determined by amino-acid replacement to inactive one site versus another.  
 The work presented in this chapter describes convincing biophysical evidence in favor of 
half-of-the-sites binding of metal (Ni2+) in E. coli GlxI.  This data indicates that full occupancy of 
both active sites does not occur readily in solution as observed in the E. coli holo-GlxI crystal 
structures (Ni2+, Cd2+, Co2+ and Zn2+ substituted) (52).  The E. coli GlxI backbone resonances from 
1H-15N HSQC NMR do not indicate major domain motions that accompany metal binding, but rather 
subtle reorientations of small, discrete regions of the protein.  This is in keeping with the crystal 
structure data, indicating that the overall structural configuration of the of the apo- and holoforms of 
E. coli GlxI are conserved regardless of the metal content (52).   
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Another key experiment awaiting completion is the incremental titration of E. coli GlxI with 
Zn2+ ions.  Since the Zn2+-substituted E. coli GlxI is an inactive holoform, there must be a structural 
reason for why this metal does not confer catalytic activity in the enzyme.  A Zn2+-titration monitored 
by 1H 15N HSQC NMR on labelled E. coli apo-GlxI, a comparison of Zn2+-induced resonance shifts 
Ni2+-induced changes can be made.  Any differences in the peak shifts comparing the Ni2+ and Zn2+ 
titrations will permit identification of any different re-organizations in the GlxI polypeptide that are 
specific to binding of a certain type of metal ion.  This experiment would therefore be designed to 
assess whether the second sphere metal environment in E. coli GlxI differs depending on whether 
Ni2+ or Zn2+- is bound.  The second sphere ligands are the amino acids that have hydrogen bonding 
interaction with the primary metal ligands in the protein.  These residues may be influential in 
positioning the active site ligands, and optimizing the site for one activating metal ion versus another. 
The data obtained from this additional titration would be a seminal contribution to the literature on 
GlxI because it would constitute the first potential explanation for control of metal selectivity in E. 
coli GlxI.        
Subsequent investigation of this phenomenon should also involve identification of residues at 
sites where the polypeptide backbone undergoes reconfiguration in relation to the metal ion.  The 
residues subject to re-orientation during apoenzyme to holoenzyme conversion would be indicative of 
the “second sphere” metal ligands in the enzyme.  It is likely that the extended coordination network 
identified by NMR methods will consist of residues that are influential structural determinants of 




The data presented in this dissertation encompasses structure-function, protein-protein interaction and 
comparative biochemical studies of Glx system enzymes in the Honek laboratory.  Characterization 
of the E. coli GlxII has provided information about overall metal selectivity in the GlxI system as a 
whole. E. coli GlxII is conserved for metal activation and contains the conserved metal-binding 
residues present in previously characterized orthologous GlxII enzymes.  This finding clarifies that 
the Ni2+/Co2+ activation of E. coli GlxI is not mirrored in the metal selectivity of GlxII, so that the 
metal activation of the hydrolase is well conserved across phylogenetic divisions.   
The biochemical investigation of P. aeruginosa GlxI enzymes is an extension of previous 
comparative studies with enzyme from different bacterial sources.  This investigation was significant 
for confirming that all three GlxI homologs encoded in the PAO1 genome were for active MG-GSH 
isomerizing enzymes but with differing metal activation properties.  The reason for the presence of 
three GlxI enzymes in P. aeruginosa remains as yet unknown. 
The in vivo metal center assembly of E. coli GlxI was investigated for its potential 
dependence on the Ni2+-metallochaperone SlyD.  The previously described characterization indicates 
no detectable correlation between the amount of GlxI activity in E. coli and the presence/absence of 
the slyD gene in the organism. This indicates that there is likely no Ni2+ release from SlyD to GlxI in 
during cytosolic formation of active holoenzyme. Therefore further research is necessary to determine 
whether E. coli GlxI requires metallochaperones in vivo. 
The HSQC-NMR analysis of E. coli GlxI from the apo- to holoenzyme (Ni2+-
substituted) form is a continuation of previous biophysical studies on the nature of metal binding in 
this model protein.  The observation of maximal structural perturbation with only one equivalent Ni2+ 
per dimer converges with other data implying half-of-the-sites metal binding in this GlxI (51, 60).  
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The investigations described in this dissertation add to the general understanding of the metal 
selectivity within the Glx system. If the metal selectivities differ between the GlxI and GlxII enzymes 
within a single organism, there should be different mechanisms for regulating their production on the 
basis of metal availability. This adds to the complexity of regulating the activity of the Glx system in 
vivo.  Future investigations of the Glx system activity in situ should reveal how rates of MG 
production and metal availability contribute to regulating expression of both detoxification enzymes 
(i.e. GlxI and GlxII). Further developments in understanding Ni2+-homeostasis in E. coli will allow 
additional studies of metal delivery to GlxI in vitro and in vivo. 
The mechanistic and structural studies of E. coli GlxI described in this work are meaningful 
contributions to the field of metalloenzyme biochemistry. These studies provide a foundation to 
further investigate the nature of metal selectivity in GlxI as the mechanistic attributes of the Zn2+- and 
non-Zn2+-activated enzymes are similar. The half-of-the-sites metal binding exhibited by E. coli GlxI 
constitutes an excellent system for studying the relationship what asymmetries are present in an 
apparent homodimer and how they contribute to differences between catalytic sites.  The biochemical 
properties of E. coli GlxI provides an important example of how enzyme activities can be conserved 
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